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Abstract:  A plethora of data has been collected documenting the need for assistive 
technology. There is little information however about the efficacy, distribution, and 
impact of assistive technology. Three related studies investigating demographic, cost, and 
health related quality of life (HRQoL) factors of the provision of wheelchairs and 
scooters were completed. The first investigated demographic and clinical differences. The 
second investigated differences in wheelchair costs among Veteran Integrated Service 
Networks (VISNS) and vendors. The third investigated the relationship between 
wheelchairs provided by the Veterans Health Administration (VHA) and HRQoL. Using 
a cross-sectional, retrospective study design, three years of data from VHA National 
Prosthetic Patient and National Patient Care yielding 191,324 observations. Databases, 
and one year of data from the SF-36V of the Veterans Health Study were merged. 
Descriptive statistics, t-test, chi-square, ANCOVA, ANOVA, and logistic regression 
were used to analyze the data. The first study found more evidence for differences 
between Hispanics and Caucasians than between African Americans and Caucasians. 
When comparing manual wheelchairs, Hispanics (Odds Ratio=1.7), African Americans 
(Odds Ratio =1.1), and American Indians & Asians (Odds Ratio =1.6) were more likely 
than Caucasians to receive depot wheelchairs, and Hispanics were more likely than 
Caucasians to receive ultralight chairs (Odds Ratio=1.8).  When comparing power 
wheelchairs Hispanics (Odds Ratio=1.6) were more likely than Caucasians to receive 
iv 
custom power chairs. Older veterans were more likely to receive standard depot 
wheelchairs (p=<.0001) and younger veterans ultralight wheelchairs (p=<.0001). The 
most frequently prescribed wheelchairs for all diagnoses were the standard manual 
wheelchair (51%), the lightweight manual wheelchair (15%), and the scooter (14%). The 
second study found variation in cost by VISN and by vendor. During FY00 and FY01, of 
the $109 million spent by the VHA to provide over 131,000 wheelchairs and scooters, 
7%, or $7,747,405 was considered excessive cost. The third study found veterans who 
received adjustable, ultralight manual wheelchairs had significantly lower physical 
function scores, as measured by the SF-36V, and significantly higher mental function, 
general health, and mental component summary scores than veterans who received 
nonadjustable, standard manual chairs, when adjusting for clinical and demographic 
factors.  
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1 CHAPTER ONE 
1.1  INRODUCTION 
Too many Americans with disabilities remain outside the economic and social 
mainstream, lacking the necessary tools and access for full participation in society [1, 2].  
Fortunately, individuals with disabilities are demanding to be treated as competent 
citizens, with their capabilities recognized, and their civil rights fulfilled (Susan 
McDaniels, PhD, former Deputy Commissioner for Disability and Income Security, oral 
communication, December, 2001). The Disability Rights Movement, the most recent civil 
rights initiative, views disability as a product of interaction between humans and their 
surroundings, shifting the emphasis from the individual with an impairment to the 
broader, social, cultural, economic, and political environments. Implied is that disability 
stems from the failure of a structured social environment to adjust to the needs and 
aspirations of individuals with impairments, rather than from the inability of individuals 
with disabilities to adapt to the demands of society [3]. 
The Disability Rights Movement, spawned in the 1970s, has chipped away at the 
stigma with which society views individuals with disabilities [4, 5], resulting in change in 
societal attitudes. Advent of the microcomputer chip during the 1970s has also elicited 
change. Advances in technology are providing new options for individuals with 
disabilities as well as making environments more accessible. Technology designed to be 
utilized in assistive technology devices or services is referred to as assistive technology 
(AT) [6].  
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“The term assistive technology (AT) means technology designed 
to be utilized in an assistive technology device or assistive 
technology service. The term AT device means any item, piece of 
equipment, or product system, whether acquired commercially, 
modified, or customized, that is used to increase, maintain, or 
improve functional capabilities of individuals with disabilities. 
The term AT service means any service that directly assists an 
individual with a disability in the selection, acquisition, or use of 
an assistive technology device. The term universal design means 
a concept or philosophy for designing and delivering products 
and services that are usable by people with the widest possible 
range of functional capabilities, which include products and 
services that are directly usable (without requiring assistive 
technologies) and products and services that are made usable 
with assistive technologies” [6]. 
AT can range from simple, low technological devices such as reachers to highly 
technical electronic equipment such augmentative and alternative communication devices 
and specialized power wheelchairs. As the terms would imply, low technologies do not 
require mobilization of many financial and human resources. These devices tend to be 
less expensive, simple to make, and easy to obtain. Low technology solutions can be 
implemented faster, are easier to learn, and usually more cost effective. Examples of low 
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technology include communication boards, raised toilet seats, bath benches, rocker 
knives, letter boards, hand signals, eye signals, lip reading, and eye blink charts [7-9]. 
High technologies evolved from biomedical and rehabilitation engineering. These 
technologies require major capitol investments and mobilization of greater human, 
physical, and administrative resources. High technology devices are often expensive, 
require commercial manufacturing, and are harder to obtain [7]. Because high technology 
devices are mediated by electronic circuits and microprocessors, they may not always be 
under the direct control of the user. They tend to be more difficult to learn how to use, 
require configuration, and usually need to be sent away for repairs. Examples of high 
technology include environmental control units, cochlear implants, on-screen keyboards, 
text-to-speech software, voice synthesizers [9, 10], alternative and augmentative 
communication devices [11, 12], and power stair climbing wheelchairs [13]. 
The focus of this dissertation research is on just one aspect of AT, wheeled 
mobility devices, specifically wheelchairs and scooters. The wheel and chair were man’s 
two earliest inventions, dating back to 4000B.C. [14]. Paintings of Philip II of Spain are 
perhaps the earliest graphic representations of a wheelchair. The wheelchair used by 
Philip II, who had gout, was built by Jehan L. Hermite, who wrote in his memoirs 
“Though it was but of wood, leather, and ordinary iron [it] was worth ten times its weight 
in gold and silver for his Majesty’s comfort” [15]. 
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In 1919, a mining engineer, Herbert A. Everest, broke his back in a mining 
accident, losing the use of his legs. Dissatisfied 
with his large, wooden chair, and wanting one that 
could be stowed in an automobile, Everest, with the 
help of a friend, Harry Jennings, a mechanical 
engineer, created and patented a wheelchair that 
was easily transported and practical to use (Figure 
2) [16, 17].  
This sling upholstery, chrome plated, steel 
folding X-frame design is still in use today (Figure 1). 
 
 
A 1924 advertisement for an “electric 
wheelchair for invalids with all the luxuries of an auto” 
[18] resembles the scooters of today (Figure 3). 
 
 “Chairs with wheels” have been used for 
centuries to provide mobility for 
individuals for whom the task of 
walking is difficult or impossible, 
due to impairments of their lower 
extremities. Not only have 
wheelchairs provided mobility, they 
 
Figure 1  Everest and Jennings 
Wheelchair 
 
Figure 2  Everest and 
Jennings Patent 
Figure 3  Early Scooter 
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have made the physical environment more accessible. 
Advances in technology have produced devices that 
function indoors, outdoors, can climb curbs, and 
elevate to a standing position (Figure 4). Modern 
wheelchairs are light enough to be folded and lifted into 
a vehicle by the user, and can be used for sports such as 
basketball and rugby. In turn, theaters, buses, schools, 
and places of employment are increasingly more able to 
accommodate these more versatile wheelchairs. 
Providing mobility and alleviating physical 
barriers are obvious benefits of wheeled mobility use. 
Less obvious are the contributions wheelchair and scooter designs have contributed to 
framing the concept of universal design and alleviating stigma. The curb cut was 
designed to increase accessibility for wheelchair users. Soon bicyclists and people with 
strollers, shopping carts, or rolling luggage began using the curb cuts as well. Sidewalks 
with curb cuts were simply better sidewalks for everyone [19]. The curb cut concept has 
since been extended to the “Electronic Curb-Cut Effect" [19], a metaphor for electronic 
accessibility mandated by the Section 508 addendum to the Rehabilitations Act [20], and 
curb cut learning, a barrier free design approach to distant learning [21]. The term 
universal design, coined by Ronald L Mace in 1988, is defined as “the design of products 
and environments to be usable by all people, to the greatest extent possible, without the 
need for adaptation or specialized design” [22]. The goal of universal design is to 
integrate people with disabilities into the mainstream, whereas AT is more directed at 
 
 
Figure 4  Wheelchair with 
seat elevation 
option 
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meeting the specific needs of individuals [22]. What universal design and AT have in 
common is they both reduce the physical and attitudinal barriers between people with and 
without disabilities.  
In addition to providing mobility and environmental access, advances in wheeled 
mobility technology and design have contributed decreasing the stigma associated with 
wheelchair use. Three-wheeled scooters, more socially acceptable than wheelchairs, are 
now widely used by senior citizens. As wheeled mobility devices are increasingly more 
visible and customary, a cycle is created where non-disabled individuals become more 
accustomed to interacting with individuals who use wheeled mobility devices. This 
interaction in turn increases environmental accommodation and access, which further 
increases visibility. 
Concurrently with the increasing demand for wheeled mobility, is tightening of 
the purse strings to control health care costs that have soared since the implementation of 
Medicare in the 1960s. In addition, policy has not been adequately updated to 
systematically determine who should get which and how many wheeled mobility devices 
[23]. The purpose of this research was to investigate the outcomes of the wheelchair 
provision process: how many wheeled mobility devices are being provided? To whom? 
And at what cost?  The long-range goal of this research topic is to measure the impact of 
these “chairs with wheels” documented pictorially, anecdotally, and by “self-evident 
benefits” [24] through the centuries.  
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This dissertation is comprised of three related studies:  
• Demographic Characteristics of Veterans Receiving Wheelchairs and 
Scooters from the Veterans Health Administration 
• Veterans Health Administration Costs in Providing Wheeled Mobility 
Devices 
•  Relationship Between Type of 
Wheelchair and Health Related 
Quality of Life.  
The research design for all three studies 
was retrospective and spanned the Federal fiscal 
years 1999, 2000, 2001.  Three Veterans Health 
Administration (VHA) databases [25], the 
National Prosthetic Patient Database (NPPD), the 
National Patient Care Database (NPCD), and the SF-36V of the Veterans Health Study 
(VHS) [26], were merged to investigate the demographic characteristics of veterans who 
received wheelchairs and scooters from the VHA, the 
cost incurred by the VHA for these devices, and the 
relationship between health related quality of life 
(HRQoL) and receipt of a wheeled mobility device 
from the VHA.  
The primary database was the NPPD 
developed by the VHA Prosthetic and Sensory Aids 
Service (PSAS) [25, 27] to monitor the provision of 
 
Figure 5  Depot wheelchair 
.  
Figure 6  Ultra light 
wheelchair 
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orthotic, prosthetic, and sensory devices to eligible veterans. Records of veterans who 
received wheelchairs and scooters from the VHA during the study years were extracted 
from the NPPD. This NPPD data was then merged, by scrambled patient identification 
numbers, with the NPCD and the SF-36V data of the VHS to obtain demographic, 
clinical, and HRQoL information on veterans who received wheelchairs and/or scooters 
from the VHA during FY99, FY00, and FY01. This data set comprised the sample for 
this study. 
Prior studies of the relationship between demographics and AT, including 
wheelchair use [28-30], have looked at whether the individual used a wheelchair, with no 
differentiation made between types of wheelchair, i.e. manual versus power. Other 
studies have compared the durability of types of wheelchairs, i.e. depot, (Figure5) 
lightweight, ultralight, (Figure 6) and power wheelchairs [31-35]. Only one study [36], in 
press, was found that compared type of wheelchair with demographic, and no studies 
were found that compared type of wheelchair with cost or HRQoL. The first study 
categorized wheelchairs into eight types: four types of manual wheelchairs, three types of 
power wheelchairs and scooters (Table 1). These categories comprised the dependent 
variable (DV) for the analysis of all but one of the hypotheses in this dissertation research 
(type of wheelchair was the independent variable (IV) in the first HRQoL hypothesis). 
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1.3.1  Demographic Characteristics of Veterans Receiving Wheelchairs and     
Scooters from the Veterans Health Administration  
Use of AT has increased dramatically over the past two decades. Influencing 
factors include the aging of the population, advances in technology, public policy 
initiatives, and changes in the delivery and financing of health care [37, 38]. In fact, use 
of AT has increased while reliance on personal assistance by individuals with disabilities 
has decreased [39]. For example, use of power mobility has been shown to increase 
individual’s ability to fulfill life roles [40]. During the 10 year period from 1990 to 2000, 
individuals with disabilities have become more aware of AT and how AT can affect 
independence, productivity, and community integration [41]. AT has been shown to 
decrease the rate of functional decline of elders [42] and elicit improvement in function 
of individuals with developmental disabilities [43].  
Table 1   Operational definitions: wheelchair type 
Code Type of 
Wheelchair 
Description 
K0001 = manual wc 
depot  
> 36 lbs, non-adjustable; “depot”  wheelchair 
K0002 = manual wc 
hemiplegia  
> 36 lbs, non-adjustable, lower seat only; depot wheelchair 
K0003 =  manual wc 
lightweight  
 
 
 
M1 
 < 36 lbs, non-adjustable; lightweight, depot wheelchair 
K0004 =  manual wc 
lightweight  
 
M2 
<34 lbs., adjustable seat/back height, some adjustment in 
axle; high strength, lightweight; rehabilitation wheelchair 
K0005 =  manual wc 
ultralight  
 
M3 
< 30 lbs., adjustable seat/back height/axle/camber; ultralight 
wheelchair 
K0006-7 =  manual wc 
heavy duty  
K0009 =  manual wc  
other 
 
 
M4 
 
Miscellaneous manual wheelchairs 
 
K0010 =  power  wc  
P1 
non-adjustable, seat height only, standard weight non-
programmable controls 
K0011 =  power  wc 
K0012 =  power  wc 
 
P2 
Miscellaneous power wheelchairs 
K0014 =  power  wc 
 
P3 custom power  wheelchairs, other motorized wheelchair base 
 
E1230 = scooter S1 scooter 
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The prevalence of mobility limitations has risen by over 10 million in 10 years 
[44]. Of the 49.7 million people identified by the 2000 U.S. census as having a disability, 
approximately 18 million reported mobility limitations, and 2.2 million reported using a 
wheelchair [45]. More people use AT to compensate for mobility impairment, i.e. 
wheeled mobility devices, than any other general type of impairment [38, 46].  
As the availability of and demand for wheeled mobility devices increases, two 
factors emerge: policy must be put in place to allocate the devices, and clinicians must be 
kept abreast of this rapidly changing field if they are to meet the needs of their clients and 
the fiscal scrutiny of their employers. The NPPD offers a unique opportunity to study 
wheeled mobility outcomes. Only one published study of the NPPD [47] was found, a 
study comparing VHA and Medicare AT expenditures. Thus the purpose of the first study 
of this dissertation research was to examine demographic and clinical outcomes of the 
provision of wheeled mobility devices provided by the VHA. 
This study had two objectives. The first was to provide a description of NPPD 
data, asking questions such as how many wheeled mobility devices were provided and 
what were the most frequent diagnoses and demographic and clinical characteristics of 
the veterans who received these devices. The second objective introduced the concept of 
wheelchair type and tested the significance of differences in demographic and clinical 
characteristics in relation to type of wheelchair provided. The IVs for this study were the 
demographic variables (age, gender, and race/ethnicity) controlling for diagnosis and 
number of comorbidities. The significance of this study was to provide demographic and 
clinical outcomes information on the provision of wheeled mobility devices by the VHA 
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for the purposes of improving the consistency in and quality of care of veterans, and to 
assist in developing PSAS policy guidelines. 
1.3.2  Cost of Wheeled Mobility Devices to the Veterans Health Administration  
The next step in this dissertation research was to look at the cost of providing 
wheeled mobility devices. A VHA preliminary report on the top total dollar cost 
prosthetic items (Fred Downs, Chief Consultant, PSAS, written communication, 
December, 2000) indicated for the first three quarters of 2000, scooters were the second 
highest spending total, manual wheelchairs the third highest spending total, and power 
wheelchairs the fifth, (oxygen equipment was the first). For these three quarters, over 
40,000 wheelchairs (manual wheelchairs, power wheelchairs, and scooters), were 
provided at a government cost of over 20 million dollars. Similarly, wheelchairs are the 
most frequently reimbursed durable medical equipment (DME) by Medicare [48, 49]. 
Render et. al concluded that the VHA spends less providing prosthetic devices than 
Medicare [47], possibly because the VHA purchases and dispenses the devices. Yet, the 
VHA is seeking to improve their provision system [27], (Fred Downs, Chief Consultant, 
PSAS, written communication, January and December, 2000) to reduce cost and improve 
the quality of care provided to veterans. In addition, cost outcomes data can help identify 
opportunities for consolidated contracting of wheeled mobility devices. 
The second study also had two objectives. The first was to examine cost 
differences among regional areas; the IV was geographical area as defined by the Veteran 
Integrated Service Network (VISN) [50]. The second objective was to determine whether 
variance in wheelchair and scooter cost by vendor exists; the IV was vendor. The VISN 
and vendor analyses were done for each wheelchair, using Health Care Common 
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Procedure Coding System (HCPCS) codes rather than by wheelchair type categories. In 
order to be reimbursed by Medicare, the VHA, and most other insurers, wheelchairs ands 
scooters sold in the U.S. must be approved as devices by the U.S. Food and Drug 
Administration (FDA) [51]. The FDA then forwards application information to the 
Center for Medicare and Medicaid HCPCS code, developed for reimbursement purposes. 
The NPPD also uses HCPCS codes, as a means of tracking wheelchairs. Thus the 
significance of this study was to determine whether variance in cost exists regionally or 
by vendor, and if so to identify and describe high cost outliers by VISN and by vendor, as 
a method of assessing the efficiency of the VHA system of providing wheeled mobility 
devices.   
1.3.3  Relationship Between Type of Wheelchair and Health Related Quality of Life  
The NPPD is an administrative database. One of the limitations of administrative 
databases is they do not provide patient specific outcomes [52]. The third study in this 
dissertation research linked NPPD administrative data with patient specific HRQoL VHS 
data. The significance of this study was to lay a foundation for future studies quantifying 
the impact of the “chairs with wheels” that have only thus far been documented 
pictorially, anecdotally, and with self-evidence [24] (the long-range goal of this research). 
The benefits of AT have eluded researchers for years [53, 54]. While AT 
outcomes are important “to facilitate marketing decisions, enhance accountability, and 
not least of all, augment our knowledge base”[24], there is a paucity of appropriate 
outcome measures [24, 53, 54]. AT outcomes research is needed to provide information 
for consumers, to establish a cost-benefit ratio, to provide reliable and valid measurement 
instruments, and increase the understanding of device abandonment [55]. Wheeled 
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mobility devices are of the few AT devices that have to provide a benefit before they will 
be reimbursed [24, 51]. 
Three national research centers have been established to increase the 
understanding of the effect of AT [56]. In 1991, the National Institute on Disability and 
Rehabilitation Research (NIDRR) funded two 5-year projects to advance AT outcomes 
measurement [55, 57], and the Office of Special Education Programs funded the National 
Assistive Technology Institute [58], targeting the school-age population. Within the 
VHA, the lack of functional outcomes has been reported by the Chief Consultant of the 
PSAS (Fred Downs, Chief Consultant, PSAS, written communication, December, 2000). 
 The third study merged the NPPD with the SF-36V data from the Veterans 
Health Study (VHS) [26, 59] to investigate the relationship between wheeled mobility 
devices and veteran specific health related quality of life (HRQoL). The SF-36V is a 
patient-derived measure of health status consisting of eight scales and two summary 
scores [59-61] used to characterize the case-mix of the VHA clientele as a baseline for 
future studies. 
This study also had two objectives. The first was to investigate the effect of 
adjustability of wheelchairs on social participation; type of wheelchair was the IV and 
social participation the DV. The second objective was to investigate whether health need 
(HN), as measured by the SF-36V, predicted the type of wheelchair prescribed; HN was 
the IV and type of wheelchair the DV. The most elusive (in interpretation of data) of the 
three studies, due to the complexity of relating assistive technology outcomes to 
individuals with disabilities [24, 53, 54], this study would provide at least pilot data for 
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furthers studies on the impact of wheeled mobility devices on the individual lives of the 
users. 
Separate analyses were performed for manual and for power wheelchairs for 
analysis of all hypotheses. An alpha level of 0.05 was used to determine significance 
when testing the hypothesis. An alpha level of 0.10 was used when comparing groups for 
baseline differences during univariate analyses. SAS® Version 8.2 was used for all 
analyses. The appendices of this dissertation contain the SAS® programs written to 
analyze the data. A table of abbreviations used in this study is provided (Table 2). 
Table 2   Abbreviations/acronyms:  
Abbreviation Description 
AAC Austin Automation Center 
ADL Activities of daily living, i.e. dressing, bathing 
ALS Amyotrophic lateral sclerosis 
AT Assistive technology 
ATDS Assistive technology devices 
ATS Assistive technology specialist 
BP Bodily Pain (SF-36V) 
COPD/CHF Chronic obstructive pulmonary disorder/chronic heart failure 
CMS Center for Medicare and Medicaid Services 
CV Confounding variable 
DV Dependent variable 
DME Durable Medical Equipment 
FBI Federal Bureau of Investigation 
FDA Food and Drug Administration 
FIM Functional Independence Measure 
FSOD Functional Status Outcomes Database 
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Table 2   Abbreviations/acronyms:  
Abbreviation Description 
FY Fiscal year 
GH General health (SF-36V) 
HCPCS Healthcare common procedure coding system 
HS Health status 
HIPAA Health Insurance Portability and Accountability Act of 1996 
HRQoL Health related quality of life 
ICD-9 International classification of disease-revision 9 
ICF International classification of function 
IV Independent variable 
MCS Mental Component Summary Score of SF-36V 
MH Mental health (SF-36V) 
MOS Medical outcome study 
MS Multiple sclerosis 
NHIS-D National Health Interview Survey on Disability 
NPCD National Patient Care Database 
NPPD National Prosthetics Patient Database 
NSC/IP Service connected, inpatient 
NSC/OP Service connected, outpatient 
NLTCS National Long Term Care Survey 
OR Odds ratio 
PCS Physical Component Summary Score of SF-36V 
PD Parkinson disease 
PH Physical health (SF-36V) 
POW Prisoner of war 
PSAS Prosthetics and Sensory Aids Services 
RE Role limitation due to physical problems (SF-36V) 
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Table 2   Abbreviations/acronyms:  
Abbreviation Description 
RESNA Rehabilitation Engineering & Assistive Technology Society of North America 
RP Role limitation due to emotional problems (SF-36V) 
SCI Spinal cord injury 
SCIP Spinal cord injury-paraplegia 
SC/IP Service connected, inpatient 
SCIT Spinal cord injury-tetraplegia 
SC/OP Service connected, outpatient 
SF Social functioning (SF-36V) 
SF-36V Short form 36 item health survey for veterans 
TBI Traumatic brain injury 
VACO Veterans Administration Central Offices 
VAMC Veterans Affairs Medical Center, facility 
VHA (VA) Veterans Health Administration 
VHS Veterans Health Study 
VISN Veterans Integrated Service Network 
VIReC VA Information Resource Center 
VT Vitality (SF-36V) 
WHO World Health Organization 
WMD Wheeled mobility device, i.e. wheelchair or scooter 
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2.1  Abstract 
The purpose of this study was to characterize veterans who received wheelchairs and 
scooters from the Veterans Health Administration (VHA) and to determine if differences 
in the provision of wheelchairs, based on gender, race/ethnicity, diagnosis, and age, exist. 
Using a retrospective study design, three years of data from two VHA databases, the 
National Prosthetic Patient Database (NPPD) and the National Patient Care Database 
(NPCD) were merged yielding of over 77,000 observations per fiscal year. Wheelchairs 
and scooters were categorized into eight types based on function, adjustability and 
Medicare codes. Descriptive statistics were used to characterize veteran participants. Chi-
square and ANOVA univariate analyses and logistic regression were used to quantify the 
association between provision of wheeled mobility devices and age, gender, and 
race/ethnicity, controlling for diagnosis and number of comorbidities. Differences were 
more evident between Hispanics and Caucasians than between African Americans and 
Caucasians. The results indicated Hispanics (Odds Ratio=1.9), African Americans (Odds 
Ratio=1.4), Asians and American Indians (Odds Ratio=1.6) were more likely than 
Caucasians to receive standard wheelchairs.  Hispanics (Odds Ratio=0.8) and African 
Americans (Odds Ratio=0.9) were less likely than Caucasians to receive power 
wheelchairs.  Hispanics (Odds Ratio=0.4), African Americans (Odds Ratio=0.7), Asians 
and American Indians (Odds Ratio=0.4) were less likely than Caucasians to receive 
scooters.  The most frequently prescribed manual wheelchair was the standard, depot 
wheelchair (66%) compared to the ultralight wheelchair (4%), and the lightweight 
rehabilitation wheelchair 20% 
2.2  Introduction
 
Though data on disability and assistive technology devices (ATDS) has been 
gathered [1-3] from the National Health Interview Survey on Disability (NHIS-D), the 
National Long Term Care Survey (NLTCS) [4], and other studies [5, 6], there remains a 
paucity of in depth information on how many devices are provided, by whom, and to 
whom. As of September of 2002, there were over 25 million veterans [7]; more than two 
million (8%) of these veterans have been classified by the Veterans Health 
Administration (VHA) as having a disability [7]. Approximately 15% of the veteran 
population receives their health care from the VHA [7]. No published information on 
how many veterans use wheelchairs and scooters is currently available. The National 
Patient Prosthetics Database (NPPD), designed to collect data on the provision of 
wheeled mobility devices in order to improve the quality of care for veterans [8, 9], was 
implemented in 1997 and made available to researchers in 1999.  
Little is known about the decision process in which clinicians engage when 
prescribing a wheeled mobility device. Equally unknown is the outcome of this decision 
process, i.e. how many devices are being prescribed and to whom? how often? at what 
cost? While several studies have found demographic variance in the provision of ATDS 
(including wheelchairs) in the non-veteran population [2, 5, 10, 11], no studies were 
found that addressed the provision of wheelchairs or the even broader topic of assistive 
technology (AT) in general within the veteran population. 
Several studies have examined the relationship between the use of AT and age, 
gender, race, chronic disease, income, and/or education in the non-veteran population. 
The majority of persons using ATDS are over 65 years of age [10]. UsiUsing NHIS-D data,
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Kaye et al.[2] found more women (58.8%) use wheeled mobility devices than men. 
Tomika et al. [5] found African American elderly, when compared to Caucasian elderly, 
used significantly less ATDS designed for vision impairment, with no significant 
difference in the use of mobility devices. In the same study, Tomika et al. found living 
alone and a higher number of illnesses predicted AT use for African American elders, 
whereas higher cognitive status, higher income, increased disability, and age (for every 
10 years of aging, elders used 2.64 less devices, mean age ~ 73) predicted ATD use for 
Caucasian elders. Using data from the Canadian Aging Research Network collected in 
1991-1992 (with questions similar to the U.S. 1984 NHIS study) Zimmer and colleagues 
[6] found rural, older elders (mean age=78) with more chronic conditions and more 
mobility difficulties tended to use ATDS more often. Each year of age increased chances 
of device use by 1.04. Each chronic condition increased chances of device use by 1.18, 
and each additional mobility problem increased chances of device use by 2.47. The 
contrast between Tomika et al.’s finding that increasing age decreased device use and 
Zimmer et al.’s finding that increasing age increased device used may be attributed to the 
way the dependent variable, device use, was measured. Tomika et al. counted devices 
owned and used whereas Zimmer et al. counted the tasks for which devices were used. 
Like Zimmer et al., Rubin et al. [11], using 1994 NLTCS data, also found AT use by the 
elderly to vary by nature of chronic disease. However, in contrast to Tomika et al., Rubin 
et al. found device use to vary according to race: elderly African Americans were two to 
20 times more likely to use some types of AT than Caucasians. There was no significant 
difference however, between African Americans and Caucasians in their use of 
wheelchairs. Rubin et al. also found Caucasians reported using devices requiring home 
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modification whereas African Americans reported using portable devices. In addition, 
African Americans who used AT tended to be older; Caucasian users tended to be 
female, with more education. Kaye et al. [2] found wheelchair use to be highest for 
Native Americans (0.81%), then Caucasians (0.63%), then African Americans (0.56%), 
then Hispanics (0.36%). 
In summary, relationships between AT use and age, gender, race, chronic disease, 
income, and/or education have been found. Number of chronic conditions predicts AT 
use for African Americans and Caucasians [5, 6, 11]; device users are more likely to live 
alone [5] and to be female [2, 11]. African Americans users are more likely to be older 
[11], Caucasian device users are more likely have a higher education [11], higher 
cognitive status, and higher income [5]. While there was variance between African 
Americans and Caucasians in the use of some ATDS, variance was not apparent for the 
use of wheelchairs [5, 11]. Low-tech mobility devices (i.e. canes, walkers) are used by 
individuals with difficulty performing a task, whereas wheelchairs tend to be used by 
individuals who could not otherwise perform the task [6]. 
Wheelchairs, like ATDS in general, span the technology spectrum [12]. At the 
origin is the standard, sling upholstery, chrome-plated, steel folding X-frame design, 
standard, “depot” manual wheelchair. On the other end of the continuum are electric 
power wheelchairs with options for tilt and recline - allowing postural changes that 
reduce pressure and thus the risk for the formation of pressure ulcers [13, 14], seat 
elevation - which can provide assistance when transferring from the wheelchair to 
another surface and allow users to hold eye-level discussions with colleagues, and 
programmable electronic controls - that can be individualized for abnormal muscle tone, 
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tremor, and cognitive impairment [15]. Substantial improvements in wheeled mobility 
offer consumers more and better choices [16-20]. However, as the technology becomes 
more complex, so do the decisions as to who gets what wheelchair, with both cost and 
clinical expertise as factors. Clinicians making these decisions may not have training in 
wheeled mobility options and features, thus may have difficulty in comprehending the 
complexity of the technology and its application [21-25].  
Studies of the use and benefits of AT typically include wheelchairs [5, 11, 26], 
but do not differentiate among types or quality of wheelchairs. Other studies have 
investigated the quality and durability of wheelchairs [27-32]. Only one other study, 
presently in press, was found that examined the relationship between demographic and 
clinical characteristics and types of wheelchairs. The purpose of this study was to 
characterize veterans (according to age, gender, race/ethnicity, diagnosis, number of 
comorbidities) who received wheeled mobility devices from the VHA, and to determine 
whether demographic characteristics vary significantly according to the type of wheeled 
mobility device (WMD) provided. We investigated how many veterans received initial 
issue, spare, and replacement wheelchairs from the VHA during each of the fiscal years 
(FY) 1999, 2000, and 2001, the demographic characteristics of the veterans receiving 
these wheelchairs, and their most frequent diagnoses. Our hypothesis was the type of 
wheelchair provided to veterans would differ significantly according to age, gender, and 
race/ethnicity for FY99, FY00, and FY01 combined. Analyses were performed for 
manual and power wheelchairs and scooters inclusive, and separate analyses were 
performed for manual and power wheelchairs. 
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2.3  METHODS 
 2.3.1  Design and Participants 
Using a cross-sectional, retrospective study design, three years of data from two 
VHA databases, the NPPD and the National Patient Care Database (NPCD) were merged 
to create a dataset of demographic and clinical information on veterans who received 
wheeled mobility devices from the VHA during FY99, FY00, and FY01.  
2.3.2  Databases 
NPPD: The National Patient Prosthetics Database (NPPD), housed at the Veteran 
Administration Central Offices (VACO) [33, 34], contains detailed information on the 
procurement of prosthetic, orthotic, and sensory technology by tracking every device 
issued to veterans by the VHA. Seven of the 25 data fields included in the NPPD were 
used in this study: code and description of the device, type of service (initial issue, 
replacement, or spare), create date, delivery date, category of service, and priority group.  
NPCD: The National Patient Care Database (NPCD) [35], housed at the Austin 
Automation Center (AAC), contains VHA outpatient and inpatient health care 
administrative datasets. The NPCD data fields used in this study included date of birth, 
sex, race, and primary and secondary International Classification of Disease - Revision 9 
(ICD-9) codes [36].  Data from both the inpatient and outpatient databases was used to 
decrease the number of missing values. For example, if gender was missing in the 
inpatient dataset, it was retrieved from the outpatient dataset. 
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2.3.3  Operational Definitions of Variables 
Dependent Variable 
Type of Wheelchair: Wheelchairs sold in the U.S. must be approved as devices by 
the U.S. Food and Drug Administration (FDA) [37]. The FDA then forwards application 
information to the Center for Medicare and Medicaid Services (CMS). CMS [38] assigns 
the wheelchair a Health Care Common Procedure Coding System (HCPCS) code, 
developed for reimbursement purposes. Because of the large quantity of unique 
wheelchair-related HCPCS codes included in the NPPD (N=71), analysis of each 
wheelchair code was not feasible; therefore, for the purpose of this study, the HCPCS 
codes used in the NPPD to describe wheelchairs were assigned by the investigators to one 
of eight types based on function, weight, and adjustability. Adjustability (i.e. axle 
position, camber for manual wheelchairs and position of wheels, tilt, recline options, etc.) 
is essential to customizing a wheelchair to meet individual needs. See Table 3 for the 
assigned wheelchair types by K-code.  See Appendix A for a full list of HCPCS codes 
used in the NPPD, including E-codes.  
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Independent Variables 
Age: Veteran age was calculated by subtracting the day on which the wheelchair 
order was entered into the system from the date of birth. VHA policy specifies the device 
must be entered within five days of prescription.  
Race: Race (term used in the NPPD) was initially defined according to the six 
NPCD race categories: Hispanic Black, Hispanic White, American Indian, African 
American, Asian, and Caucasian. During the univariate chi-square analyses, it was 
determined Hispanic White, American Indian, and Asian had inadequate cell size for 
further analysis. Thus, Hispanic black and Hispanic white were combined and the 
remaining minority populations, American Indian and Asian, were combined. 
Table 3   Operational definitions of dependent variable: wheelchair type 
Code Type of 
Wheelchair 
Description 
K0001 = manual wc 
depot  
> 36 lbs, non-adjustable; “depot”  wheelchair 
K0002 = manual wc 
hemiplegia  
> 36 lbs, non-adjustable, lower seat only; depot wheelchair 
K0003 =  manual wc 
lightweight  
 
 
 
M1 
 < 36 lbs, non-adjustable; lightweight, depot wheelchair 
K0004 =  manual wc 
lightweight  
 
M2 
<34 lbs., adjustable seat/back height, some adjustment in axle; high 
strength, lightweight; rehabilitation wheelchair 
K0005 =  manual wc 
ultralight  
 
M3 
< 30 lbs.,  adjustable seat/back height/axle/camber; ultralight 
wheelchair 
K0006-7 =  manual wc 
heavy duty  
K0009 =  manual wc  
other 
 
 
M4 
 
Miscellaneous manual wheelchairs 
K0010 =  power  wc  
P1 
non-adjustable, seat height only, standard weight non-programmable 
controls 
K0011 =  power  wc 
K0012 =  power  wc 
 
P2 
Miscellaneous power wheelchairs 
K0014 =  power  wc 
 
P3 custom power  wheelchairs, other motorized wheelchair base 
 
E1230 = scooter S1 scooter 
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Gender: Gender (sex was the term used in the NPPD) was specified as male or 
female. 
2.3.4  Confounding Variables 
Diagnosis: To determine the primary diagnosis, ICD-9 codes from the primary 
diagnoses variables for all FY99, FY00, and FY01 encounters for all participants were 
extracted from the inpatient and outpatient NPCD datasets. In order to characterize 
veterans by diagnosis, it was necessary for participants to have only one diagnosis, 
preferably the one most related to wheelchair-use. Thus, for the purpose of using SAS® 
to make this assignment, the 10 most frequent primary diagnoses were ranked (based on 
the authors’ clinical experience) according to their likelihood of being the diagnosis most 
relevant to the wheelchair prescription. The most frequently occurring wheelchair-use 
related ICD-9 codes, in order of ranking were: amyotrophic lateral sclerosis (ALS), 
multiple sclerosis (MS), spinal cord injury-tetraplegia (SCIT), spinal cord injury-
paraplegia (SCIP), stroke, traumatic brain injury (TBI), Parkinson’s disease (PD), 
amputee, and chronic obstructive pulmonary disorder / chronic heart failure 
(COPD/CHF), and arthritis. An “other” category was established for primary diagnoses 
other than those listed.  
A SAS® program was then written that used an array to rank the diagnoses. The 
rationale for the ranking was as follows: if a veteran had a diagnosis of SCI and arthritis, 
it was assumed that SCI played a more important role in wheelchair use than arthritis, 
thus SCI was considered the primary diagnosis and arthritis a comorbidity. ALS and MS 
were ordered in front of SCI because they are a primary condition and the spinal cord 
injury that occurs is secondary to the ALS and MS. For example, the SAS® program 
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would look for ALS ICD-9 code(s). If none were present, it would look for MS ICD-9 
codes, and on down the rank. If the veteran did not have any of the listed diagnosis, the 
primary diagnosis was coded as “other”.  
Comorbidities: To determine the number of comorbidities, ICD-9 codes 
representing secondary diagnoses were extracted from the FY99, FY00, and FY01 
inpatient and outpatient NPCD datasets. The ICD-9 codes were sorted into 30 medical 
categories (anemia, chronic heart failure, diabetes, stroke, etc.) developed by Perlin and 
colleagues [39, 40] during the development of the Veteran Health Study (VHS).  A 
continuous variable was created representing number of comorbidities. Since there were 
nine secondary diagnosis fields in the inpatient NPCD, and nine secondary diagnosis 
fields in the inpatient NPCD, there was a possibility for 18 comorbidities per veteran. If a 
veteran had a primary diagnosis that was also one of the 30 medical categories, the 
comorbidity count was adjusted, i.e. if the veteran’s primary diagnosis was stroke, the 
comorbidity count was reduced by one since stroke was also one of the 30 medical 
categories.   
Fiscal Year: Fiscal year was specified either as FY99, FY00, or FY01. 
2.3.5  Other Variables Included in Descriptive Analyses 
Type of Service: Type of service designates whether the device issued was an 
initial issue, i.e. the first wheelchair the veteran had received, a spare, i.e. a back-up chair, 
or a replacement, i.e. for a wheelchair that was no longer operable or no longer met the 
veteran’s needs [41].   
Priority Group: Congress requires the VA to manage the health care system 
using seven priority groups, which determine eligibility to receive health care benefits 
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each year. Priority Groups are defined as follows [7]: (1) veterans with service-connected 
disabilities rated > 50%, (2) veterans with service-connected disabilities rated 30% or 
40%, (3) veterans who are former Prisoners of War, have a service-connected disability 
rated 10% or 20%, discharged from active duty for a disability incurred or aggravated in 
the line of duty, received the Purple Heart, or were awarded special eligibility 
classification under 38 U.S.C., Section 1151, "benefits for individuals disabled by 
treatment or vocational rehabilitation", (4)  veterans who are receiving aid and attendance 
or housebound benefits, or who have been determined by VA to be catastrophically 
disabled (i.e. SCI), (5) low income nonservice-connected veterans, (6) special category 
veterans (Agent Orange, radiation exposure) who are not required to make co-payments 
for their care, and (7) high income nonservice-connected and high income 0% service-
connected veterans. While all enrolled veterans receive the same prosthetic benefits, 
regardless of priority level, knowing the priority groups of veterans who receive AT from 
the VHA contributes to an understanding of the relationship between level of disability, 
economic status, and AT use. In addition, veterans in priority groups 1 – 3 receive 
priority for scheduling of appointments that could affect prosthetic services. Should there 
be financial constraints, veterans classified in the higher priority groups (priority groups 1 
- 5) would be granted priority consideration to receive health care benefits [42]. 
Category: There are four “categories” of service: service-related and inpatient 
(SC/IP), service-related and outpatient (SC/OP), non-service-related and inpatient service 
(NSC/IP), and non-service-related and outpatient (NSC/OP). Categories are assigned for 
each device provided, so for example, a veteran could have one wheelchair that is SC/OP 
and a scooter that is NSC/OP. 
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2.3.6  Procedures  
Following approval by the VA Pittsburgh Healthcare System Institutional Review 
Board, the NPPD was provided by VACO and the demographic data from the NPCD 
were obtained from the AAC [33]. Unique scrambled patient identifiers from the NPPD 
were submitted to the AAC using a computer program written with SAS® [43] software. 
Within the AAC system, the scrambled patient identifiers were unscrambled long enough 
to secure the data for the specific veteran identifiers submitted. The patient identifiers 
were then re-scrambled and the NPCD data returned. Thus at no time did the 
investigators have access to unscrambled patient identifiers. SAS® [43] was used for all 
data retrieval and analyses. 
Data Cleaning:  Decision rules developed during a collaborative validity study of 
the NPPD [34] were applied. A comparison of the frequency counts of the records 
contained in the “NPPD_Line” and “HCPCSPSAS” fields determined the “NPPD_Line” 
field was the most reliable and valid method of selecting the wheelchair and scooter 
items. The “NPPD_Line” field is a VA code that specifies the type of device within 27 
categories of devices. For example “100” represents wheelchairs, “100 A” represents 
power wheelchairs, and “100 C” represents wheelchair accessories” [35]. The 
“HCPCSPSAS” field is the Prosthetics and Sensory Aids Services (PSAS) code that 
corresponds to the CMS HCPCS code. The “HCPCSPSAS” and the CMS HCPCS codes 
are usually but not always the same. When inconsistencies between these fields were 
found, other fields including vendor, cost, and item description were considered, then the 
record recoded accordingly. For all three fiscal years (FY), only three wheeled mobility 
devices required recoding: a scooter and two manual wheelchairs.   
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2.4  ANALYSES  
Descriptive methods (frequency, means, standard deviations, and medians for 
skewed data) were used to answer Research Question 1: the characterization of veterans 
according to number of wheelchairs and wheelchair components provided, type of service 
(initial issue, spare, replacement), gender, race/ethnicity, diagnosis, service category, 
priority group, age, and number of comorbidities. Because an extensive research study 
using NPPD data was not found and FY99 was the first year the NPPD was available to 
researchers, it seemed prudent to initially explore the data year by year rather than 
combining the three years of data. Thus, the demographic characterization was performed 
for each of the FYs, with the exception of priority group. Priority group data was not 
included in the NPPD until FY01. The data subset used to answer Research Question 1 
included only wheelchairs and scooters; device components were excluded. Also only 
one record per veteran was included. For example, a veteran was only counted as male 
once, or as having a stroke as their primary diagnosis once. 
ANOVA and chi-square univariate analyses and logistic regression were used to 
test Hypothesis 1: a determination of whether the characterization differed by wheelchair 
type. The three years of data were combined. In addition, since the focus of this analysis 
was on wheelchair types rather than the characteristics of veterans receiving wheelchairs, 
all wheelchair and scooter records per veteran were included (components were 
excluded). For example, a veteran may receive more than one wheelchair, or receive a 
wheelchair and a scooter, within a fiscal year, per VHA policy. This resulted however in 
some overlap in the data. For example, if a veteran received more than one wheelchair 
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per FY, their demographic data was counted more than once in the analysis of 
demographics – wheelchair relationship. 
First, ANOVA and chi-square univariate analyses were performed between the 
independent variables (IV), potential confounding variables (CV), and the dependent 
variable (DV). The IVS were age, gender, and race/ethnicity. The CVS were diagnosis, 
number of comorbidities, and fiscal year. See Operational Definitions for details. The DV 
was type of wheelchair. Univariate analyses were tested at alpha = 0.10. All IVS and 
CVS were significant thus all were entered into a logistic regression model. A separate 
logistic regression was run for each wheelchair type using four different data subsets: 
manual and power chairs and scooters, just manual chairs, just power chairs, and power 
chairs and scooters. The logistic regression model was tested at alpha = 0.5. Odds ratios 
(OR), Wald confidence intervals (CI), and p-values were reported [43-46].  
2.5  RESULTS  
Table 4 displays the number of veterans who received wheelchairs, scooters, and 
wheelchair components from the VHA during FY99, FY00, and FY01. Approximately 
70% of the wheeled-mobility related technology provided was either a wheelchair or 
scooter; the remaining 30% were wheelchair related components, i.e. cup holder, oxygen 
holder, gloves, seating system not associated with a wheelchair purchase. The number of 
veterans receiving wheelchairs, scooters, and/or related components was 77,249 in FY99, 
80,753 in FY00, and 85156 in FY01; these numbers most accurately reflect wheelchair 
users. For example, a new seating system for a wheelchair provided prior to the study 
years would be considered a component. The 30% of veterans who received only 
components were likely wheelchair users whose chair did not need replacement during 
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the study years. In contrast, the number of veterans who received a wheelchair and/or 
scooter was 52,309 in FY99, 55,752 in FY00, and 59,877 in FY01.  
Table 5 displays the number of wheeled mobility devices provided by the VHA. 
Approximately 80% of the wheelchairs provided in FY99 were manual, decreasing to 
77% in FY01. The proportion of power wheelchairs increased from 8% in FY99 and 
FY00 to 14% in FY01, while the proportion of scooters provided decreased from 13% in 
FY99 and FY00 to 9% in FY01.  
Table 4   Number and percentages of veterans receiving wheelchairs, 
scooters, and components during FY99, FY00, and FY01 
  FY99 FY00 FY01 
Number of veterans who received: # % # % # % 
Wheelchairs, scooters, and/or components 77249 100% 80753 100% 85156 100%
Wheelchairs & scooters 52309 68% 55752 69% 59877 70%
 
Table 5   Number and percentages of devices provided by the VHA 
during FY99, FY00, and FY01 
  FY99 FY00 FY01 
Number of devices provided: # % # % # % 
Wheelchairs - manual 48433 80% 49898 79% 52223 77% 
Wheelchairs - power 4664 8% 5309 8% 9451 14% 
Scooters 7015 13% 8144 13% 6187 9% 
 
Table 6 displays the proportions of initial issue, replacement, and spare 
wheelchairs provided to veterans.  More than 80% of the wheelchairs and scooters 
provided were the veteran’s first wheeled mobility device. Less than 1% were spares, and 
17 - 18% were replacements. Tables 7 and 8, and Figure 7 display the demographic (age, 
gender, race, priority group) and clinical (diagnosis, number of comorbidities) 
characteristics. COPD/CHF was the most frequent primary diagnosis of veterans who 
received WMD followed by stroke. 
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Table 6   Number and percent of initial, spare, and replacement 
wheelchairs provided during FY99, FY00, and FY01 
 FY99 FY00 FY01 
Type # % # % # % 
Initial 48891 81% 52070 82% 5595 82% 
Spare 396 1% 397 1% 347 1% 
Replacement 10825 18% 10884 17% 11563 17% 
 
Table 7  Gender, race/ethnicity, diagnosis, and priority group of 
veterans who received wheelchairs and scooters 
during FY99, FY00, and FY01 
  FY99 FY00 FY01 
Variable # % # % # % 
Gender                Male 43783 96% 52305 96% 56503 96% 
Female 1672 4% 1934 4% 2186 4% 
Race  Hispanic, Black 2180 5% 2961 5% 3157 5% 
Hispanic, White 110 0% 187 0% 208 0% 
American Indian 210 0% 233 0% 220 0% 
Black 6749 15% 7724 14% 7905 13% 
Asian 143 0% 164 0% 228 0% 
White 30091 66% 34916 64% 36710 63% 
Unknown 5971 13% 8054 15% 10261 17% 
Diagnosis             ALS 431 1% 545 1% 532 1% 
MS 1661 4% 1862 3% 1957 3% 
SCI-tetra 2015 4% 2111 4% 2166 3% 
SCI-para 1677 4% 1670 3% 1766 3% 
Stroke 7645 17% 8688 16% 8619 15% 
TBI 56 0% 58 0% 48 0% 
PD 1199 3% 1575 3% 1835 3% 
Amputee 2106 5% 2323 4% 2176 4% 
COPD/CHF 10245 23% 12191 23% 13035 22% 
Arthritis 5059 11% 6180 11% 7033 12% 
Other 13227 29% 16853 31% 19297 33% 
Priority Group            I 14988 26% 
2 3190 6% 
3 4703 8% 
4 11919 21% 
5 17511 31% 
6 158 0% 
7 
Priority Group not included in NPPD until 
FY01 
2636 5% 
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Figure 7  Number of veterans receiving wheelchairs and scooters per diagnostic group 
for FY99, FY00, and FY01 
 
 
Table 8  Mean age and number of comorbidities of veterans who received 
wheelchairs and scooters during FY99, FY00, and FY01   
  FY99 FY00 FY01 
Variable n mean std dev n mean std dev n mean std dev 
Age in Years 45455 66.6 13.1 54239 67.4 13.1 58689 67.8 13.0 
# Comorbidities 43865 3.0 2.3 52606 3.0 2.2 57096 3.0 2.2 
 
Figure 8 compares the priority groups of veterans who received WMD from the 
VHA during FY01, the general veteran population [7], and veterans who receive their 
healthcare from the VHA (as identified by the 1999 VHS) [40]. As expected, veterans 
with disabilities rated 50% or more and catastrophic (priority groups 1 and 4) were more 
than twice as likely to have received a wheelchair versus the general veteran population 
and veterans who receive their healthcare from the VHA. Veterans with disabilities rated 
40% or less and low-income veterans (priority groups 2, 3 and 5), were only slightly less 
likely to have received a wheelchair versus the general veteran population. Relatively few 
 42
veterans who receive wheelchairs from the VHA are in the higher income/co-pay priority 
group 7.  
Priority Groups of Veterans Who Receive Wheelchairs 
from the VHA, Receive Healthcare from the VHA, and the 
General Vet Population
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 Figure 8  Priority groups of veterans who received wheelchairs from the VHA 
versus priority groups of entire veteran population for FY01 
 
Univariate Analyses: According to the univariate analyses, in a distribution that 
was generally 98% male and 4% female, more male veterans (97%) received Type M1 
(depot chairs) and fewer male veterans (95%) received Type P1 (standard power chairs).  
See Table 9 for the number and percent of wheelchairs and scooters provided to males 
versus females for all wheelchair types. Approximately 5 - 6% of the data had missing 
values for gender. 
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Table 9  Univariate analysis results: gender by 
wheelchair type and by manual/power 
wheelchairs and scooters for FY99-FY01 
combined 
IV: Gender   
    freq male 
% 
male freq female % female p value 
M1 92261 97% 3275 3% 
M2 28090 96% 1150 4% 
M3 4498 96% 193 4% 
M4 11672 96% 476 4% 
P1 6118 95% 302 5% 
P2 4884 96% 204 4% 
P3 3673 96% 148 4% 
S1 22477 96% 886 4% 
<.0001 
manual 136521 96% 5094 4% 0.0004 
power 14675 96% 654 4% <.0001 
D
V: Type of W
heelchair  
scooter 22477 96% 886 4% 0.325 
 
More variance in the type of wheelchair provided was noted between Hispanics 
and Caucasians than between African Americans and Caucasians (Table 10). When 
comparing all WMD (the first eight rows of Table 10), Hispanics received higher 
percentages of Types M1 and M3 (depot and ultralight wheelchairs) and lower 
percentages of Types P1 and S1 (standard power wheelchairs and scooters) than other 
race/ethnic categories. All three minority categories received a higher percentage Type 
M1 (depot chairs) than Caucasians. Caucasians received a higher proportion of scooters 
than minorities.  
When comparing the proportion of manual and power wheelchairs and scooters 
per ethnic group (rows 9-11 of Table 10), 90% of the WMDS received by Hispanics were 
manual chairs, 5% were power chairs, and 5% were scooters. In contrast, 77% of the 
WMDS received by Caucasians were manual chairs, 9% were power chairs, and 14% 
were scooters. The percentages for African Americans were in between those for 
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Hispanics and Caucasians: 82% were manual chairs, 8% were power chairs, and 10% 
were scooters. With the exception of Types M1 and S1 (depot chairs and scooters), there 
was relatively little variance in types of wheelchairs received by African Americans 
compared to types of wheelchairs received by Caucasians. Approximately 5 to 6% of the 
race/ethnicity data had missing values. 
Table 10  Univariate analysis results: race/ethnicity by wheelchair type and by 
manual/power wheelchairs and scooters for FY99-FY01 combined 
    IV: Race/Ethnicity          
    Hispanic Am Indian African Am Caucasian   Total 
      Asian         Devices 
    # % # % # % # % 
p 
value # % 
M1 6677 68% 861 63% 14599 57% 60216 52% 82353 53% 
M2 1461 15% 192 14% 3779 15% 18590 16% 24022 16% 
M3 435 4% 39 3% 734 3% 2758 3% 3966 3% 
M4 237 2% 58 4% 1903 7% 8083 7% 10281 7% 
P1 199 2% 47 3% 882 3% 4262 4% 5390 4% 
P2 141 1% 39 3% 704 3% 3354 3% 4238 3% 
P3 171 2% 23 2% 587 2% 2561 2% 3342 2% 
S1 522 5% 104 8% 2454 10% 16248 14% 
<.0001 
19328 13% 
manual 8810 90% 1150 84% 21015 82% 89647 77% <.0001 120622 79% 
power 511 5% 109 8% 2173 8% 10177 9% <.0001 12970 8% 
D
V: Type of W
heelchair  
scooter 522 5% 104 8% 2454 10% 16248 14% <.0001 19328 13% 
devices per                   
race/ethnic 9843 5% 1363 <1% 25642 14% 116072 64%    
category                
 
The average age of veterans receiving Types M3 and P3 (ultralight and custom 
power wheelchairs) was 55 (16) and 60 (14) respectively, compared to the average age of 
veterans receiving Types M1, M2, and S1 (depot, lightweight rehabilitation wheelchairs 
and scooters): 67 (13), 66 (14), and 66 (12) respectively. See Table 11 for age means and 
standard deviations. Age was normally distributed for all wheelchairs types. The 
percentage of missing values for age of veterans ranged from 56% to 69% across 
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wheelchair types. Age was calculated from the date the wheelchair was ordered and the 
veteran’s date of birth, so either of these fields could have contributed a missing value.  
Table 11  Univariate analysis results: mean 
and standard deviation of age by 
wheelchair type and 
manual/power wheelchairs and 
scooters for FY99-01 combined 
IV: Age 
    n mean std dev p value 
M1 33053 67.0 13.1 
M2 9749 65.5 13.9 
M3 1835 55.2 15.8 
M4 4732 62.5 13.9 
manual 49369 65.8 13.7 
P1 3025 62.0 13.6 
P2 1838 62.7 13.5 
P3 1670 59.9 13.9 
power 6533 61.7 13.7 
D
V:Type of W
heelchair 
S1 -scooter 8787 65.5 11.6 
<.0001 
 
The most frequently prescribed type of wheelchair for all diagnoses was the M1 
(depot chair). See Table 12. The second most frequently prescribed wheelchair type 
varied by diagnosis: type M2 (lightweight rehabilitation wheelchairs) for veterans with 
MS, SCI, stroke, TBI, PD and amputee, type S1 (scooters) for veterans with ALS, 
COPF/CHF, and arthritis. Power devices, Types P1-P3 and S1 (power wheelchairs and 
scooters) were prescribed more often for veterans with ALS, MS, and SCI-tetraplegia 
(~40%) than for veterans with SCI-paraplegia, stroke, TBI, PD, amputee, COPD/CHF, 
and arthritis (<30%). Approximately 5% of the diagnosis data had missing values. 
Table 13 provides similar data as Table 12, the difference being that manual 
wheelchairs were analyzed separately from power wheelchairs, and scooters were 
excluded since there was only one type, thus no comparison. Whereas Table 12 displays 
 46
the most frequently prescribed wheelchairs across diagnoses, Table 13 displays the type 
of chair most frequently prescribed within a diagnosis. 
 
Table 12  Univariate analysis results: frequency of wheelchairs by type and 
manual/power wheelchairs and scooters across diagnoses for FY99-01 
combined 
    DV: Wheelchair Type   
    M1 M2 M3 M4 Manual P1 P2 P3 Power S1 
p 
value 
ALS          37%** 13% 2% 8% 60% 8% 9% 6% 40% 16%* 
MS 27%** 16%* 7% 8% 58% 12% 8% 9% 43% 13% 
SCIT   23%** 15%* 13% 11% 62% 13% 7% 12% 38% 6% 
SCIP 28%** 20%* 13% 11% 73% 7% 5% 5% 27% 10% 
Stoke  55%** 19%* 2% 6% 83% 3% 3% 1% 17% 10% 
TBI  58%** 14%* 1% 10% 83% 1% 1% 1% 17% 14%* 
PD  59%** 20%* 2% 5% 86% 2% 2% 1% 14% 9% 
Amputee 48%** 19%* 3% 7% 78% 4% 3% 2% 22% 13% 
COPD/CHF 52%** 14% 1% 6% 73% 3% 2% 1% 27% 21%* 
C
onfounding Variable: D
x 
Arthritis  54%** 15% 1% 7% 78% 3% 2% 1% 22% 16%* 
<.0001 
 **most frequently provided wheelchair type per diagnostic group     
 *2nd frequently provided wheelchair type per diagnostic group      
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Table 13  Univariate analysis results: frequency of type of manual and power wheelchairs diagnoses for FY99-01 
combined 
  DV: Wheelchair Type 
  ALS MS SCIT SCIP Stoke TBI PD Amputee COPD/CHF Arthritis 
  Manual Wheelchairs 
M1 62% 48% 38% 39% 67% 70% 69% 63% 72% 70% 
M2 22% 27% 24% 27% 23% 16% 23% 24% 19% 19% 
M3 4% 12% 21% 18% 2% 1% 2% 4% 1% 2% 
M4 13% 14% 17% 15% 8% 12% 6% 8% 9% 9% 
 Power Wheelchairs 
P1 36% 42% 40% 41% 43% 40% 43% 43% 40% 46% 
P2 39% 27% 23% 31% 38% 40% 34% 34% 39% 36% 
D
V: W
heelchair Type 
P3 25% 32% 37% 28% 19% 20% 22% 22% 22% 18% 
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The mean number of comorbidities (Table 14) appears to be lower for Type M3 
(ultralight) and Types P1 and P3 (standard and custom power wheelchairs); however, 
relatively large standard deviations preclude making this assumption. The percent of 
missing values for the number of comorbidities data ranged from 6% to 12% across 
wheelchair types. 
Table 14  Univariate analysis results: mean 
and standard deviation of # of 
comorbidities by wheelchair type 
and manual/power wheelchairs 
and scooters for FY99-01 
combined 
Confounding Variable: # of Comorbidities 
    n mean std dev p value 
M1 92870 3.0 2.2 
M2 28218 2.9 2.2 
M3 4535 2.3 2.1 
M4 11803 3.0 2.2 
manual 137426 30.0 2.2 
P1 6624 2.9 2.4 
P2 4906 3.0 2.4 
P3 3719 2.8 2.4 
power 14849 2.9 2.4 
D
V:Type of W
heelchair 
S1 -scooter 22773 3.2 2.3 
<.0001 
 
Logistic Regression Results: Tables 15-18 display the likelihood of veterans to 
receive a certain type of wheelchair if they are older versus younger, male versus female, 
and Hispanic versus Caucasian, American Indian/Asian versus Caucasian, or African 
American versus Caucasian. The results displayed in Table 15 were derived from a data 
subset that included all WMD (manual and power wheelchairs and scooters). The results 
displayed in Table 16 were derived from a data subset that included only manual 
wheelchairs, Table 17 power wheelchairs and scooters, and Table 18 only power 
wheelchairs. 
 49
Age: When comparing all WMD, younger veterans were more likely to receive 
Types P3 (custom power wheelchairs) (p=.027) and S1 (scooters) (p=<.0001) whereas 
older veterans were more likely to receive Types M1-M4 (manual wheelchairs) 
(p=<.0001). Within manual wheelchairs, older veterans were more likely to receive Type 
M1 (depot chairs) (p=<.0001) while younger veterans were more likely to receive Type 
M3 (ultralight wheelchairs) (p=<.0001). 
According to adjusted OR (when comparing all WMD), as an example, a veteran 
age 70 was 1.04 times more likely to receive a manual wheelchair (Types M1-M4) than a 
veteran age 60. Similarly, a veteran age 60 was 1.04 times more likely to receive a power 
wheelchair or scooter (Types P1-P4 and S1) than a veteran age 70. When comparing the 
adjusted OR for Types M1-M4 (manual wheelchairs), for every 10-year gain in age, a 
veteran was 1.08 times more likely to receive a Type M1 (depot chair) and 1.04 times 
more likely to receive a Type M2 (lightweight wheelchair). For every 10-year decrease in 
age, a veteran was 1.25 times more likely to receive a Type M3 (ultralight wheelchair).  
Race: When comparing all wheeled mobility devices (Table 15), Hispanics 
(OR=1.9), American Indians & Asians (OR=1.6), and African Americans (OR=1.4) were 
more likely than Caucasians to receive Types M1-M4 (manual wheelchairs), Hispanics 
(OR=0.8) and African Americans (OR=0.9) were less likely than Caucasians to receive 
Types P1-P3 (power wheelchairs), and Hispanics (OR=0.4), American Indians & Asians 
(OR=0.4), and African Americans (OR=0.7) were less likely than Caucasians to receive 
scooters. This was not the effect however, when manual wheelchairs and power 
wheelchairs were compared separately.  
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When including only manual wheelchairs in the analysis (Table 16), Hispanics 
were more likely than Caucasians to receive Type M1 (depot) (OR=1.7) and Type M3 
(ultralight) (OR=1.8) wheelchairs. Hispanics (OR=0.7) and African Americans (OR=0.9) 
were less likely than Caucasians to receive Type M2 (lightweight) wheelchairs.  
When power wheelchairs and scooters were included in the analysis (manual 
wheelchair excluded) (Table 17), minorities were more likely than Caucasians to receive 
power chairs, Hispanics (OR=1.9), American Indian/Asians (OR=1.9), African American 
(OR=1.3), and less likely to receive Type S1 (scooters) Hispanics (OR=0.5), American 
Indian/Asians (OR=0.5), African American (OR=0.8).  
When only power wheelchairs were included in the analysis (scooters and manual 
wheelchairs excluded) (Table 18), Hispanics were more likely than Caucasians to receive 
Type P3 (custom power) wheelchairs (OR=1.6).  
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Table 15  Regression results for manual vs power wheelchairs vs. scooters for FY99-01 combined 
         Independent Variables 
     Age Sex Race/ethnicity 
 n=62377          Hispanic American Indian/Asian African American 
        male vs Caucasian vs Caucasian vs Caucasian 
    % OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p 
manual 76% 1.003 1.002-1.005 <.0001 1.061 0.961-1.171 0.242 1.864 1.682-2.067 <.0001 1.585 1.247-2.015 0.0002 1.360 1.285-1.440 <.0001 
power 10% 1.000 0.998-1.002 1.000 0.889 0.776-1.018 0.089 0.804 0.703-0.918 0.001 1.036 0.772-1.391 0.813 0.881 0.815-0.953 0.002 
scooter 14% 0.995 0.993-0.997 <.0001 1.006 0.891-1.135 0.929 0.422 0.364-0.488 <.0001 0.413 0.286-0.597 <.0001 0.682 0.634-0.734 <.0001 
significant at 0.05 & CI does not include 1               
D
V W
heelchair 
Type 
%=percent of wheelchairs in sample that were of type of wheelchair being analyzed        
 
 
Table 16  Regression results for manual wheelchairs for FY99-01 combined 
         Independent Variables    
     Age Sex Race/ethnicity 
 n=47436          Hispanic vs American Indian/Asian African American 
         male vs Caucasian vs Caucasian vs Caucasian 
    % OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p
M1 66% 1.008 1.006-1.010 <.0001 1.064 0.957-1.182 0.250 1.709 1.554-1.878 <.0001 1.553 1.232-1.958 0.0002 1.087 1.029-1.149 0.003 
M2 20% 1.003 1.002-1.005 0.0004 0.907 0.804-1.023 0.113 0.665 0.595-0.744 <.0001 0.775 0.594-1.011 0.060 0.870 0.815-0.928 <.0001
M3 4% 0.978 0.974-0.982 <.0001 1.006 0.780-1.298 0.962 1.766 1.475-2.114 <.0001 0.733 0.394-1.363 0.326 0.951 0.829-1.091 0.471 
M4 10% 0.984 0.982-.0987 <.0001 1.037 0.882-1.220 0.661 0.278 0.222-0.348 <.0001 0.591 0.393-0.889 0.012 1.062 0.978-1.154 0.151 
D
V W
heelchair 
Type 
significant at 0.05 & CI does not include 1           
 %=percent of wheelchairs in sample that were of type of wheelchair being analyzed    
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Table 17  Regression results for power wheelchairs and scooters for FY99-01 combined 
          Independent Variables 
      Age Sex Race/ethnicity 
 n=14816          Hispanic American Indian/Asian African American 
        male vs Caucasian vs Caucasian vs Caucasian 
    % OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p 
Power 19% 1.000 
0.997-
1.003 0.887 0.936 0.784-1.118 0.468 1.850 1.518-2.254 <.0001 1.928 1.190-3.124 0.008 1.256 1.129-1.397 <.0001 
Scoot 58% 1.000 
0.997-
1.003 0.887 1.068 0.894-1.275 0.468 0.541 0.444-0.659 <.0001 0.519 0.320-0.840 0.008 0.796 0.716-0.886 <.0001 
D
V:W
C
  Type significant at 0.05 & CI does not include 1               
 %=percent of wheelchairs in sample that were of type of wheelchair being analyzed        
 
 
Table 18  Regression results for power wheelchairs for FY99-01 
         Independent Variables 
     Age Sex Race/ethnicity 
 n=6278          Hispanic American Indian/Asian African American 
         male vs Caucasian vs Caucasian vs Caucasian 
    % OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p 
P1 46% 1.001 0.996-1.005 0.799 0.879 0.688-1.123 0.302 0.901 0.702-1.157 0.413 0.925 0.538-1.591 0.778 1.018 0.882-1.175 0.809 
P2 28% 1.004 1.000-1.009 0.067 1.128 0.853-1.491 0.397 0.706 0.523-0.953 0.023 1.658 0.944-2.911 0.078 0.997 0.851-1.169 0.974 
P3 26% 0.994 0.990-0.999 0.027 1.048 0.788-1.394 0.748 1.564 1.198-2.041 0.001 0.615 0.314-1.204 0.156 0.978 0.830-1.152 0.792 
significant at 0.05 & CI does not include 1     
D
v W
heelchair 
Type 
%=percent of wheelchairs in sample that were of type of wheelchair being analyzed  
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2.6  DISCUSSION 
Demographic and clinical outcomes of the provision of wheelchairs and scooters 
by the VHA were examined. The purpose was twofold: to characterize veterans who 
received wheeled mobility devices (by age, gender, race/ethnicity, diagnosis, number of 
comorbidities, priority group) and to determine whether a significant relationship exists 
between type of wheelchair and age, gender, or race/ethnicity (controlling for diagnosis 
and number of comorbidities). Studies investigating demographic differences of 
individual who receive and/or use AT have included wheelchairs [5, 11, 26]. These 
studies have assumed all wheelchairs are created equal, i.e. included wheelchairs as one 
category of AT. Most studies that have compared types of wheelchairs have focused on 
the durability of the device [27-30]. There is one known study, in press, [47] that 
examined the association between wheelchairs categorized according to their 
customizability and demographic and socioeconomic factors. Manual wheelchairs were 
categorized into two types: adjustable and non-adjustable. Power wheelchairs were 
categorized into three types: standard without programmable controls, standard with 
programmable controls, and custom with programmable controls. Participants included 
412 fulltime wheelchair users with SCI. In comparison, the study described herein 
categorized wheelchairs and scooters into eight types: four types of manual wheelchairs 
and three types of power wheelchairs and scooters (based on function, adjustability and 
customizability). Participants were veterans representing a range of diagnoses who 
received WMDS from the VHA. The average veteran participant was a white, 69 year old 
male, with COPD/CHF and three comorbidities, who was receiving his wheeled mobility 
device for a condition that was not incurred during military service. 
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Although the veteran population is decreasing (~ 3% from FY99 to FY01), the 
percent of veterans receiving services from the VHA is increasing  (~ 3% from FY99 to 
FY01) [7]. During this same 3-year period, this study found number of veterans receiving 
wheelchairs and scooters has increased by 13%. Approximately 2% of veterans who 
receive their healthcare from the VHA received wheelchair related AT from the VHA. 
Approximately 0.5% of the general veteran population received wheeled-related 
technology from the VHA, a figure similar to the 0.6% of the U.S. general population 
reporting themselves as wheelchair users [2].  
In FY99, 60,116 wheelchairs and scooters were provided by the VHA to 52,309 
veterans. If a one to one correspondence between wheeled mobility devices and 
individuals receiving the devices is assumed, there were 7,803 more wheelchairs and 
scooters provided than there were veterans to receive them. This suggests some veterans 
received more than one wheelchair during a FY, in accordance with VHA Handbook that 
states veterans “who require the constant and continued use of a wheelchair are to be 
furnished a second manual wheelchair  . . . when absence of a manual wheelchair during 
repair periods would create a severe hardship” [41]. Further, the handbook states “spare 
motorized wheelchairs may be furnished when an unusual circumstance occurs” and the 
“issuance of a manually propelled wheelchair should be considered for all outpatients 
who have been furnished a motorized wheelchair” [41]. In fact ~ 1% of the wheelchairs 
provided were coded as spares, which would account for as many as 6000 of the 7,803 
wheelchairs and scooters.  
Upon examination of the data (a comparison of cost and code variables), a second 
factor emerged as an explanation of the difference between number of devices provided 
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and number of veterans receiving them. Wheelchair components were inconsistently 
coded as wheelchairs, perhaps in an effort to associate the component with the wheelchair 
it accompanies. Coding components as the actual device may have inflated the actual 
wheelchair count. Scooters tend not to have accessories or components, so the scooter 
count was less likely to be impacted. The numbers for FY00 were 63,551 devices 
provided to 55,752 veterans (a difference of 7,799 devices) and in FY01, 67,861 devices 
were provided to 59,877 veterans (a difference of 7,984).  
A third factor is coding error. Consistency in coding (the second factor) among 
facilities must be implemented however, before the degree of coding error can be 
determined.  
An interesting finding was that in FY00 scooters made up 13% of the WMDS 
provided to veterans, and power wheelchairs 9% of WMDS provided. In FY01 these 
percentages shifted to 8% scooters, and 14% power wheelchairs. This change is attributed 
to advances in power wheelchair technology, i.e. availability of front-wheel, mid-wheel 
and rear-wheel drive allowing for indoor and outdoor use. 
Race:  Most research investigating the relationship between race/ethnicity and the 
use of AT [5, 11] has compared African Americans and Caucasians. This study found 
more variance between Hispanics and Caucasians than between Caucasians and African 
Americans.  
According to FY01 NPPD data and FY01 VA statistics for the general veteran 
population [7], 63% of veterans receiving wheeled mobility devices from the VHA were 
Caucasian, 13% were African American, and 5% Hispanic. During the same FY, 85% the 
general veteran population was Caucasian [7], 9% African American, and 4.5% Hispanic. 
 56
Thus the Caucasian and African American veterans receiving wheelchairs from the VHA 
were disproportionate to the general veteran population.  
Race/ethnicity statistics for veterans receiving their healthcare from the VHA was 
only found in the 1999 VHS report [40]. When comparing VHS results with FY99 NPPD 
data, 66% of veterans receiving wheeled mobility devices from the VHA were Caucasian, 
15% were African American, and 5% Hispanic. During the same FY, 73% of veterans 
receiving their healthcare from the VHA were Caucasian, 15% were African American, 
and 6% Hispanic. In this comparison, only Caucasians are disproportionate. The 
following discussion will reveal that Caucasians share equal risk for injury in combat. 
Both of the previously comparisons reveal that a fewer proportion of Caucasians however 
receive their healthcare or wheeled mobility devices from the VHA.  
Presently, a trend of increasing minorities in the VA general population exists [7]. 
For example, between FY00 and FY01 the percentage of African Americans increased by 
1.4% while the percentage of Caucasians decreased by 0.8% [7]. There has been an 
increase in the proportion of Hispanics receiving wheeled mobility devices (0.5% over 
FY99-FY01) and a decrease in the proportion of Caucasians (2.5% FY99 to FY01) and 
African Americans (nearly 1.5% FY99 to FY01) receiving wheeled mobility devices. Not 
only are a higher proportion of Hispanics are receiving their wheelchairs from the VHA, 
they tend to receive the more adjustable ultralight manual and custom power wheelchairs. 
Publications can be found both in supporting [48-50] and denying [51-54] that 
since the Vietnam War, the percent of minority soldiers who have been wounded or died 
in action has been disproportionate. Few African Americans and Hispanics were assigned 
to front-line combat units during World War II [52]. It was during the Korean War that 
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the military became racially integrated; parity with the population percent was 
approached during the Vietnam War [52].  During the Vietnam War, 10.6% of the troops 
and 12-12.5% of the causalities and deaths were African American veterans, while 12-
13.5% of the U.S. population was African American [49, 52, 55]. During Vietnam, 
Hispanics were classified by the Department of Defense (DoD) as “whites”. The DoD 
database was sampled by Hispanic surnames yielding the estimate that 5-6% of the troops 
serving in Vietnam were Hispanic, when Hispanics made up 4.5% of the U.S. population 
[49]. Estimates of Hispanic deaths in Vietnam range from 0.6% [52] to 5.2% [55] to 
5.5% [56]. Since Vietnam, African American soldiers have opted for technical and 
communications positions that do not involve direct combat, i.e. positions that provide 
marketable skills upon discharge [48, 49, 52]. In the 1991 Gulf War, 17% of the fatalities 
were African Americans and 4.1% Hispanic [52] when the U.S. population was 18% 
African American and 4% Hispanic [7]. In the Iraq war, the front line combat force is 
mostly Caucasian [50] , though unfortunately, the non-combat, support troops in Iraq 
have been unexpectedly subject to battle [52].  
In summary, the increased likelihood of Hispanics to receive ultralight and 
custom wheelchairs does not appear to bear a relationship to representation in front-line 
combat. In addition, more than 50% of the ultralight and custom wheelchairs were 
prescribed for non-service connected injuries. Subsequent analyses performed by this 
research team controlling for VISN, service category, and priority group yield a slight 
increase in the likelihood of Hispanics to receive ultralight and power wheelchairs. 
Future studies could repeat this analysis controlling for facility rather than the VISN to 
determine more specifically whether location is a factor. For example, a SCI specialty 
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center in an area with a high Hispanic population may prescribe more ultralight and 
custom wheelchairs, which may not be reflected when the analysis is performed by 
VISN. 
Evidence that Caucasians were more likely to receive scooters than minority 
groups was found in both comparisons that included scooters in the data subsets: all 
wheeled mobility devices and power wheelchairs and scooters. This finding may reflect 
the aging status of the World War II veterans who now require WMDS for nonservice-
connected conditions such as COPD and arthritis. It was established in a previous 
paragraph that there were very few minority veterans in World War II, therefore, it is not 
surprising that the older veterans receiving scooters are predominantly Caucasian.  
The study described herein and a study by Hunt et. al [47] found minorities were 
more likely than Caucasians to receive standard manual wheelchairs when only manual 
wheelchairs are considered. These two studies classified manual chairs differently. Hunt 
et. al [47] considered the lightweight rehabilitation wheelchair as a standard wheelchair 
whereas the study described herein created a third category for the lightweight chair. 
Thus when comparing the fully customizable ultralight manual wheelchair with the 
lightweight rehabilitation wheelchair, the study described herein found Hispanics were 
more likely to receive the customizable ultralight chair whereas Caucasians were more 
likely to receive the light weight rehabilitation wheelchair, an unexpected finding that 
deserves further investigation. 
The study described herein and the study by Hunt et. al [47] used a similar 
categorization of power wheelchairs: a standard power chair without programmable 
controls, a standard power chair with programmable controls, and a customizable 
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wheelchair. In the Hunt et. al [47] study, none of the participants received a standard 
wheelchair without programmable controls. Minorities were more likely to receive 
standard wheelchairs with programmable controls, and Caucasians customizable 
wheelchairs. It should be noted Hunt et. al’s [47] study only included individuals with 
SCI recruited from the National Spinal Cord Injury Model Systems database, funded by 
the Department of Education. In the study described herein, the standard wheelchair 
without programmable controls was the most frequently prescribed power wheelchair for 
individuals with tetraplegia and paraplegia due to SCI. It was beyond the scope of the 
study described herein to compare type of wheelchair by diagnosis and race/ethnicity 
because of the increasing complexity and quantity of the data. Rather, because diagnosis 
was a significant determinant of type of wheelchair prescribed, it was used as a control 
variable. A proposal has been submitted to study the provision and utilization of ATDS 
within diagnosis (stroke).  
Diagnosis: Type M1 (depot) wheelchairs were provided more than 50% of the 
time for veterans with stroke, TBI, PD, COPD/CHF, and arthritis. Conditions such as 
stroke and TBI may require only temporary use of a wheelchair. For example, in a study 
of use or nonuse of the wheelchair following a stroke, Garber and colleagues [57] found  
31% of participants stopped using their wheelchair, all of which were manual 
wheelchairs, typically because of improved physical function or use of alternative 
mobility devices such as walkers or canes. Veterans with COPD/CHF and arthritis may 
be household ambulators, but require a wheelchair for longer distances. Type M1 (depot) 
chairs may be considered a more cost effective solution to part time wheelchair use. 
Depot wheelchairs do however require more exertion and energy to propel [19, 58], 
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which needs to be considered when prescribing a wheelchair for veterans with 
deconditioning disorders.  
Veterans with SCI and some veterans with MS are more likely ro rely on their 
wheelchairs for mobility. Veterans with SCI and MS received Type M1 (depot) chairs 
less than 30% of the time. In contrast, Hunt et. al [47], in their study of full-time 
wheelchair users with SCI who received their wheelchairs from SCI centers of 
excellence, found 97% of manual wheelchair users had customizable chairs (equivalent to 
the untralight wheelchair). The remaining 3% used manual wheelchairs that were not 
ultralights. Because of differences in gathering and coding the information and reporting 
the data, only approximate comparisons can be made between the findings of the Hunt et. 
al study and the study described herein. However, a secondary univariate analysis found 
38% of veterans with SCI received standard, depot manual wheelchairs from the VHA, 
and 20% received customizable, ultralight wheelchairs. Caution is advised when 
interpreting these comparisons as some of the depot chairs provided may have been 
spares. It was beyond the scope of this study to conduct an in depth analysis of initial, 
spare, and replacement chairs by wheelchair type at the patient level.  
None of the power wheelchair users in the Hunt et. al [47] study received a 
standard power chair without programmable controls, 46% received standard power 
chairs with programmable controls, and 54% received customizable chairs. In 
comparison, approximately 40% of veterans with SCI received standard power chairs 
without programmable controls from the VHA, 26% received standard power chairs with 
programmable controls, and 33% received customizable chairs.  
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The results of these two studies lead one to wonder if veterans with SCI are more 
likely to go to an SCI specialty-seating clinic for their wheelchairs. Hunt et. al [47] found 
participants with customizable wheelchairs were more likely to have private health 
insurance (p = 0.018). While specialty-seating clinics exist within the VHA, there is no 
way to differentiate which wheelchairs were prescribed by clinicians in these clinics. This 
is fact is one of the limitations of the NPPD and this study. 
Service Category: Nearly 80% of the wheelchairs were prescribed for non-service 
related conditions. It should be noted that within the NPPD, one veteran can receive a 
wheeled mobility device for a service-connected and a nonservice-connected condition. 
For example, a veteran may receive an ultralight wheelchair for a service-connected 
injury (perhaps a SCI incurred while serving in Vietnam), and a scooter for a nonservice-
connected condition (i.e. COPD as the veteran ages, and perhaps with a lifestyle that 
includes smoking and little exercise).  
Secondary analyses revealed a higher proportion of depot (37% versus 26%) and 
lightweight (24% versus 19%) wheelchairs are provided for nonservice-connected 
conditions than service-connected conditions (p=<.0001). A higher proportion of 
standard power (7% versus 4%), custom power (5% versus 3%), and scooters (22% 
versus 17%) wheelchairs are provided for service-connected conditions than nonservice-
connected conditions (p=<.0001). A limitation of this analysis is that it did not control for 
diagnosis. Diagnoses resulting from a service connected condition are likely to differ 
from those resulting from a nonservice-connected i.e. a veteran is less likely to receive a 
wheelchair for a diagnosis of COPD or arthritis while on active duty.  
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Age: Younger veterans were more likely to receive ultralight wheelchairs. These 
veterans, mean age = 55, who may be more active, more likely to compete in sports, and 
associate with peers who use sportier wheelchairs, are likely Vietnam veterans. Older 
veterans, mean age = 67, likely World War II veterans, were more likely to receive depot 
chairs. If older veterans are perceived as less active, they may also be perceived as having 
less need for sportier chairs. The problem with this logic is depot wheelchairs are heavier 
and non-adjustable therefore increase the demands upon already arthritic joints for 
propulsion. The lighter the chair, the easier it is to push. Wheelchair propulsion requires 
the upper extremities to produce repeated, forceful movements, which can result in carpel 
tunnel syndrome and injury to the shoulder [59-64]. Lighter chairs reduce the propulsion 
workload, thus lower the risk of secondary injuries to the user’s arms and shoulders [58, 
65-67]. In addition, the heavier depot chairs are difficult to load into the car by aging 
caregivers. When World War II veterans were injured, depot chairs (patented in 1937) 
were the only available wheelchair design. If a veteran is a depot chair user, their 
replacement wheelchair is also likely to be a depot wheelchair. An analogy would be Iraq 
veterans who have recent blast injuries are receiving state of the art “C-leg” prosthetics, 
whereas veterans from previous wars are more likely to continue to use more traditional 
prosthetic extremities. It should be noted that while depot wheelchairs were the most 
frequently prescribed wheelchair, the lighter weight rehabilitation chairs are also being 
provided to older veterans, mean age = 65.5 years old. While rehabilitation wheelchairs 
are lighter weight, they do not provide the axle position adjustability that reduces the 
repetitive stress generated during propulsion [16]. 
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Both the study described herein (p = 0.27) and the study by Hunt et. al [47] (p = 
0.28) found younger individuals were more likely to receive customizable power 
wheelchairs (p = 0.28). Hunt et. al did not find significant age differences for manual 
wheelchairs, perhaps because the mean age of participants was 42 (14) and 97% of 
participants who used manual wheelchairs used an ultralight. In comparison, in the study 
described herein, the finding that veterans who received an ultralight manual wheelchair 
from the VHA (when all manual wheelchairs were compared) had a mean age of 55 (16) 
was significant (p=<.0001).   
The mean age of veterans receiving wheeled mobility devices from the VHA 
during FY99-01 was 67 (13), 9 years older than the general veteran population (mean age 
= 58) [7].  Similarly, the mean age of veteran wheelchair users and wheelchair users in 
the U.S. population [2, 10] was similar, 67 and over 65 years respectively.  
Limitations: A limitation of health disparity research is that it tends to compare 
groups, most frequently racial/ethnic groups, without taking into consideration 
interrelated factors such as culture, environment, health behaviors and beliefs, literacy, 
SES, and power differentials [68]. Thus, caution must be taken when interpreting 
differences between groups.  
A second limitation of this study is that it describes what was provided, but does 
not describe how it was prescribed. For example, the databases WMDS and scooters, i.e. 
where and by whom. We do not know which if any devices were prescribed by a 
specialty clinic, such as an SCI clinic, or a clinic staffed by clinicians trained and 
certified in seating and mobility technology.  
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A third limitation of this study is administrative databases, which “are the by-
product of running a healthcare system” [69], do not provide information unique to each 
veteran, for example, a description of their mobility, activity, and participation needs and 
functional levels. Because functional level data was not available, the distinction between 
type of wheelchair per functional level could not be made. For example, veteran with a 
mild stroke will have different mobility needs than a veteran with a more massive brain 
stem stroke.  
Policy Implications: In spite of its limitations, this study provides important 
policy implications. First, the VHA provides wheelchairs to veterans no matter what there 
priority group, though for some there may be a co-pay. Second the VHA provides not 
only an initial wheelchair, but will provide a spare wheelchair and a sports wheelchair 
(encouraging veterans to remain physically and socially active). Third, a profile of types 
of wheeled mobility devices provided by VHA facilities across the U.S. was provided 
and compared to a profile of devices provided by seating and 13 mobility specialty 
centers across the U.S. These are the first two studies known that have provided such 
information that can be used as a baseline from which to establish wheelchair 
prescription practice guidelines. What is missing from both these studies are the 
functional outcomes of the individuals who received the devices which ultimately are 
needed to determine if the prescription decision was in the best interest of the user. 
Alternatively, training in rapidly advancing seating and mobility technology training for 
clinicians may be indicated.   
While the NPPD did provide a HCPCS code, there was no information on the 
make or model of the wheelchair, which could assist in policy decisions such as 
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competitive bidding, or in the validation some of the other NPPD fields, i.e. having a 
brand name, model number, and HCPCS code could differentiate inconsistencies in 
coding procedures across facilities and data entry persons within facilities, and identify 
coding error. It would also have been helpful to have been able to differentiate whether a 
chair was purchased from a vendor or from a manufacturer.  The vendor field did not 
make this distinction clear. 
While making inquiries about the data entry process at the facility level, it was 
found there might be discrepancies at times between prescription and provision at at least 
one facility. The clinician prescribes a wheelchair. The prescription is then given to a 
vendor. The vendor purchase order is entered into the VA system, and the device is 
delivered to the veteran’s home (if outpatient). There appears to be no check built in to 
the system to insure that the vendor has ordered what the clinician prescribed, thus 
prescription should not be used interchangeably with provision.  
While making inquiries among wheelchair vendors with Assistive Technology 
Specialist (ATS) certified by the Rehabilitation Engineering and Assistive Technology 
Society of North America (RESNA), it was found that the NPPD includes outdated 
HCPCS codes from the 1970s. It is possible that using outdated codes could contribute to 
confusion between vendors and the VHA. It was unclear where these outdated “E” codes 
where originating: from the vendor or the VHA, but ATS vendors interviewed by the 
investigators were unfamiliar with most of the “E” codes.  Knowing what happens to the 
wheelchair after it is delivered should be included in the continuum of care of the veteran. 
Tracking what happens to the chair is also important. Wheelchairs, especially power 
wheelchairs, are expensive, and frequently take many months before delivery. In the 
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meantime, a veteran’s condition can change or the veteran may die (i.e. veterans with 
ALS). A chair no longer beneficial to one veteran may benefit another, and eliminate the 
months of waiting. While the VHA does refurbish and reissue wheelchairs, this study 
found this process is not being well tracked by the NPPD, suggesting the process itself, 
which could improve the quality of care to veterans and save dollars, needs further 
investigation.  
Another suggestion to improve the effectiveness of the NPPD for research thus 
the generation of data to support policy decisions is to include the diagnosis for which the 
WMD is being prescribed in the NPPD.  
In closing, consistency in the decision process in which clinicians engage when 
prescribing a wheelchair is important to the continuum of care of veterans. A database is 
only as valid as the data that is input. The value of availability of quality training for 
clinicians working in seating and mobility cannot be underestimated. Alternatively, the 
market will be driven by manufacturers and vendors [9]. 
2.7  CONCLUSION 
This was the first large-scale study to look at the types of wheelchairs prescribed 
in the context of disability. The findings were strongly suggestive of disparity in how 
wheelchairs are provided to veterans and that the standard of care for the provision of 
wheeled mobility devices within the VHA is not of the same quality as in other 
populations.   
The results of this study indicate Caucasians were more likely than Hispanics and 
African Americans to receive power wheelchairs.  Caucasians were more likely than 
minorites (Hispanics, African Americans, Asians and American Indians) to receive 
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scooters and less likely to receive standard, depot wheelchairs. Site level analyses need to 
be completed to further investigate these findings. 
Within the veteran population, the wheelchair most frequently prescribed 
wheelchair for all diagnoses was a standard or depot wheelchair. For veterans with SCI 
receiving services from the VHA, 13% received ultralight manual wheelchairs in 
comparison to 97% of clients with SCI receiving services from Model Spinal Cord Injury 
Centers [47].   
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3.1  ABSTRACT   
The purpose of this study was to examine the costs of wheelchair and scooter, per 
HCPCS code, for geographic and supplier variation. Using a cross-sectional, 
retrospective, study design, two years of data from the VHA National Prosthetic Patient 
Database (113,724 records) were analyzed. Due to the distribution of the cost data, 
descriptive statistics (median costs) were used to identify high median costs. A high 
median threshold (national median times 2) was calculated for each HCPCS code. The 
percentage of HCPCS codes with median costs exceeding the threshold ranged from 0% 
to 17% across Veteran Integrated Service Networks Veteran Integrated Service Networks 
(VISNs).  The percentage of the top 100 vendors (by cost volume) with median costs 
exceeding the threshold ranged from 2% to 19% for the top 20 HCPCS codes (by 
frequency volume). During FY00 and FY01, the Veterans Health Administration (VHA) 
provided over 131,000 wheelchairs and scooters, at a cost of $109,010,198. Of this $109 
million, $7,747,405 exceeded an established threshold, and is considered potential 
excessive cost.  
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3.2  INTRODUCTION 
A Veterans Health Administration (VHA) preliminary report on the top total 
dollar cost prosthetic items (Fred Downs, Chief Consultant, Prosthetic and Sensory Aid 
Service, written communication, November, 2000) indicated for the first three quarters of 
2000, scooters were the second highest spending total, manual wheelchairs the third 
highest spending total, and power wheelchairs the fifth, (oxygen equipment was the first). 
For these three quarters, well over 40,000 wheelchairs (manual wheelchairs, power 
wheelchairs, and scooters), were issued at a government cost of over 20 million dollars.  
The VA, as does any institutional purchaser, seeks to obtain goods at a fair market 
price, commensurate with quality and with the discounts normally associated with high 
purchase volumes.  However, “assistive devices, like pharmaceuticals, have eluded 
intensive analysis that adequately addresses fair market pricing” [1] due, according to 
Render et. al, to lacking assistive technology (AT) expertise outside of the industry, lack 
of expert review of prescription practices, and inconsistencies in billing and 
reimbursement.  
These shortcomings have led to opportunities for fraudulent billings.  Fraudulent 
power wheelchair scams are the fastest growing scam in Medicare [2]. DME scams in 
California are at the center of what one Federal Bureau of Investigation (FBI) field office 
is calling the largest healthcare undercover fraud investigation in U.S. history. The FBI in 
California have charged 263 DME providers who allegedly have collected $164 million 
in fraudulent claims against the state’s Medicaid program, Medi-Cal [3]. In Miami, $14 
million in false claims were submitted over several years [4]. The FBI believes one out of 
10 DME, prosthetics, orthotics, and supply providers is a “crook” (sic) [5]. In response to 
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the increasing volume of fraudulent billing, the Center for Medicare and Medicaid 
Services (CMS) announced “stringent efforts aimed at stopping abuse of the power 
wheelchair benefit” [6, 7]. Like Medicare, the VHA is vulnerable to DME fraud. In fact, 
a DME company uncovered a plan to fabricate $30 million in non-existent sales of DME 
to the VHA by one of their consultants [8]. In response, payors have fought back by 
applying more stringent interpretations of durable medical equipment (DME) policy.  
Unfortunately, this tactic punishes consumers with legitimate needs.   
The National Patient Prosthetics Database (NPPD) was developed by the VHA 
Prosthetics and Sensory Aids Service (PSAS) to track WMD and other prosthetic 
expenditures. In addition, the NPPD provides an opportunity to review prescription 
practices between clinical teams, facilities, and Veteran Integrated Service Networks 
(VISNS).  For over 50 years, wheeled mobility prescriptions have been written by 
multiple clinical services and teams in each of the 172 VHA medical centers with little 
contact between centers (Fred Downs, Chief Consultant, Prosthetic and Sensory Aid 
Service, written communication, December 2000). Today, not only is the demand for 
WMDS increasing [9-13], technology is changing rapidly. As wheelchair technology 
becomes increasingly more sophisticated and complex, so do the clinical decision 
processes as to who gets what device. Thus, the question that comes to mind is: Are there 
variations in cost of WMDS provided by the VHA and if so, do these variations reflect 
varying prescription practices that may ultimately affect the quality of care provided to 
veterans?  
The objective of this study was to use NPPD data to investigate whether the 
expenditures for wheeled mobility devices (WMD), or wheelchairs and scooters, varied 
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geographically or by vendor. The first question asked if WMD costs at the Veteran 
Integrated Service Network (VISN) [14] level differed from the national median. The 
second research question asked if WMD costs varied by vendor.  The answer to these 
questions can guide VA policy makers toward more enlightened decisions than merely 
"tightening the noose" as other payors have done. 
3.3  METHODS 
3.3.1  Design and Data Source 
This study was approved by the VA Pittsburgh Healthcare System Institutional 
Review Board. A cross-sectional, retrospective, design used two years of data from the 
NPPD, extracting the records of veterans who received wheelchairs or scooters from the 
VHA during FY00 or FY01. NPPD data, housed at the VA Information Resource Center 
(VIREC) [15] at Hines, IL. 
3.3.2  Database Description 
NPPD: The NPPD contains information on every device issued to veterans 
including the description of the device, prescribing station and VISN, type of service 
(initial issue, replacement, spare, or repair), date, cost, and vendor. The fields used for 
this study were “VISN”, “cost”, “createdate”, “vendor”, “hcpcspsas”, “nppdline”, and 
“patientid”. 
3.3.3  Data Cleaning 
General NPPD data cleaning was performed according to decision rules 
developed during a collaborative validity study of the NPPD [16]. A comparison of the 
frequency counts of the records contained in the “nppdline” and “hcpcspsas” fields 
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determined the “nppdline” field was the most reliable and valid method of selecting the 
wheelchair and scooter items. The “nppdline” field is a VA code that specifies the type of 
device. For example, the “100” category represents wheelchairs, “100 A” represents 
power wheelchairs, “100 B” manual wheelchairs,  and “100 C” wheelchair accessories” 
[17]. The “hcpcspsas” field is the Prosthetics and Sensory Aids Services (PSAS) code 
that corresponds to the CMS HCPCS code. During data cleaning, when inconsistencies 
between the “nppdline” and “hcpcspsas” fields were found, other fields including vendor, 
cost, and item description were considered, and the record recoded accordingly. For fiscal 
years (FY) 2000 and 2001, only three WMDs required recoding: a scooter and two 
manual wheelchairs.   
Cost data was further cleaned by excluding 3,799 observations with missing cost 
values and 5,639 observations with $0.00 cost values, with 121,774 observations 
remaining for FY00 and FY01 combined. HCPCS codes with five or less observations 
over the 2-year study period were excluded (E1085 n=5, E1091 n=1, E1170 n=5, and 
E1299 n=1) leaving 64 HCPCS codes and 121,762 observations (see following section 
for definition of HCPCS codes). HCPCS code E1065 (n=161) was also deleted because 
of inconsistent coding: it was used as a code for scooters, attachments that transform a 
manual wheelchair to a power wheelchair, and power wheelchairs. 
Wheelchair costs that were too low to represent wheelchairs or scooters (assumed 
to be either accessories or coding error) were excluded (because of the lowering effect 
they had on mean and median values) leaving 113,724 records. The determination of 
which low values to exclude was made as follows: Logical high dollar cut-off points were 
selected based the code and description of the device, market value, and the VHA 
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contract amount if known. Frequencies were run on each HCPCS code by the cost 
variable. The cost value at the cumulative frequencies of 10%, 50%, 75%, and 100% 
were assessed as well as the percent of records excluded at proposed cutoff. See 
Appendix A for the selected cutoffs per HCPCS code and corresponding frequency 
information. High cutoff points were not implemented as the purpose of this study was to 
identify high cost outliers by VISN and by vendor. 
The vendor data was also cleaned. Multiple names were used for the same vendor, 
for example, WHEELCHAIR, Wheelchair, WheelChair, Wheel Chair Inc, WheelChair 
Inc., and WheelChair/ Inc. were combined if these vendors were also serving the same 
VISNs, reducing the number of unique vendors from over 1,325 to 696. Devices from 
VHA PSAS orthotic and prosthetic labs and warehouses were combined so the PSAS 
could be considered as a cost source. Number of vendors was further limited by 
excluding vendors with less than five total wheelchair or scooter sales to the VHA 
leaving 243 vendors and 113,336 records. So results could be presented in a 
comprehensible manner, data was further reduced to the top 100 vendors (measured in  
dollars) and the top 20 HCPCS codes (measured in frequency) were extracted leaving 
103,833 records to be included in the vendor analysis. 
3.3.4  Operational Definitions 
HCPCS codes:  Wheelchairs and scooters sold in the U.S. must be approved by 
the Federal Drug Administration (FDA). The FDA forwards information on the 
wheelchair application to the Center for Medicare and Medicaid Services (CMS). CMS 
assigns the wheelchair a standard code, referred to as HCPCS (Healthcare Common 
Procedure Coding System) code designed for billing purposes. HCPCS codes are used to 
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identify the type of device in the NPPD.  Table 19 provides the list of codes included in 
the clean dataset (prior to exclusion of all but the top 20 HCPCS codes) and typical CMS 
and NPPD descriptions. 
 
Table 19  HCPCS codes and typical NPPD 
descriptions 
Code Description 
E1050 W/c reclining fxd arms 
E1060 W/c detachable arms 
E1070 W/c detachable foot r 
E1083 Hemi w/c fixed arms 
E1084 Hemi w/c detachable a 
E1086 Hemi w/c detachable a 
E1087 W/c lightwt fixed arm 
E1088 W/c lightweight det a 
E1089 W/c lightwt fixed arm 
E1090 W/c lightweight det a 
E1092 W/c wide/w leg rests 
E1093 W/c wide/w foot rest 
E1100 W/c s-recl fxd arm leg res 
E1110 W/c semi-recl detach 
E1130 W/c stand det arm ft rest 
E1140 W/c standard detach a 
E1150 W/c standard w/ leg r 
E1160 W/c fixed arms 
E1171 W/c amputee w/o leg r 
E1172 W/c amputee /detach ar 
E1180 W/c amputee w/ foot r 
E1190 W/c amputee w/ leg re 
E1195 W/c amputee heavy dut 
E1200 W/c amputee fixed arm 
E1210 W/c motorfxd arm leg rest 
E1211 W/c motorized w/ det 
E1212 W/c motorized w full 
E1213 W/c motorized w/ det  
E1220 W/c special size/constrc 
E1221 W/c spec size w foot 
E1222 W/c spec size w/ leg 
E1223 W/c spec size w foot 
E1224 W/c spec size w/ leg 
E1225 W/c spec sz semi-recl 
E1226 W/c spec sz full-recl 
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Table 19  HCPCS codes and typical NPPD 
descriptions 
E1227 W/c spec spec sz spec ht A 
E1228 W/c spec spec sz spec ht B 
E1230 Powered operated vehicle 
E1240 W/c litwt det arm leg rest 
E1250 W/c lightwt fixed arm 
E1260 W/c lightwt foot rest 
E1270 W/c lightweight leg r 
E1280 W/c h-duty det arm leg res 
E1285 W/c heavy duty fixed 
E1290 W/c hvy duty detach a 
E1295 W/c heavy duty fixed 
E1296 W/c special seat heig 
E1297 W/c special seat dept 
E1298 W/c spec seat depth/w 
K0001 Standard wheelchair 
K0002 Std hemi (low seat) w/c 
K0003 Lightweight wheelchair 
K0004 High strength ltwt whlchr 
K0005 Ultralightweight wheelchair 
K0006 Heavy duty wheelchair 
K0007 Extra heavy duty wheelchair 
K0008 Custom manual wheelchair/base 
K0009 Other manual wheelchair base 
K0010 Std wt frame power w/c 
K0011 Std wt pwr whlchr w control 
K0012 Ltwt portbl power whlchr 
K0013 Custom motorized/power wheelchair base 
K0014 Other power whlchr base 
 
 
Cost:  Cost was determined by summing wheelchairs and wheelchair components 
as follows. Veterans with more than one record per fiscal year were identified. These 
records were then grouped by veteran and sorted by the date the record was created 
(variable = “createdate”), which according to PSAS policy must be within five days of 
prescription. Using the “nppdline” variable, wheelchairs were coded as “1” and 
wheelchair components (such as seating systems, removable armrest not included in the 
price of the chair) were coded as “2”. All wheelchairs (code=1) were included in cost 
calculations. Wheelchair components (code=2) were added to the cost of the wheelchair 
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if their “createdate” was within 20 days (plus or minus 10 days) of the “createdate”. If the 
component “createdate” was not within 20 days of a wheelchair “createdate”, the record 
was not considered part of the wheelchair purchase and was excluded. If the component 
“createdate” was within 20 days of more than one wheelchair “createdate”, it was 
included into the cost of the wheelchair with the nearest “createdate”. If there were more 
than one wheelchair with the same “createdate” as the component “createdate”, the 
component was included in the cost of the first wheelchair listed with matching 
“createdate”.  
According to VHA policy, a WMD order has to be entered into the system within 
five days of prescription. Initially the window set at five-days from the date the device 
was entered, based on the assumption that a component would not likely be ordered prior 
to the device itself. This assumption proved false. Based on examination of the data, the 
window was extended to capture components entered 10 days prior and 10 days post 
entering the device into the system. 
VISN: There are approximately 1127 VHA facilities [14] nationally which are 
organized according to 22 Veteran Integrated Service Networks (VISNS). A VISN may 
include more than one state (i.e. in New England), or for large states (i.e. Texas) there 
may be more than one VISN per state. In this study, VISNS were used as the 
geographical unit of comparison, as it is the geographical unit used in all the VHA 
databases. 
Vendor: The “vendor” field of the NPPD is a text description of the company that 
provided the device [15]. 
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3.4  ANALYSES  
SAS® [18] software was used for all analyses. The distribution of the clean 
dataset (low values excluded) was extremely skewed and could not be normalized with a 
log transformation. Thus, descriptive statistics, median values, were used to answer 
question 1, whether cost varied by VISN, and question 2, whether cost varied by vendor.  
More specifically, the investigators were interested in high dollar costs. To identify the 
high dollar costs, a threshold was calculated for each HCPCS code as follows: the median 
cost for each HCPCS code X 2 = high median threshold. The high median threshold was 
then subtracted from the cost of the device. The remainder, if positive, was the amount 
exceeding the high median threshold.  
To answer the first research question, records with costs exceeding the high 
median threshold were sorted by VISN. For each VISN, HCPCS codes with median 
values exceeding the high median threshold were identified and displayed in table format. 
The high cost variation was then quantified by identifying all records with cost exceeding 
the high median threshold, then summing the excessive costs per VISN.   
A similar procedure was used to answer the second research question. Records 
with costs exceeding the high median threshold were sorted by vendor. For the top 100 
vendors (as described in data cleaning), HCPCS codes with median values exceeding the 
high median threshold were identified and displayed in table format. The variation was 
then quantified by identifying all records with cost exceeding the high median threshold, 
then summing the excessive costs by vendor.   
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3.5  RESULTS   
The answer to both research questions was yes, variation in the cost of WMD 
among VISNs and among vendors exists. A conservative approach was used to calculate 
HCPCS high median cost thresholds (national median for each HCPCS times 2) to 
identify variance. For each HCPCS code, the national median, the high median threshold, 
and VISN median costs that exceed the threshold, are displayed in Tables 20 – 23. Table 
20 displays the high median values per HCPCS code for VISN 1 – 7. Table 21 displays 
the high cost median values for VISN 8 – 14, and Table 22 the high cost values for VISN 
15 – 22.  The percentage of HCPCS codes with median costs exceeding the threshold 
ranged from 0% to 17% across VISNs. A limitation to median values is they do not 
reflect the high excess costs. Thus the dollar amount each VISN exceeded the high 
median cost threshold was calculated as follows: for all records the threshold was 
subtracted from the device cost. Positive results (greater than 0) were summed and the 
totals displayed in Table 23.  
VISN 13 had no HCPCS median values that were over the threshold. However, 
VISN 13 did have individual records that exceeded the threshold, totaling over $100,000. 
The total dollar amounts VISNs were over the threshold ranged from $102,000 (VISN 
13) to $903,000 (VISN 16). While only 12% of the VISN 16 HCPCS median values that 
were over the threshold, VISN 16 had the highest frequency and dollar amount of 
individual devices with costs that exceeded the thresholds. The total dollar amount 
exceeding HCPCS thresholds, for all VISNS, was $7,747,405 (data not presented in a 
table)3. The $7.7 million dollar excess cost represents approximately 7% of the $109 
million dollar VHA expenditure for wheelchairs and scooters during FY00 and FY01. 
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For each HCPCS code, the national median, the high median threshold, and 
vendor median costs that exceed the threshold, are displayed in Tables 24 – 27. In order 
to present the results in a more concise manner, only median value results for the top 100 
vendors and top 20 HCPCS codes (as described in “Data Cleaning”) are presented.  
Table 24 displays the high median values per HCPCS code for the five highest volume  
(16-20/20) HCPCS codes: K0001, K0004, E1230, K0003, and K0005. Table 25 displays 
the next highest volume (11-15/20) HCPCS codes: K0011, E1140, K0006, K0014, and 
E1150. Table 26 displays the third highest volume (6-10/20) HCPCS codes: K0007, 
E1211, E1260, E1212, and E1088.  Table 27 high median values per HCPCS code for the 
lowest volume (1-5/20) HCPCS codes: K0008, E1070, E1060, K0010, and K0012.  
As an example of how to read and interpret these tables, Table 24 contains one of 
the highest volume HCPCS codes, the K0004, a lightweight manual rehabilitation 
wheelchair with a national median cost of $362 and a high median threshold of $723. For 
the K0004, 13 vendors had excess median costs totaling $172,562 for 266 wheelchairs, 
with an average of $649 per chair over the $723 threshold. While 13 of the top 100 
volume vendors (13%) had median costs exceeding the threshold for the K0004, the 
percent of vendors with median costs exceeding the threshold ranged from 2% to 19% 
across the top 20 HCPCS codes.    
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Table 20  VISN 1 – 7  high median costs: VISN median costs higher than national median costs per HCPCS code for FY00 & 
FY01 combined 
VISN Median Costs Over the High Median Cost Threshold (National Median x 2) for VISNS 1 - 7 
 NATIONAL VISN 1 VISN 2 VISN 3 VISN 4 VISN 5 VISN 6 VISN 7 
HCPCS    high median                       
Code n median $ threshold n median n median n median n  median n median n median n median 
Manual 
E1050 75 $392 $784 4 $1,076                     
E1060 910 $370 $740        12 $990              
E1070 976 $178 $356 17 $446 4 $418 16 $365              
E1084 53 $436 $872        2 $996              
E1086 44 $387 $774     1 $3,015                  
E1110 250 $709 $1,418     10 $1,531        7 $1,560        
E1130 563 $156 $312 7 $450        51 $487           
E1140 2441 $170 $340 14 $468        55 $436           
E1150 1384 $211 $422                  8 $426 2 $579 
E1160 138 $166 $332 2 $1,125 3 $1,007           1 $340    
E1171 24 $455 $910            1 $1,863        2 $1,125 
E1172 119 $351 $702 1 $1,469    2 $709       7 $749    
E1180 82 $379 $758               1 $845        
E1190 164 $237 $474            6 $800 4 $481 4 $844 2 $504 
E1195 47 $626 $1,252 2 $1,951 4 $1,971               1 $1,700 
E1200 47 $145 $290            5 $1,011 1 $516 1 $386    
E1220 208 $1,126 $2,252               6 $1,729     12 $1,764 
E1221 125 $696 $1,392     1 $1,791                  
E1223 254 $182 $364     1 $1,117 1 $981       1 $371 1 $1,669 
E1224 20 $405 $810                  2 $1,713    
E1226 240 $497 $994     1 $1,874 5 $1,913 1 $1,854 6 $1,409        
E1228 25 $349 $698 2 $1,086                     
E1240 316 $411 $822 1 $844    2 $878              
E1260 830 $292 $584                  1 $1,435    
E1280 152 $596 $1,192                      92 $1,614 
E1296 67 $421 $842     6 $1,056           4 $866    
E1298 166 $788 $1,576                  1 $1,755    
K0002 459 $359 $718 3 $2,217           2 $733        
K0007 1322 $496 $992 40 $1,143                     
K0009 668 $661 $1,322               18 $1,799        
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Table 21  VISN 8-14  high median costs: VISN median costs higher than national median costs per HCPCS code for FY00 & FY01 
combined 
 
VISN Median Costs Over the High Median Cost Threshold (National Median x 2) for VISNS 8 - 14 
 NATIONAL VISN 8 VISN 9 VISN 10 VISN 11 VISN 12 VISN 13 VISN 14 
HCPCS    high median                         
Code n median $ threshold n median n median n median n  median n median n median n median 
Manual 
E1050 75 $392 $784              3 $810     1 $1,905 
E1070 976 $178 $356 24 $515         26 $451       
E1087 115 $444 $888       1 $1,483            
E1089 58 $588 $1,176     1 $1,531                
E1090 461 $570 $1,140                    1 $1,244 
E1093 74 $376 $752          1 $2,700         
E1100 73 $640 $1,280     3 $1,374                
E1130 563 $156 $312     1 $380                
E1140 2441 $170 $340              5 $410     4 $386 
E1150 1384 $211 $422              3 $423       
E1190 164 $237 $474              2 $497       
E1200 47 $145 $290              2 $331       
E1221 125 $696 $1,392              1 $9,053       
E1228 25 $349 $698       2 $1,141             
E1240 316 $411 $822     1 $997                
E1250 53 $452 $904 1 $1,578                  
E1290 503 $573 $1,146                    7 $1,580 
E1295 61 $622 $1,244     1 $1,364              1 $1,351 
E1297 44 $320 $640 2 $1,899      1 $1,002         
K0007 1322 $496 $992                    35 $993 
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Table 22  VISN 15-22  high median costs: VISN median costs higher than national median costs per HCPCS code for FY00 & FY01 
combined 
VISN Median Costs Over the High Median Cost Threshold (National Median x 2) for VISNS 15 - 22 
 NATIONAL VISN 15 VISN 16 VISN 17 VISN 18 VISN 19 VISN 20 VISN 21 VISN 22 
HCPCS    high median                          
Code n median $ threshold n median n median n median n median n median n median n median n median 
Manual                                       
E1050 75 $392 $784             3 $1,141       3 $1,660 
E1060 910 $370 $740       2 $1,772       1 $1,125        
E1087 115 $444 $888       3 $1,400   1 $1,000          
E1088 1068 $455 $910                   25 $922    
E1089 58 $588 $1,176       1 $2,593             1 $4,778 
E1090 461 $570 $1,140       1 $1,174             16 $1,168 
E1092 69 $382 $764                 1 $1,322        
E1100 73 $640 $1,280           1 $2,165 1 $1,726       2 $1,294 
E1130 563 $156 $312             56 $388   2 $409    
E1140 2441 $170 $340           1 $549 54 $415 1 $560        
E1160 138 $166 $332 11 $522                      
E1171 24 $455 $910           1 $1,389              
E1172 119 $351 $702     8 $1,045 1 $883                
E1180 82 $379 $758     3 $953           1 $934 1 $950    
E1190 164 $237 $474 7 $488 3 $889                    
E1195 47 $626 $1,252             1 $1,406       1 $2,777 
E1200 47 $145 $290           4 $1,015 1 $1,485          
E1220 208 $1,126 $2,252       16 $2,435       7 $4,280     4 $2,607 
E1221 125 $696 $1,392             1 $1,988          
E1223 254 $182 $364 4 $675 1 $592       1 $8,079          
E1225 38 $1,073 $2,146 2 $2,325                      
E1228 25 $349 $698     2 $1,214                    
E1250 53 $452 $904                    2 $1,903 2 $1,812 
E1260 830 $292 $584     19 $682                    
E1280 152 $596 $1,192                       1 $1,728 
E1295 61 $622 $1,244                   1 $1,740    
E1296 67 $421 $842                       3 $1,622 
E1297 44 $320 $640 1 $756 7 $869                    
E1298 166 $788 $1,576                   1 $4,697    
K0002 459 $359 $718                 2 $1,018     8 $828 
K0007 1322 $496 $992       6 $1,615         17 $1,354    
K0009 668 $661 $1,322       12 $1,343   18 $1,867 8 $1,815 15 $1,357    
Power 
E1213 363 $3,599 $7,198                     2 $7,384    
K0012 748 $1,993 $3,986     16 $4,204       3 $4,683          
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Table 23  Total dollar amount each VISN is over 
the high cost threshold 
Total $ Amount Individual Observations Exceed  
National Median X 2 Threshold  by VISN 
    % of medians   $ exceeding 
  exceeding   nat'l medianx2 
    nat'l median Sum n threshold † 
1 17% 93 $58,254 
2 14% 31 $68,897 
3 11% 40 $69,754 
4 9% 119 $215,799 
5 12% 45 $45,187 
6 15% 30 $89,080 
7 11% 112 $141,258 
8 9% 27 $118,991 
9 7% 7 $27,459 
10 3% 3 $52,418 
11 3% 2 $55,007 
12 11% 42 $48,712 
13 0% 0 $34,516 
14 9% 49 $23,717 
15 7% 25 $169,348 
16 12% 43 $211,674 
17 12% 42 $108,041 
18 6% 7 $57,665 
19 15% 119 $60,151 
20 11% 21 $41,087 
21 14% 64 $72,634 
VISN
 
22 15% 41 $117,670 
T O T A L 2727 $1,887,318 
 †formula:   
 Sum (COST-High Median $ Threhold (Nat'l medianx2)) 
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Table 24  Dollar amount over cutoff:  high volume vendors and 15-20/20 highest volume HCPCS codes for FY00 and FY01 
combined 
  Top 15-20 of Top 20 HCPCS Codes per Frequency Volume 
 K0001 K0004 E1230 K0003 K0005 
Nat'l Median $ by HCPCS $163 $362 $1,935 $356 $1,067 
Nat'l Median $ x 2 Threshold $326 $723 $3,870 $712 $2,133 
   median $over   median $over   median $over   median $over   median $over 
Top Vendors by Cost Volume n cost threshold n cost threshold n cost threshold n cost threshold n cost threshold
21ST CENTURY SCIENTIFIC          1 $5,638 $1,768 1 $3,562 $2,850     
ACCESS AND MOBILITY PROD 1 $255 $72                 
ACTION MEDICAL EQUIP & SUPPLY 8 $368 $42                 
ADVANCED MEDICAL CONCEPT     23 $1,445 $721 5 $5,595 $1,725        
C W HEALTHCARE 7 $1,047 $721                 
CENTRAL ALABAMA MOBILITY 1 $493 $167                 
CENTRAL OHIO WHEELCHAIR 1 $970 $644 1 $1,180 $456            
CHESAPEAKE REHAB EQUIP 1 $2,789 $2,463             1 $2,534 $401
CHOICE MOBILITY     1 $2,858 $2,134            
ECONOMY MEDICAL 1 $2,789 $2,463                 
EQUIPMENT COMPANY UNLIMIT     2 $2,579 $1,855        1 $2,183 $50
FASTSERV MEDICAL 1 $385 $59                 
GUARDIAN PRODUCTS     71 $1,102 $378     40 $1,032 $320     
GULF COAST REHAB EQUIPMENT 1 $725 $399                 
HEALTHCARE EQUIPMENT     22 $1,444 $720            
HOVEROUND CORP          12 $4,647 $777        
KLINGENSMITH HEALTH CARE          7 $4,725 $855 1 $868 $156     
KWIK KARE INC 4 $850 $524 75 $841 $117     4 $1,010 $298     
LABAC SYSTEMS INC     4 $2,306 $1,582        1 $2,677 $544
LEVO USA INC     1 $5,806 $5,082     1 $4,103 $3,391 2 $5,786 $3,653
MEDBLOC INC 1 $2,462 $2,136 1 $2,157 $1,433     2 $2,107 $1,395     
MIDSTATE MEDICAL SVC 11 $390 $64                 
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Table 24  Dollar amount over cutoff:  high volume vendors and 15-20/20 highest volume HCPCS codes for FY00 and FY01 
combined 
 Top 15-20 of Top 20 HCPCS Codes per Frequency Volume 
 K0001 K0004 E1230 K0003 K0005 
Nat'l Median $ by HCPCS $163 $362 $1,935 $356 $1,067 
Nat'l Median $ x 2 Threshold $326 $723 $3,870 $712 $2,133 
   median $over   median $over   median $over   median $over   median $over 
Top Vendors by Cost Volume n cost threshold n cost threshold n cost threshold n cost threshold n cost threshold
MOBILE HELP 1 $2,447 $2,121                 
OTTO BOCK ORTHOPEDIC 4 $557 $231 3 $1,925 $1,201     2 $810 $98  
PERMOBIL INC 2 $1,614 $1,288 10 $1,877 $1,153 3 $13,500 $9,630 5 $1,537 $825  
PRIDE HEALTH CARE INC     2 $2,750 $2,026     2 $3,568 $2,856     
SS MEDICAL/ INC. 26 $648 $322 1 $775 $51     7 $830 $118     
TI SPORT 3 $2,196 $1,870 21 $2,310 $1,586     23 $2,213 $1,501 65 $2,312 $179
TOP END INC 2 $998 $672 13 $1,973 $1,249     30 $1,601 $889     
WHEELCARE INC              1 $849 $137     
WHEELCHAIR&SCOOT EXPRES     1 $1,589 $865     1 $980 $268     
WHEELCHAIR INSTIT OF KANSAS 13 $1,914 $1,588 2 $3,128 $2,404 1 $8,699 $4,829 2 $1,610 $898     
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Table  25  Dollar amount over cutoff:  high volume vendors and 10-15/20  highest volume HCPCS codes for FY00 and FY01 combined 
  Top 10-15 of Top 20 HCPCS Codes per Frequency Volume 
 K0011 E1140 K0006 K0014 E1150 
Nat'l Median $ by HCPCS $3,897 $170 $450 $4,504 $211 
Nat'l Median $ x 2 Threshold $7,793 $340 $900 $9,008 $422 
   medn $over   medn $over   medn $over   medn $over   medn $over 
Top Vendors by Cost Volume n cost threshold n cost threshold n cost threshold n cost threshold n cost threshold
21ST CENTURY SCIENTIFIC 6 $8,539 $746        10 $9,214 $206    
ADVANCED MEDICAL CONCEPT          1 $1,302 $402         
ALL ACTIVE MOBILITY          1 $6,240 $5,340         
AMERICAN MED EQUIP&SERV          3 $990 $90         
CHESAPEAKE REHAB EQUIP      3 $436 $96         36 $441 $19
ELECTRIC THREE WHEELER          1 $4,022 $3,122         
EQUIPMENT CO UMLIMIT 1 $11,724 $3,931                
EVEREST & JENNINGS          154 $1,027 $127         
FALCON REHAB PROD             4 $10,963 $1,955    
KLINGENSMITH HEALTH CARE      1 $476 $136         4 $655 $233
KWIK KARE INC          3 $2,000 $1,100         
LABAC SYSTEMS INC          2 $1,781 $881         
LEVO USA INC             1 $10,475 $1,467    
MEDBLOC INC          2 $2,057 $1,157         
MOBILE HELP          1 $5,050 $4,150         
PERMOBIL INC 13 $12,463 $4,670        40 $12,901 $3,893    
REDMAN POWER CHAIR LLC             2 $18,328 $9,320    
SUNRISE MEDICAL INC          99 $911 $11         
SUPPLY WAREHOUSE      136 $410 $70            
TD COMPLETE MEDICAL             2 $18,784 $9,776    
TEFTEC CORP 6 $17,459 $9,666                
WHEELCHAIR&SCOOT EXPRES      3 $1,250 $910            
WHEELCHAIR INSTIT OF KANSAS          30 $1,806 $906         
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Table 26  Dollar amount over cutoff:  high volume vendors and 5-10/20  highest volume HCPCS codes for FY00 and FY01 combined 
 Top 5-10 of Top 20 HCPCS Codes per Frequency Volume 
 K0007 E1211 E1260 E1212 E1088 
Nat'l Median $ by HCPCS $496 $3,804 $244 $4,200 $455 
Nat'l Median $ x 2 Threshold $992 $7,608 $488 $8,400 $910 
   medn $over   medn $over   medn $over   medn $over   medn $over 
Top Vendors by Cost Volume n cost threshold n cost threshold n cost threshold n cost threshold n cost threshold 
21ST CENTURY SCIENTIFIC     7 $9,785 $2,177 1   7 $9,785 $1,385    
AMIGO MOBILITY          2 $2,217 $1,729         
C W HEALTHCARE 7 $1,140 $148                 
CHESAPEAKE REHAB EQUIP                  3 $2,265 $1,355 
EVEREST & JENNINGS 169 $1,405 $413                 
GUARDIAN PRODUCTS                  3 $1,046 $136 
GULF COAST REHAB EQUIPMENT          1 $1,195 $707      13 $1,276 $366 
HEALTHCARE EQUIPMENT 3 $1,755 $763              2 $5,318 $4,408 
LABAC SYSTEMS INC 1 $2,560 $1,568                 
OTTO BOCK ORTHOPEDIC 1 $2,055 $1,063                 
PERMOBIL INC     21 $12,143 $4,535    21 $12,143 $3,743    
SENIOR NOTES INC                  1 $1,252 $342 
SUNRISE MEDICAL INC 43 $1,205 $213                 
TEFTEC CORP     6 $16,205 $8,597    6 $16,205 $7,805    
TI SPORT          1 $2,237 $1,749      10 $2,356 $1,446 
TOP END INC          1 $2,149 $1,661      1 $1,706 $796 
WHEELCHAIR & SCOOTER EXPRES 1 $3,436 $2,444      2 $1,065 $577      1 $2,680 $1,770 
WHEELCHAIR INSTIT OF KANSAS 51 $2,087 $1,095                 
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Table 27  Dollar amount over cutoff:  high volume vendors and 1 - 5/20  highest volume HCPCS codes for FY00 and FY01 combined 
  Top 1-5 of Top 20 HCPCS Codes per Frequency Volume 
 K0008 E1070 E1060 K0010 K0012 
Nat'l Median $ by HCPCS $917 $178 $370 $2,932 $1,993 
Nat'l Median $ x 2 Threshold $1,835 $356 $740 $5,864 $3,987 
   medn $over   medn $over   medn $over   medn $over   medn $over 
Top Vendors by Cost Volume n cost threshold n cost threshold n cost threshold n cost threshold n cost threshold 
21ST CENTURY SCIENTIFIC                  1 $10,808 $6,821 
ADVANCED MEDICAL CONCEPT 3 $2,199 $364        2 $13,971 $8,107    
AMERICAN MEDICAL EQUIP&SERV     2 $524 $168 1 $1,299 $559         
AMIGO MOBILITY 1 $2,130 $295                
C W HEALTHCARE         2 $925 $185         
CHOICE MOBILITY            4 $6,343 $479    
ELECTRIC 3 WHEELERS INC                 1 $4,103 $116 
ELECTRIC MOBILITY CORP 1 $2,302 $467                
EVEREST & JENNINGS     54 $473 $117            
FRONTIER ACCESS&MOBILITY                 1 $4,875 $888 
GUARDIAN PRODUCTS                 1 $5,242 $1,255 
GULF COAST REHAB EQUIPMENT 1 $8,339 $6,504                
HOVEROUND CORP                 1 $6,116 $2,129 
KLINGENSMITH HEALTH CARE         58 $818 $78         
LABAC SYSTEMS INC 5 $2,974 $1,139                
LEVO USA INC 3 $4,551 $2,716                
MEDBLOC INC                 2 $5,454 $1,467 
MEDICAL HOME CARE INC     2 $620 $264         2 $4,043 $56 
MOBILITY KING                 1 $4,200 $213 
MOBILITY PLUS INC     1 $484 $128            
OTTO BOCK ORTHOPEDIC 1 $2,340 $505                
PERMOBIL INC            2 $12,336 $6,472 2 $11,325 $7,338 
PRIDE HEALTH CARE INC 4 $3,523 $1,688                
REDMAN POWER CHAIR LLC            1 $15,965 $10,101    
SUNRISE MEDICAL INC     45 $868 $512 47 $974 $234         
TI SPORT 12 $2,181 $346                
TOP END INC         2 $1,998 $1,258         
TRAVIS MEDICAL SALES CORP            1 $8,243 $2,379    
WHEELCHAIR & SCOOTER EXPRES     1 $537 $181    1 $8,243 $2,379    
WHEELCHAIR INSTIT OF KANSAS 5 $2,120 $285             1 $4,009 $22 
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3.6  DISCUSSION    
Nationally, the VHA purchased over 131 million wheelchairs and scooters at a 
cost of approximately $109 million during FY00 and FY01. When these cost data were 
adjusted for wheelchair components, i.e. wheelchairs and associated wheelchair 
components, such as arm rests or seating systems were summed (see Methods/ 
Operational Definitions/ Cost), the dollars spent increased by 2 million dollars in FY00 
and nearly 2.5 million in FY01. The objective of this study was to compare VHA WMD 
expenditures across VISNS and vendors to identify variation and potential excessive 
costs. 
The results of this study suggest variation in cost by VISN and by vendor exist. At 
least part of this variation is attributed to lack of standardization of prosthetic purchase 
procedures and data entry within the VHA. Another consideration is the possibility of 
fraud and abuse, which merits further investigation, but was beyond the scope of this 
study. 
The cost data were not normally distributed and were extremely skewed by both 
low and high median costs. Low cost outliers were excluded from the dataset as a method 
of cleaning the data for error and known coding inconsistencies and because of the 
lowering effect low values had on median values. High cost outliers were not excluded, 
as an objective of this study was to identify and describe high cost outliers in an effort to 
further validate NPPD cost data [16].          
Low Cost Outliers: There are several explanations for low cost outliers: 
wheelchair components were coded as wheelchairs, refurbished wheelchairs had costs 
ranging from $0.00 to half the purchase price, and data entry error. The data entry error is 
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self-explanatory. Re-furbished WMDs are devices that were returned to the VHA by one 
veteran for redistribution to another. VHA policy states “whenever possible, reclaimed 
wheelchair that have been restored will be re-issued” (1173.6)[19]. Initially, policy stated 
the cost entered for re-issued devices was $0.00, resulting in 5199 $0.00 entries in FY00. 
The policy then changed: refurbished wheelchairs were to be assigned a value equal to 
half their original cost. In FY01 there were only 440 $0.00 entries. Implementation of this 
change in policy is based on the assumption that the data entry person has access to the 
original purchase record of the device from which to determine half of its value.  
A third explanation for low cost outliers was inconsistency in coding. Wheelchair 
components were frequently coded as the wheelchair they complemented rather than as 
the component itself. For example, one veteran may have 10 “K0010” HCPCS codes all 
with the same “createdate” associated with his “patientid” suggesting prescription of 10 
power wheelchairs in one day. Upon examination of the “cost” and text “description” 
fields, the veteran actually received one power wheelchair and nine related components, 
such as leg rests, etc.  Coding inconsistencies can inflate the count of wheelchairs 
provided by the VHA. Scooters, which usually do not have components, are less likely to 
be effected.  
Coding of Wheeled Mobility Devices: Coding a component as a component versus 
the device it accompanies was but one of the inconsistencies. The number of HCPCS 
codes used was also inconsistent. The prescribed device in the previous example could 
also have been entered as one record: i.e. HCPCS = K0010 with one cost for the complete 
power wheelchair, with all components, delivery, and set-up included in that price. This 
same device could have been entered as one wheelchair code (i.e. K0010) and separate 
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HCPCS codes for the components, battery, battery charger, delivery, and set-up. In a 
comparison study of VHA and Medicare AT expenditures, Render et. al [1] concluded 
the non-standardization of data entry made cost comparison difficult, noting that vendors 
may bill for as many as seven HCPCS codes.  
The study described herein did not include power wheelchair batteries and battery 
chargers in the data analysis because in the NPPD they are coded as “medical equipment” 
rather than as “wheelchairs/scooters”, thus difficult to systematically separate from other 
types of batteries and miscellaneous medical equipment. HCPCS codes used for delivery 
and set up were occasionally found but did not appear to be used in a systematic manner.  
Further contributing to the inconsistencies in coding are the many combinations 
of purchasing options available to VHA facilities: purchase from vendors, purchase 
directly from manufacturers, maintaining a stock, and employing a seating and mobility 
specialist. Each of these options can produce a different wheelchair cost. For example, a 
wheelchair from a facility that stocks a basic lightweight rehabilitation wheelchair, and 
employs a technician to fit the arm and leg rests may be less expensive than the same 
wheelchair fitted by the manufacturer, because the NPPD does not reflect the Veterans 
Affairs Medical Center (VAMC) costs in employing a technician. In this same example, 
if the manufacturer fits the wheelchair, the cost could be entered as one line item (leg and 
arm rests included in the cost of the device), as two line items (arm rests included in the 
cost of the device and leg rests itemized separately), or as three line items (leg and arm 
rests itemized separately from the cost of the device), as previously discussed. While the 
flexibility of having multiple purchase options is not only a plus but unique to the VHA, 
the cost effectiveness of each needs to be determined. 
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High Cost Outliers: Zero-cost values and costs too low to be attributed to a 
wheelchair were contrasted by extreme cost entries. For example there was a cost of 
$9,000 for a standard “depot” manual wheelchair that typically retails for $200 to $400, 
and can be purchased under VHA contract for $119 to $240 fully accessorized (Fred 
Downs, Chief Consultant, PSAS, written communication, 2003).  
Some of the high median cost dollars appeared due to erroneous HCPCS codes. 
When the three fields, cost, vendor, and code were considered, the cost and vendor fields 
frequently matched, but the HCPCS code did not. As an example, 21st Century Scientific 
supplied one scooter (N=1, HCPCS code = E1230) at a cost of $5,638 with an over the 
cutoff dollar amount of $1,768. According to an Internet search, 21st Century Scientific 
does not manufacture a scooter, but rather high performance power wheelchairs, which 
would explain the high dollar amount. 21st Century Scientific and “cost” were congruent; 
the HCPCS code E1230 was not.    
As another example, Hoveround had a high median cost for scooters, but for an 
n=12. Based on an internet search, it was difficult to determine if Hoveround 
manufactured scooters. A link from the “Google” search engine to the Hoveround 
corporation web site included “Scooter” in the title of the link but once at the website, 
scooters were not listed as one of their products.  While an Internet battery company 
provided batteries for Hoveround scooters, a review on a “Tech Guide” website 
sponsored by the United Spinal Association stated the Hoveround scooter was actually 
manufactured by Invacare. Of the 51 WMDS were purchased from Hoveround by the 
VHA (by 14 VISNs), 12 were coded as scooters (E1230) and the remaining as power 
wheelchairs (E1210, E1211, E1212, E1220, K0010, K0011, K0012, K0013, K0014), 
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with costs ranging from $2,318 (high for a scooter) to $10,551 (reasonable for a custom 
power wheelchair).  Again, Hoveround and “cost” were congruent; the HCPCS code 
E1230 was not. In the analyses, Hoveround had costs exceeding the threshold for 11 
devices, nine of which were scooters. It is likely that the excessive costs for Hoveround 
can be explained by coding error. 
In contrast, Invacare, who holds the VHA competitive bidding contract for depot 
wheelchairs (K0001) was the vendor with the largest amount of excessive dollars: 43% 
(1759 devices) of these excess dollars were for depot chairs. The national median was 
$163. The cutoff threshold was $326. This example, with 1,759 instances, is more 
difficult to attribute to coding error. 
There were other manufacturers with high cost apparently due to erroneous 
HCPCS codes. Many of the codes associated with the high costs were also associated 
with a wheelchair not manufactured by that particular manufacturer. For example, 
according to the data presented in Table 25, Labac Systems Inc, had a high median cost 
for the K0006 (n=2) which is a manual wheelchair. Labac Systems Inc. however, does 
not manufacture a manual wheelchair. Similarly, Levo USA Inc makes wheelchairs that 
stand up; Levo does not make a K0003 or K0004. Teftec Corporation only manufactures 
a K0014, and not a K0011. Ti Sport and Top End Inc. manufacture only K0005, yet had 
high costs for K0001 and K0004 wheelchairs. All of these are examples of possible 
coding errors. 
For the vendor with the second highest total dollars exceeding the threshold, the 
most frequent HCPCS codes were K0003 (28%) and K0004 (29%) both lightweight 
rehabilitation wheelchairs, and K0001 (16%). For vendor with the third highest total 
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dollars, the most frequent HCPCS codes were K0001 (33%) and K0004 (11%). The 
vendor with the forth highest frequency of devices (206 devices) exceeding the threshold, 
98% were for the depot wheelchair, K0001. 
The vendors that ranked forth, fifth, and sixth in total dollars exceeding the 
threshold were primarily power device vendors. It is not surprising for power wheelchairs 
to exceed the threshold. For example, the national median for a K0014, a custom power 
wheelchair was $4,504. The cutoff threshold was $9,008. It is not uncommon for a 
custom power wheelchair with features such as tilt in space, recline, and seat elevation to 
approach a cost of $20,000, a sum far less than the cost of a surgery to repair a pressure 
ulcer or to provide skilled nursing for wound management. It is not as easy to explain 
why a scooter would exceed the $3,870 threshold as was the case for the vendor ranked 
fifth in excessive dollars; 49% of this vendor’s excess dollars were for scooters (E1230). 
One last vendor worthy of mention was the PSAS, or VHA stock: 94% of the 
excess dollars were for the K0001 depot chair and 80% of these entries were from VISN 
6. This finding suggests inconsistent interpretation of VHA policy. Why would a standard 
wheelchair from VHA stock, a chair that should be purchased via government contract, 
not only be the most frequent chair to exceed the $326 threshold, but occur 
predominantly in one VISN? 
Policy Implications: Cost-benefit analysis is fundamental to policy development 
and implementation. Advances in wheelchair technology and the aging of U.S. veterans 
will increase the demand for WMDS 6.9% per year through 2007 [9]. WMDs provided 
by the VHA increased by 6% from FY99 to FY00, and 7% from FY00 to FY01 [20]. 
The NPPD, developed to provide a better understanding of the relationship 
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between quality, function, and cost [21], is a valuable and promising source of prosthetic 
data. Before any cost conclusions can be drawn from analyses of NPPD data, however, 
the coding must be consistent and reliable. Coding policy should be standardized across 
VHA facilities.  
The HCPCS codes used by the VHA should be current, functional, and consistent 
with the codes vendors use for other markets. For example, K0002 is a current HCPCS 
code for a standard wheelchair for an individual with hemiplegia. E1083, E1084, and 
E1086 are also used by the VHA to designate chairs for individuals with hemiplegia. See 
Table 29.  Four codes used to designate basically the same wheelchair invites error. 
Multiple E-codes were used by CMS in the 1970s to differentiate whether the chair had 
fixed, detachable, or swing-away arm-rests for example, with another set of codes to 
differentiate leg-rests and the combination of arm-leg rests. It is difficult to imagine the 
usefulness of this information in today’s world of customizable (and someday modular) 
wheelchairs. What is useful is the cost of the finished chair.  
Seating systems should be itemized with separate HCPCS codes as they are 
frequently replaced independently of the wheelchair, or may be retained and transferred 
to the new chair.  Batteries should be included in the cost of power device and coded 
accordingly, rather than coded with other batteries in the miscellaneous medical 
equipment category. Set-up and delivery should be itemized in a manner that can be 
systematically evaluated.  
Setup is a particularly important safety factor when providing powered devices 
with programmable controls to veterans. The purpose of programmable controls is the 
capacity to adjust responsiveness and speed of the wheelchair to meet the individual 
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needs of the veteran. Factory settings may be inappropriate. Errors in factory settings can 
occur, that can cause for example, a chair to drive at excessive speed with only a light 
touch to the joystick. Manual wheelchairs also require setup. Axle and camber positions 
and seat and leg/foot rest angles need to be adjusted for each user (for wheelchairs that 
allow these adjustments) to maximize propulsion efficiency and minimize secondary 
injuries to the shoulder, elbow, and wrist joints [22-25].  
The concept of re-issuing a wheelchair has tremendous cost and time saving 
implications.  It is not unusual for 6 to 18 months to lapse between order and delivery of 
a custom power or manual wheelchair. During this time, the intended user’s motor skills 
may change. A veteran with amyotrophic lateral sclerosis (ALS), for example, may not 
be able to use a chair that had been prescribed six months prior. Providing this veteran 
with an on-hand wheelchair could improve the quality of the veteran’s care versus having 
no chair or an obsolete chair while waiting for the new one.  
There is an additional cost benefit: one VHA wheelchair purchase can be used for 
more than one veteran. Often times, expensive chairs can no longer be used by veterans 
because of changing needs and abilities. When the chairs remain in good condition, 
recycling these devices becomes very cost effective. In addition, devices are sometimes 
prescribed for veterans who do not have progressive conditions but none the less, once 
the chair arrives, it does not meet the veteran’s needs. In a qualitative study of individuals 
with spinal cord injury, Kittle et. al [16] found participants receiving their first 
wheelchair (as inpatients) had little insight into their own needs and expectations upon re-
entering community life, plus they lacked to ability to learn from other wheelchair users. 
Their second wheelchair was more satisfactory than the first because they had an 
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opportunity to realize their wheelchair needs and lifestyle preferences. An ill-prescribed 
chair for one veteran could be the perfect chair for another.  
While the NPPD has potential for tracking dollars saved as a result of re-issuing 
chairs, it appears to be more of a concept than a reality at this time. It is difficult to 
identify re-furbished WMDs in the NPPD. The variable “TYPE” includes only “initial 
issue”, “replacement”, “spare”, and “repair” to chairs. There is a variable “SOURCE” 
that designates whether a device came from “stock” or from a “commercial source”. At 
one time devices with a cost of $0.00 could be inferred to be re-issued chairs, but this 
policy has changed as discussed earlier. Refinement of the reclaim and reissue system 
could improve the quality of care for veterans and provide a model for other agencies.  
Resources expended to update a DOS-based data entry system like the NPPD, can 
ultimately save dollars in improved reissue processes and tracking high costs while 
improving the quality of care of veterans. A windows environment with automated fields, 
i.e. that prevent a code – vendor mismatch, would be a significant improvement. In 
addition, the number of possible HCPCS code choices should be consolidated by 
replacing outdated “E” codes with more current “K” codes. When linked with functional 
outcomes databases, such as the SF-36V of the 1999 Veterans Health Study [26] and the 
Functional Status Outcomes Database (FSOD) [17, 27], a valid and reliable cost-benefit 
analysis could be made.   
Many of the high median costs found during this study could be resolved with the 
standardization of data entry. For others, clinical inquiries may be warranted [21]. 
Clinical inquiries have been used in the past to resolve counterintuitive data. For 
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example, an inquiry made into the records of a veteran who received two prosthetic limbs 
within a seven month period revealed the veteran had lost 68 pounds [21].   
Lack of standardization in prosthetic data entry and terminology exchanged 
between the VHA and the vendor can result in devices delivered to the veteran’s home 
that do not match the script written by the prescribing clinician. It is uncertain as to 
whether there is a system in place to check whether the correct device was received and if 
so, whether the device is functional in the veteran’s environment. Should these expensive 
and potentially harmful devices (power wheelchairs and scooters not correctly set-up) be 
delivered to the veteran’s home, or should the clinician have an opportunity to observe 
the veteran with the device in case the device is incorrect or adjustment is needed. Others 
considerations include the interaction between operating the device and medications, and 
transportation of the device. Was the veteran’s vehicle taken into consideration when the 
device was ordered?  
Variation in coding can occur at the prescribing clinician level, the vendor level, 
the government contract website, the data entry person level, the facility level or the 
VISN level. In at least one VAMC, the clinical team recommends a wheelchair. The 
prescription is passed along to a vendor, or technician, or directly to the data entry 
person, thus one translation made. If the vendor, or technician decides how to fill the 
prescription, this information is then passed on the data entry person for entry into the 
system, the second translation. For more standard chairs, the data entry person may select 
a chair from the General Services Administration (GSA) website.  Each translation is 
made by individuals with varying skills and experience with wheelchair design. Typically 
the device is delivered directly to the veteran’s home with no follow-up by the 
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prescribing clinical team. In essence, current prescription processes may not support the 
optimal continuum of care for veterans.  
Clinical practice guidelines for the prescription of motorized WMDs (written 
communication, Charles Levy, MD, Gainesville VAMC, July 16, 2004) have been 
drafted. While these guidelines will assist in the decision making process of providing a 
manual versus power device, purchase options and device coding need to be standardized 
before useful feedback can be provided to prescribing clinicians, i.e. as to cost 
effectiveness and functional outcomes.  
Limitations: A foremost limitation to this study was the nature of the data itself. 
First the distribution of the data was not normal and extremely skewed. While two other 
studies were found that came to a similar conclusion [1, 16] this study provided more 
detail on the nature of the high and low outliers, statistical measures that can be taken to 
normalize the data, and policy recommendation to address the cause of the outliers. 
Inconsistent coding of vendors, in addition to inconsistent coding of devices was a 
persistent problem. Data cleaning efforts were made to consolidate vendors with multiple 
spellings of their named, i.e. “Wheelchair Inc” and WHEELCHAIR INC’. However 
questions remained. For example, is “SUPPLY WAREHOUSE” the name of a company, 
or another phrase for PSAS stock? Vendors with the name of  “1” and “DO NOT USE” 
could not be recoded. 
Another limitation of this study was that while administrative databases are useful 
for cost analyses, they don’t provide information on the functional benefit to the veteran 
for whom the cost was expended [28]. The NPPD does not provide information on 
individual veterans, or the circumstances under which the WMD was provided. It is 
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beyond the scope of the NPPD to reflect whether a high cost custom power chair was 
more appropriate in meeting the needs of a veteran with significant gross and fine motor 
impairments than a less expensive chair. Once the parameters of reliability and validity of 
the NPPD cost data are established, the NPPD can be linked with functional outcomes 
databases to better determine whether the cost was spent to improve the quality of care 
and quality of life of veterans.   
 Future Work: Future studies need to consider case-mix by using a risk-
adjustment  approach to account for patient characteristics that could significantly 
influence the type of wheelchair provided [26, 29, 30]. For example, patient’s need may 
vary across VISNS. Northern VISNS are more likely to have a larger population of 
veterans with multiple sclerosis [31]. Prevalence of stroke is higher in the mid-west and 
south-east VISNS and the prevalence of COPD highest in the Midwest VISNS with 
headquarters in Omaha and Kansas City [26]. Diagnosis was found in the study described 
herein, to effect the type of chair provided. 
Studies are planned that expand upon the study described herein to investigate 
other prosthetics devices such as prosthetic extremities, devices for activities of daily 
living such as bathing and dressing, and mobility devices such as canes and walkers, and 
to examine WMD repair data.  
 It is important to identify and rank the most effective purchase options for 
WMDs. For example, when are government contracts the best choice and when does a 
custom device need to be provided. This data is not presently included in the NPPD thus 
may require a prospective study of high volume sites using various purchase options. An 
inquiry could be made to determine how many of top 100 vendors have GSA or 
109 
competitive bid contracts? Are there cost advantages to maintaining a stock versus 
purchasing from a vendor or directly or does this depend on the type of device needed? 
It would be interesting to know the variance in cost and prescription practices by 
clinicians who have received training in current in seating and mobility techniques versus 
those who have not. This would require a study done at the VAMC level versus the VISN 
level as was this one.  
An important outcome is how satisfied veterans are with their devices and the 
services they have received. Garber et al. [32] found in general, veterans reported a high 
level of satisfaction with the wheelchair they received, however, 67% reported they had 
received no written information about their chair, 53% reported receiving no verbal 
instruction about the use/maintenance of the chair, and 45% did not know who to contact 
if they had problems with the chair. Four veteran participants were waiting for equipment 
that had been ordered but never delivered and 2 participants received equipment they 
were unable to use. This factor reiterates the need for clinician training and follow-up. 
Veterans are an important source of information on the quality and durability of chairs 
that have as yet only been tested in the laboratory.  
3.7  CONCLUSION 
During FY00 and FY01, the Veterans Health Administration (VHA) provided 
over 131,000 wheelchairs and scooters, at a cost of $109,010,198. Of this $109 million, 
$7,747,405 exceeded an established threshold, and was determined by this study to be 
excessive cost. Variation in median and potential excessive cost was found both by VISN 
and by vendor. At least part of this variation is attributed to lack of standardization of 
prosthetic purchase procedures and data entry within the VHA. Another consideration is 
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the possibility of fraud and abuse, which merits further investigation, but was beyond the 
scope of this study. 
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4.1  ABSTRACT  
The purpose of this study was to investigate the relationship between the 
adjustability, thus capacity to customize, manual and power wheelchairs and Health 
Related Quality of Life (HRQoL), as measured by the SF-36V. Using a cross-sectional, 
retrospective study design, three years of data from three Veterans Health Administration 
(VHA) databases, the National Prosthetic Patient Database (NPPD), the SF-36V data of 
the Veteran Health Study (VHS), and the National Patient Care Database (NPCD) were 
merged to create a dataset 61,428 veterans who received a wheelchair during the 1999, 
2000, 2001 fiscal years and completed the SF-36V in 1999. ANCOVA and ANOVA 
were used to analyze the first hypothesis stating veterans who are provided with more 
adjustable thus customizable wheelchairs will have significantly more ability to 
participate in society. Logistic regression was used to analyze the second hypothesis 
stating veterans with better health status will be prescribed more adjustable thus 
customizable wheelchairs. Three regression models were tested. Model I: veterans who 
received adjustable, ultralight manual wheelchairs had significantly lower physical 
function (p=<.0001) and significantly higher mental function scores (p=0.019) than 
veterans who received nonadjustable, standard manual wheelchairs, when adjusting for 
diagnosis and number of comorbidities. Model II: veterans who received adjustable, 
ultralight manual wheelchairs had significantly lower physical function (p=<.0001) and 
significantly higher general health scores (p=0.015) than veterans who received 
nonadjustable, standard manual chairs, when adjusting for clinical and demographic 
factors. Model III: veterans who received adjustable, ultralight manual wheelchairs had 
significantly higher mental component summary scores (p=0.001) than veterans who 
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received nonadjustable, standard manual chairs when controlling for clinical and 
demographic factors.  
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4.2  INTRODUCTION 
There is “a point at which the body and wheelchair seamlessly merge” [1], a point 
where the wheelchair maximizes the user’s potential - wheelchair and user become one. 
This harmonious blend is a balance achieved between wheelchair quality and design and 
user needs [2]. Key attributes of a quality manual wheelchair are reduced weight and 
freedom to select critical physical dimensions. Combined, these factors provide the 
consumer who uses manual wheelchairs with improved comfort, ease of transfers, and 
propulsion efficiency. Key attributes of a quality power wheelchair are programmable 
electronic controls, freedom to select critical physical dimensions, and flexibility to 
navigate indoor and outdoor terrain. Ideally, in power chairs, these factors translate into 
reduced attendant dependence, decreased probability of collisions, lower risk of device 
breakdown, better environmental access, and faster overall transit speeds. In essence, a 
more adjustable, customizable wheelchair facilitates more efficient mobility. 
Compelling evidence exists that suggests mobility, access to the community, and 
social integration, enhance health related quality of life (HRQoL) [3-6]. In fact, social 
participation is a more important predictor of HRQoL than physical functioning or extent 
of injury. A poorly designed wheelchair can limit the potential of a user for community 
access [7] thus increasing disability.  
A poorly designed manual wheelchair can contribute to secondary injuries, such 
as carpal tunnel syndrome and injury to the shoulder resulting from repeated, forceful 
movements required by the upper extremities during wheelchair propulsion [8-13]. 
Heavier manual wheelchairs with fewer options for adjustment are more physically 
demanding of the user and caregiver. The standard, steel, folding X-frame frame, sling 
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upholstered wheelchair design is inexpensive but provides no options for adjustment. In 
contrast, the ultralight wheelchair has options to select wheel-axle position, seat-back 
height angle, and camber (position the user in a more appropriate position in relation to 
gravity). Adjustable wheelchairs reduce stress and injury to the upper extremities 
acquired during manual wheelchair propulsion [14-17], provide better postural alignment 
(less head-flexion, less shoulder protraction, and more neutral pelvic tilt) resulting in 
greater active humeral flexion, and improved vertical reach [18], and improved functional 
mobility skills [19]. 
A poorly designed power chair can limit access of the user to the environment if 
the wheelchair design and features are not matched to the needs of the user (i.e. indoor 
versus outdoor use). Many individuals are not able to drive a standard power chair [20] 
due to fine and visual motor, postural, and coordination issues. Adjustable and 
customizable power wheelchairs offer options to maximize function for users who cannot 
propel a manual wheelchair. Front-wheel drive power chairs can be driven close to 
objects, an important consideration for individuals with visual impairment, and have 
better obstacle climbing abilities, i.e. climbing a curb. Rear-wheel drive power 
wheelchairs tend to be more stable outdoors and at faster speeds. Options available for 
adjustable power wheelchairs include power tilt and reclining seat, which reduces edema, 
shear forces, and pressure on tissues thus, diminishing the risk for the formation of 
pressure ulcers [21-23]. Power features such as seat elevation allow users to hold eye-
level discussions with colleagues and reach items on upper shelves [24]. Programmable 
electronic controls can be individualized to compensate for abnormal muscle tone 
including tremor, sensory motor processing speed, and cognitive impairment [25]. 
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“Smart” wheelchairs are being developed that utilize computer systems and sensors based 
on robotic technology to reduce both the cognitive and physical requirements of 
operating a power wheelchair [26-29]. Adjustable and customizable power wheelchairs 
can improve posture, physical and social function, and access to multiple environments, 
while decreasing the sensory, motor, and cognitive demands placed on the user.   
The purpose of this study was to investigate the relationship between adjustable 
thus customizable versus nonadjustable manual and power wheelchairs and HRQoL. 
Acknowledging the debate over quality of life, health status, and life satisfaction 
terminology [6, 30-34], in this study, HRQoL encompasses the construct of self-reported 
health status (HS); the two terms are used interchangeably [35]. The SF-36V (Short Form 
36 Item Health Survey for Veterans) [36] adapted from the Medical Outcomes Study 
(MOS) SF-36 [37] was used to measure HRQoL or HS. The SF-36V measures eight 
health concepts: physical functioning, role limitation due to physical health problems, 
body pain, general health, vitality, social functioning, role limitations due to emotional 
problems, and mental health, all universally relevant to HS [38, 39]. The physical 
component summary score and the mental component summary score are composite 
measures of the eight scales and orthogonal to each other [37, 40, 41]. 
The first hypothesis postulated controlling for diagnosis, number of 
comorbidities, and demographic factors, veterans who are provided with more adjustable 
thus customizable manual and power wheelchairs will report significantly more ability to 
participate in society. The second hypothesis was based on the assumption that as the 
HRQoL of the wheelchair user declines, more demand is placed on the technology to 
maintain user function and participation [42]. The second hypothesis postulated which, 
 120
controlling for diagnosis, number of comorbidities, and demographic factors, veterans 
with lower HS would be provided with more adjustable and customizable manual and 
power wheelchairs. 
4.3  METHODS 
4.3.1  Design and Participants 
This study was approved as exempt by the VA Pittsburgh Healthcare System 
Institutional Review Board (IRB). Using a cross-sectional, retrospective design, three 
years of data from three Veterans Health Administration (VHA) databases, the National 
Prosthetic Patient Database (NPPD), the SF-36V/Veteran Health Study (VHS), and the 
National Patient Care Database (NPCD) were merged to create a dataset (N=61,428) of 
veterans who received a wheelchair during the 1999, 2000, 2001 fiscal years (FY) and 
completed the SF-36V.  
4.3.2  Databases 
NPPD: The National Prosthetics Patient Database, comprised of orthotic, 
prosthetic and sensory devices, was developed by the VHA Prosthetic and Sensory Aids 
Service (PSAS) to track devices provided to veterans and to provide clinicians with 
information regarding prosthetic prescription practices [43]. The NPPD was made 
available to researchers in 1999. The NPPD contains 25 variable fields providing 
information such as device description and code, geographic location of prescription, 
type of service (initial issue, replacement, spare, or repair), date (create date, delivery 
date, processing days), cost, vendor, and service category (defined in 
Methods/Operational Definitions). Wheelchairs, one of 14 categories of prosthetics, were 
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the focus of this study. Variables from the NPPD used in this study were device code, 
delivery date, type of service, and service category. 
SF-36V/VHS: The Veteran’s Health Study, launched in 1992, was a six-year 
prospective, observational study of health outcomes in patients receiving outpatient care 
from the VHA. One of the cornerstones of the VHS was the development of the Veterans 
SF-36 also referred to as the V/SF-36 or SF-36V, adapted from the MOS SF-36 (Kazis, 
2000; Kazis et al., 1999). In 1999, 1.4 million SF-36V questionnaires were administered 
nationally on a cross-sectional basis, representing 40% (3.4 million) of the VA enrollee 
population). Data collection took place between July 1999 and January 2000 with a 
response rate of 63.14%. Variables from the SF-36V used in this study were the eight 
scales and two component summary scores of the SF-36V. Variables from the VHS were 
the 30 comorbidity medical categories, sex, race, and priority group. “Comorbidities” are 
further described in “Methods/ Operational Definitions”. 
NPCD: The National Patient Care Database [43, 44], housed at Austin 
Automation Center (AAC) of the VHA, contains the national datasets for each outpatient 
and inpatient episode of care provided by the VHA. The variables from the NPCD used 
in this study were primary and secondary diagnoses and date of birth. 
4.3.3  Operational Definitions  
Adjustability of Wheelchair: Adjustability of wheelchair was determined using 
the Health Care Common Procedure Coding System (HCPCS) codes, developed by the 
Center for Medicare and Medicaid (CMS) for reimbursement purposes. The ultralight 
manual wheelchair (HCPCS code = K0005) and the custom power wheelchair (HCPCS 
code = K0013, K0014) were considered “more adjustable and customizable”. The 
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standard depot manual wheelchair (HCPCS code = K0001, K0002, K0003 and associated 
E-codes: E1050, E1060, E1070, E1083, E1084, E1085, E1086, E1100, E1110, E1130, 
E1140, E1150, E1160, E1170, E1171, E1172, E1180, E1190, E1195, E1200, E1240, 
E1250, E1260, E1270, E1280, E1285, E1290, E1295, E1296, E1297, E1298) and the 
standard power wheelchair (HCPCS code = K0010 and associated E-codes: E1210, 
E1211, E1212, E1213, E1220) were considered “nonadjustable”. The remaining 
wheelchair HCPCS codes included in the NPPD were not included in this study because 
they were considered medium grade or mid-quality wheelchairs, not easily 
distinguishable as “adjustable” or “nonadjustable”.  
Participation in Society: Participation in society, the dependent variable (DV) in 
Hypothesis 1, was measured using the Role-Physical (RP), Role-Emotional (RE), and 
Social Functioning (SF) scales of the SF-36V [37, 40, 41]. With the exception of the RP 
and RE scales, SF-36V raw scores undergo a linear transformation resulting in a range 
from 0-100 [36]. RP and RE scores use an algorithm developed and validated by Kazis 
[35, 45], in which the scores are converted based on the likelihood of a “yes” response, 
for the purpose of being able to compare these scores to results of studies that used the 
MOS version of the SF-36. Thus, in this study, RP scores ranged from -6.75 to 111.45, 
and RE scores ranged from –16.95 to 115.30.  The physical component score (PCS) and 
mental component score (MCS) scores undergo a t-score transformation with a norm of 
50 in a U.S. reference population, with no floor or ceiling. For all SF-36V scale and 
component summary scores, a higher score indicates better health, or health status [36]. 
Health Status: The construct of HS, the independent variable (IV) in hypothesis 
2, was measured using all eight scales and the two summary scores of the SF-36-V: PF, 
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Role-Physical (RP), Bodily Pain (BP), General Health (GH), Vitality (VT), SF, RE, 
Mental Health (MH), PCS, and MCS. Three models were analyzed, each defining HS 
somewhat differently in that each of the three models used a different combination of SF-
36V scale and summary scores. Model I used the PF and MH scores to define HS, Model 
II used all eight of the SF-36V scores to define HS, and Model III used only the PCS and 
MCS scores.  
Priority Group: The VHA has delineated seven priority groups. The first three 
are comprised of veterans with service-connected disabilities. Group 1 includes veterans 
with disabilities rated > 50%, Group 2 includes veterans with disabilities rated 30% or 
40%, and Group 3 includes veterans who have service-connected disabilities rated 10% 
or 20%, were discharged from active duty for disabilities incurred or aggravated in the 
line of duty, received the Purple Heart, or are former POWs. Veterans in Group 4 receive 
aid and attendance or housebound benefits, or have been determined by the VHA to be 
catastrophically disabled, i.e. spinal cord injury (SCI). Veterans in Group 5 are low 
income, nonservice-connected veterans. Group 6 is a special category of veterans, who 
have been exposed to Agent Orange or radiation for example, who are not required to 
make co-payments for their care. Group 7 is comprised of high income, nonservice-
connected and 0% service-connected veterans who are required to make co-payments 
[46-48]. 
Service Category: Service categories designate whether the device was provided 
for a service-connected or nonservice-connected diagnosis, and prescribed during an 
inpatient or outpatient episode. Service categories include: service-related and inpatient 
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(SC/IP), service-related and outpatient (SC/OP), nonservice-related and inpatient 
(NSC/IP), and nonservice-related and outpatient (NSC/OP). 
Demographic Variables: The demographic variables of age, gender, 
race/ethnicity, service category, and priority group were selected according to availability 
of variables and clinical relevancy. Age was defined as the age of the veteran when the 
wheelchair was prescribed. Race/ethnicity were designated as Caucasian (76% of 
sample), African American (12%), Hispanic (6%), American Indian (5%), Hawaiian 
(<1%), or Asian (<1%). Gender was either male (96%) or female (4%).  
Clinical Variables: The clinical variables were diagnosis and number of 
comorbidities. Diagnostic categories were formed by extracting International 
Classification of Disease - Revision 9 (ICD-9) codes [49] for the primary diagnoses of all 
FY99, FY00, and FY01encounters for all participants from the inpatient and outpatient 
NPCD datasets. A SAS® program was used to assign each participant one primary 
diagnosis most related to wheelchair-use. The most frequently occurring wheelchair-use 
related ICD-9 codes, ranked in order of their likelihood of being the diagnosis most 
related to the wheelchair prescription (based on the authors’ clinical experience) were: 
amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), spinal cord injury-
tetraplegia (SCIT), spinal cord injury-paraplegia (SCIP), stroke, traumatic brain injury 
(TBI), Parkinson’s disease (PD), amputee, chronic obstructive pulmonary disorder / 
chronic heart failure (COPD/CHF), and arthritis. An “other” category was established for 
primary diagnoses other than those listed.  
Number of comorbidities was a continuous variable developed by sorting the 
secondary diagnoses from the inpatient and outpatient NPCD data into 30 medical 
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categories (anemia, chronic heart failure, diabetes, stroke, etc.). This method of 
calculating comorbidities was developed by Kazis and colleagues [35, 36] during the 
VHS. If a veteran had a comorbidity that was also their primary diagnosis, the 
comorbidity count was decreased accordingly. For example, if the primary diagnosis of a 
veteran was stroke, which was also one of the 30 possible medical comorbidity 
categories, the comorbidity count of the veteran was reduced by one.  
4.3.4  Data Preparation 
Following IRB approval, the NPPD was obtained from the VA Information 
Resource Center (VIREC) [43] at Hines, IL. Demographic data from the NPCD were 
downloaded from the AAC [43]. Unique scrambled patient identifiers from the NPPD 
were submitted to the AAC. Within the AAC system, the scrambled patient identifiers 
were unscrambled to secure NPCD data for the particular veteran identifiers submitted. 
The patient identifiers were then re-scrambled and the NPCD data returned. Thus at no 
time did the investigators have access to unscrambled patient identifiers.  
After entering into a data use agreement with Office of Quality and Performance 
(OQP), scrambled patient identifiers of veterans who had received a wheelchair during 
FY99, FY00, or FY01 were provided to the Center for Health Quality, Outcomes, and 
Economic Research, at the Bedford VAMC, where the SF-36V/VHS data are housed. 
The SF-36V/VHS data for veterans receiving wheelchairs were received on a CD, and 
again, at no time did the investigators have access to unscrambled patient identifiers. 
Data Cleaning and Data Subset Preparation: General data cleaning was 
performed based upon decision rules developed during a collaborative validity study of 
the NPPD [50] and previous NPPD studies by this investigative team [51, 52]. Additional 
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data cleaning and preparation specific to this study were performed as follows: 
wheelchair records of veterans who received their wheelchairs the same day they 
completed the SF-36V, wheelchair records where the delivery date preceded the order 
date were excluded, and only wheelchairs with HCPCS codes listed in Operational 
Definitions/Adjustability of Wheelchair were included. The 61,428 records of 
wheelchairs provided to veterans during the Federal FY99, FY00, or FY01 who 
completed the SF-36V during the 1999 calendar year were reduced to 42,919 records 
with the HCPCS codes designated above. Separate analyses were run on manual and 
power wheelchairs.  
Because participants received wheelchairs across all three years of the study, but 
the SF-36V administrations took place only between July of 1999 and January of 2000, 
participants could have received their wheelchair before or after completing the SF-36V 
(Table 29). Thus, two sub-samples were formed: the determining criterion was whether 
veterans received their wheelchairs before or after completing the SF-36V. Wheelchair 
records of participants who received their wheelchairs then completed the SF-36V were 
assigned to “SampleWC-SF” (n=3,427). Wheelchair records of participants who 
completed the SF-36V then received their wheelchairs were assigned to SampleSF-WC 
(n=33,781).  
Table 28 Comparison of the administration dates of the SF-36V and the wheelchair delivery data 
Dates 
1998   1999   2000   2001   
1-Jan 1-Jul 1-Oct 1-Jan 1-Jul 1-Oct 1-Jan 1-Jul 1-Oct 1-Jan 1-Jul 1-Oct
   SF-36V       
 FY1999 NPPD FY2000 NPPD FY2001 NPPD  
 SampleWC-SF   
D
ata Source                  
&
 Sam
ple  
 Sample SF-WC  
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4.4  ANALYSES  
ANCOVA, ANOVA and the data subset “SampleWC-SF” were used to address 
hypothesis 1, stating veterans provided with more adjustable wheelchairs (IV) would 
subsequently demonstrate better social participation (DV). Social participation was 
defined by the role limitations due to physical or emotional problems, and social 
functioning SF-36V scores. The data subset “SampleWC-SF” was limited to veterans 
receiving their first wheelchair use (type service variable = “initial issue”) to control for 
the effect of previous, unknown wheelchairs on social participation, and veterans who 
had had their wheelchairs at least 90 days. Ninety days was deemed adequate time to 
adjust the wheelchair prior to measurement of social participation. The resulting 
“SampleWC-SF” = 3,427 records.  
The dataset “SampleWC-SF” was divided into two groups for analysis: Group 1 
consisted of veterans who received manual chairs (n=3,178) and Group 2 consisted of 
veterans who received power wheelchairs (n=249) (Figure 9). Therefore, manual and 
power chair users were analyzed separately as a means of controlling for severity of body 
impairment, as power chair users typically have less gross and fine motor control than 
manual chair users. 
Within Group1 (manual chair users, n = 3,178) were participants who received 
adjustable manual chairs (1MA, n=77) and participants who received nonadjustable 
manual chairs (1MN, n=3,101). Within Group 2 (power chair users, n = 249) were 
participants who received adjustable power chairs (2PA, n=73) and participants who 
received nonadjustable power chairs (2PN, n=176).  
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Dates 
1998   1999   2000   2001   
1-Jan 1-Jul 1-Oct 1-Jan 1-Jul 1-Oct 1-Jan 1-Jul 1-Oct 1-Jan 1-Jul 1-Oct
   SF-36V       
 FY1999 NPPD FY2000 NPPD FY2001 NPPD  
  
 
Hypothesis 1 
SampleWC-SF   
D
ata Source                  
&
 Sam
ple 
   
   
Hypothesis 2 
Sample SF-WC  
 
 
 
 
Figure 9 Diagram of sub-samples and groups per hypotheses 1 and 2 
 
Univariate (t-tests and chi-square) analyses were performed to compare manual 
chair users, 1MA and 1MN, and to compare power chair users, 2PA and 2PN. ANCOVA 
was then performed to test for significant differences in RE (the only significant main 
effect found) among manual chair users who received adjustable versus nonadjustable 
chairs, controlling for diagnosis and number of comorbidities. For power wheelchair 
users, ANOVA was performed to test for significant differences in RE and SF 
(significant main effects) between veterans who received adjustable versus nonadjustable 
chairs. Neither of the confounding variables, diagnosis or number or comorbidities, were 
significant for power chair users. 
Logistic regression and the data subset SampleSF-WC were used to address 
hypothesis 2, stating veterans with lower HS (IV) would subsequently be provided with 
adjustable and customizable manual and power wheelchairs (DV). All wheelchairs 
received after completing the SF-36V were included in the analysis, whether the 
Group 3
Manual 
3A & 3N 
Group 4
Power 
4A & 4N
Group 1 
Manual 
1A & 1N
Group 2
Power 
2A & 2N
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wheelchair was an “initial issue,” “replacement,” or “spare.”  The number of records 
included in the analysis of hypothesis 2 was 33,871. Since the veteran could have 
received their wheelchair in FY99, FY00, or FY01, year was included as a control 
variable.  
The dataset “SampleSF-WC” was also divided into two groups: Group 3 
consisted of participants who received manual wheelchairs (n=30,585) and Group 4 
consisted of participants who received power wheelchairs (n=3,196) (Figure 9). Within 
Group 3 were participants who received adjustable manual chairs (3MA, n=1,438) and 
(3MN, n=29,147). Within Group 4 were participants who received adjustable power 
chairs (4PA, n=1,194) and nonadjustable power chairs (4PN, n=2,002).  
Univariate (t-tests and chi-square) analyses were performed to compare manual 
chair users, 3MA and 3MN, and power chair users, 4MA and 4PN. Logistic regression 
was then performed for each of the three models, testing for significant differences in HS 
for veterans who received adjustable versus nonadjustable manual wheelchairs: Model I 
used the PF and MH SF-36V scores to predict HS, adjusting for diagnoses and number of 
comorbidities. Model II used all eight of the SF-36V scores to predict HS. Model IIA 
adjusted for diagnoses, number of comorbidities, and demographic factors, and Model IIB 
was unadjusted.  Model III used the PCS and MCS SF-36V scores to predict HS. Model 
IIIA adjusted for diagnoses, number of comorbidities, and demographic factors, and 
Model IIIB was unadjusted.   
For hypotheses 1 and 2, IV and confounding variables (CV) significant at 0.10 in 
the univariate analyses were entered into the model (ANCOVA, ANOVA or logistic 
regression). Hypotheses were tested at the alpha p< = 0.5 level of significance. For 
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hypothesis 1, both of the significant main effects, RE and SF, met the normalcy 
assumption. For hypothesis 2, correlations between the IV (SF-36V scales) were less than 
r = 0.60. SAS® version 8.2 [53] software was used for all analyses.  
4.5  RESULTS 
The results of the t-test and chi-square univariate analyses for hypothesis 1 (Table 
30) were as follows:  
Manual wheelchair users: For the main effects, veterans who received adjustable 
manual wheelchairs had higher RE scores (less role limitation due to emotional 
problems). For the confounding variables, both diagnosis and number of comorbidities 
were significant. All diagnoses received a higher percentage of nonadjustable 
wheelchairs. The diagnoses receiving the highest percentage of adjustable manual chairs 
were SCIT (22%), SCIP (15%), and MS (13%). Veterans who received adjustable chairs 
had fewer comorbidities. 
Power wheelchair users: For the main effects, veterans who received adjustable 
power wheelchairs had higher RE and SF scores. Neither of the confounding variables, 
diagnosis and number of comorbidities, were significant. The diagnoses receiving the 
highest percentage of adjustable power chairs were PD (57%), SCI-tetraplegia (42%), 
and MS (36%). In fact for veterans with a primary diagnosis of PD, a higher percentage 
of custom power chairs were provided than standard power chairs.  
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ANCOVA and ANOVA results for hypothesis 1 partially supported the 
alternative hypothesis: veterans who received adjustable wheelchairs demonstrated better 
social participation on one out of three measures for manual wheelchair users, and two 
out of three measures for power wheelchair users.  
Manual Wheelchairs: The ANCOVA results, controlling for diagnosis and 
number of comorbidities, indicated veterans who were prescribed adjustable, ultralight 
wheelchairs demonstrated significantly less (p=0.004) role limitation due to emotional 
problems than veterans who were prescribed standard, nonadjustable wheelchairs. 
Power Wheelchairs: ANOVA results indicated veterans who were prescribed 
adjustable, custom power wheelchairs also demonstrated significantly less (p=0.013) role 
Table 29 Univariate results for hypothesis 1 
    SampleWC-SF        Independent Variable: Adjustable Vs. Nonadjustable Wheelchair 
  Group 1MA Group 1MU   Group 2PA Group 2PN   
  Manual Adjust Manual Non-Adjust   Power Adjust Power Non-Adjust   
  Ultralight Depot   Custom Power Standard Power   
    n mean(sd) n mean(sd) p n mean(sd) n mean(sd) p 
Role Physical 66 9.6 (32.4) 2438 4.1 (25.2) 0.17 69 5.1 (27.7) 147  (-) 0.7 (18.8) 0.118 
Role 
Emotional 65 40.8 (50.8) 2374 23.3 (42.7) 0.008* 68 29.0 (44.2) 142 14.5 (37.0) 0.013* 
Social 
Function 68 34.0 (32.1) 2468 30.0 (27.7) 0.239 68 34.7 (27.1) 147 27.5 (24.6) 0.052* 
# 
Cormorbidity 72 5.7 (3.2) 3020 6.5 (3.7) 0.047* 66 5.7 (3.4) 170 6.1 (3.6) 0.299 
  n frequency n frequency p n frequency n frequency p 
Diagnoses 77   3065   <.0001* 72   172   0.458 
ALS 1 3% 30 97%   0 0% 4 100%   
MS 9 13% 59 87%   12 36% 21 64%   
SCI-tetra 10 22% 35 78%   11 42% 15 58%   
SCI-para 8 15% 45 85%   2 18% 9 82%   
Stroke 16 3% 569 97%   9 33% 18 67%   
PD 3 3% 115 97%   4 57% 3 43%   
Amputee 4 3% 136 97%   4 31% 9 69%   
COPD/CHF 10 1% 774 99%   13 24% 42 76%   
D
V: SF-36V Social Participation Scores and 
C
onfounding Variables 
Arthritis 4 1% 372 99%   8 25% 24 75%   
*significant at 0.10           
 132
limitation due to emotional problems than veterans who were prescribed standard, 
nonadjustable wheelchairs. In addition, veterans prescribed adjustable, custom power 
wheelchairs demonstrated better (p=0.052) social functioning than veterans who were 
prescribed standard, nonadjustable wheelchairs, though technically not statistically 
significant at p< 0.05. 
The results of the t-test and chi-square univariate analyses for hypothesis 2 (Table 
31), were as follows:  
Manual Wheelchairs: All proposed SF-36V scales had significant relationships 
with whether an adjustable versus nonadjustable manual wheelchair was provided, thus 
all were entered into at least one of the logistic regression models.  
A higher percentage of adjustable manual wheelchairs were provided for veterans 
with lower (poorer function) physical functioning (p=<.0001) and physical component 
summary (p=0.017) scores. In contrast, veterans who received adjustable manual 
wheelchairs had higher scores (better function) in all other scales: role limitation due to 
physical (p=0.017) and emotional (p=<.0001) problems, body pain (p = 0.021), general 
health (p <.0001), mental health (p = <.0001), social functioning (p = 0.037), vitality (p = 
<.0001), and mental component (p = <.0001).  
Five percent of female veterans received adjustable manual wheelchairs whereas 
only 4% of female veterans received adjustable power wheelchairs. The diagnoses 
receiving the highest percentage of adjustable manual chairs were SCI-paraplegia (34%), 
SCI-tetraplegia (37%), and MS (16%). The highest percentage of adjustable manual 
chairs were provided to priority groups 1 and 4 (wheelchairs provided for veterans with 
disability rated more than 50% or catastrophic) and for service-connected diagnoses with 
 133
the device prescribed during an outpatient episode. Hispanics received a higher 
percentage of adjustable manual chairs than any of the non-Hispanic ethnic categories. 
Power Wheelchairs: None of the SF-36V scores had a significant relationship 
with whether an adjustable versus nonadjustable power wheelchair was prescribed, thus 
no logistic regression model was created for power wheelchairs. 
The diagnoses receiving the highest percentage of adjustable power chairs were 
ALS (51%), SCI-tetraplegia (47%), and SCI-paraplegia (44%). The highest percentage of 
adjustable power wheelchairs were provided to priority groups 1, 4, and 7 (wheelchairs 
provided for veterans with disability rated more than 50% or catastrophic and veterans 
required to make a co-pay) and for service-connected diagnoses with the device 
prescribed during an inpatient episode. Hispanics received a higher percentage of 
adjustable power chairs than any of the non-Hispanic ethnic categories. 
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Table 30 Univariate results for hypothesis 2 
  SampleSF -WC      Dedependent Variable: Adjustable Vs. Nonadjustable Wheelchair 
  Group 3MA Group 3MN  Group 4PA Group 4PN  
  Manual Adjust Manual Non-Adjust  Power Adjust Power Non-Adjust  
  Ultralight Depot  Custom Power Standard Power  
  n mean(sd) n mean(sd) p n mean(sd) n mean(sd) p 
Physical Functioning 753 19.2 (24.7) 16785 25.4 (26.1) <.0001* 675 13.8 (25.2) 1062 12.7 (21.8) 0.365 
Role Limitation Physical 744 11.8 (30.9) 16466 9.1 (28.3) 0.017* 663 4.3 (27.0) 1046 4.1 (25.0) 0.833 
Body Pain 762 35.4 (25.6) 16783 33.2 (25.1) 0.021* 678 29.4 (25.8) 1083 28.8 (24.9) 0.492 
General Health 756 36.0 (24.6) 16558 30.6 (21.0) <.0001* 672 28.1 (22.4) 1073 28.9 (20.9) 0.429 
Mental Health 760 59.6 (25.2) 16745 55.5 (24.4) <.0001* 682 55.1 (26.0) 1078 54.6 (24.9) 0.667 
Role Limitation Emotional 730 36.5 (47.8) 16220 28.2 (44.5) <.0001* 652 29.2 (47.0) 1031 28.3 (44.4) 0.689 
Social Functioning 760 41.0 (31.2) 16794 38.6 (29.5) 0.037* 682 32.3 (29.3) 1086 34.1 (28.6) 0.195 
Vitality 760 35.7 (24.2) 16797 28.9 (21.9) <.0001* 682 26.4 (23.0) 1079 27.9 (21.6) 0.167 
Physical Component 702 25.0 (8.4) 15627 25.8 (8.8) 0.017* 629 22.4 (8.0) 983 22.3 (7.1) 0.762 
Mental Component 702 43.2 (14.4) 15627 39.4 (13.1) <.0001* 629 39.9 (14.7) 983 40.6 (13.8) 0.491 
# Cormorbidity 1284 4.6 (3.1) 27741 5.7 (3.2) <.0001* 1103 5.5 (3.6) 1829 5.6 (3.4) 0.328 
Age 1409 59.5 (15.0) 28664 68.7 (12.6) <.0001* 1156 62.0 (13.5) 1953 63.5 (13.2) 0.003* 
 n frequency n frequency p n frequency n frequency p 
Diagnoses     <.0001*     <.0001* 
ALS 10 5% 181 95%  32 51% 31 49%  
MS 106 16% 556 84%  153 40% 228 60%  
SCI-tetra 302 37% 515 63%  305 47% 342 53%  
SCI-para 275 34% 532 66%  95 44% 120 56%  
Stroke 151 3% 4684 97%  135 35% 250 65%  
PD 32 4% 871 96%  21 44% 27 56%  
Amputee 79 6% 1301 94%  42 28% 108 72%  
IV: SF-36V H
ealth status Scores and C
onfounding Variables 
COPD/CHF 102 1% 6761 99%  172 34% 335 66%  
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 SampleSF -WC      Dedependent Variable: Adjustable Vs. Nonadjustable Wheelchair 
 Group 3MA Group 3MN   Group 4PA Group 4PN  
 Manual Adjust Manual Non-Adjust   Power Adjust Power Non-Adjust  
 Ultralight Depot   Custom Power Standard Power  
 n mean(sd) n mean(sd) p n mean(sd) n mean(sd) p 
Arthritis 84 2% 3462 98%  69 29% 171 71%  
Priority Group        <.0001*         0.020* 
1 578 8% 67 92% 503 39% 796 61%  
2 74 3% 2132 97% 45 29% 111 71%  
3 99 3% 2899 97% 60 29% 145 71%  
4 343 9% 3513 91% 320 40% 486 60%  
5 221 2% 10969 98% 187 35% 346 65%  
6 6 4% 133 96% 2 29% 5 71%  
7 23 3% 689 97% 18 40% 27 60%  
Service Category        <.0001*         <.0001* 
NSC/IP 135 3% 4458 97%  110 51% 105 49%  
NSC/OP 762 4% 19304 96%  661 36% 1189 64%  
SC/IP 34 3% 823 96%  38 61% 24 39%  
SC/OP 507 35% 4796 90%  386 36% 687 34%  
Gender       0.003*         0.300 
Male 1364 95% 28220 97% 1132 96% 1898 95%  
Female 96 5% 982 3% 48 4% 97 5%  
Race/ethnicity        <.0001*         0.310 
Caucasian 530 4% 12253 96% 532 38% 865 62%  
African American 107 5% 2191 95% 76 40% 112 60%  
Hispanic 96 7% 1245 93% 27 51% 26 49%  
Native American 22 3% 805 97% 34 3% 63 97%  
Hawaiian 1 1% 100 99% 3 1% 10 99%  
iV: SF-36V H
ealth status Scores and C
onfounding Variables 
Asian 4 4% 122 97% 3 3% 7 97%  
 *significant at 0.10           
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Logistic regression results for hypothesis 2 are presented by model. Of the three 
models analyzed, the adjusted models (Models I, IIA, and IIIA) had a better fit [54] than 
the unadjusted models. Of the three adjusted models, Model IIA (c=0.81) and Model IIIA 
(c=0.80) had a better fit than Model I (c=0.77). 
Model I defined HS using PF and MH SF-36V scores, adjusting for diagnoses and 
number of comorbidities (Table 32). Veterans who received adjustable, ultralight manual 
wheelchairs had significantly lower physical function (p=<.0001) and significantly higher 
mental function scores (p=0.019) than veterans who received nonadjustable, depot chairs 
when controlling for diagnosis and number of comorbidities. For every 10-point decrease 
in PF score, a veteran was 1.08 times more likely to receive an ultralight chair. For every 
10-point increase in MH score, a veteran was 1.04 times more likely to receive an 
ultralight chair.  
Model II defined HS using all eight of the SF-36V scores. Model IIA adjusted for 
diagnoses, number of comorbidities, and demographic factors. Model IIB was unadjusted 
(Table 33). When all eight of the SF-36V scores were considered simultaneously, only 
physical function (p=<.0001), role limitation due emotional problems (p=0.012), general 
health (p=<.0001), and vitality (p=<.0001) were significant. When model II was adjusted, 
only physical function (p=<.0001) and general health (p=0.015) remained significant 
predictors of type of wheelchair received. 
Veterans who received adjustable, ultralight manual wheelchairs had significantly 
lower physical function (p=<.0001) and significantly higher general health scores 
(p=0.015) than veterans who received nonadjustable, depot chairs when controlling for 
clinical and demographic factors. For every 10-point decrease in PF score, a veteran was 
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1.10 times more likely to receive an ultralight chair. For every 10-point increase in GH 
score, a veteran was 1.06 times more likely to receive an ultralight chair.  
Model III defined HS using the PCS and MCS scores of the SF-36V. Model IIIA 
adjusted for diagnoses, number of comorbidities, and demographic factors. Model IIIB 
was unadjusted (Table 34). In model IIIB, both PCS (p=.013) and MCS (p=<.0001) were 
significant. However, when adjusted for clinical and demographic factors, only MCS 
remained significant (p=.001). 
Veterans who received adjustable, ultralight manual wheelchairs had significantly 
higher mental component summary scores (p=0.001) than veterans who received 
nonadjustable, depot chairs when controlling for clinical and demographic factors. For 
every 10-point increase in MCS score, a veteran was 1.10 times more likely to receive an 
ultralight chair. 
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Table 31 Model I logistic regression results 
    DV: Adjustability of Manual Wheelchair 
    Criterion = Group 2 - unadjustable manual depot wheelchair 
  Coefficient Std Error Wald CI p value Adj OR OR 95% CI c R-sq 
Physical Function-a 0.008 0.002 17.27 <.0001* 1.080 1.008 1.004-1.011 
Mental Health-a -0.004 0.002 5.42 0.020* 0.959 0.996 0.992-0.999 
0.772-a 0.056-a IV:       
SF-36V 
Scores * significant at p=0.05 abd CI does not include 1        
 a = adjusted for diagnosis, number of comorbidities, year       
 Adj OR = OR for every 10 point change in score   
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Table 32 Model II logistic regression results 
    DV: Adjustability of Manual Wheelchair 
    Criterion = Group 2 - unadjustable manual depot wheelchair 
    Coefficient Std Error Wald CI p value Adj OR OR 95% CI c R-sq 
Physical Function 0.023 0.002 107.80 <.0001* 1.252 1.023 1.018-1.027 
Physical Function-a 0.009 0.002 16.81 <.0001* 1.096 1.009 1.005-1.014 
Role Physical -0.004 0.002 4.72 0.030 0.965 0.996 0.993-1.00 
Role Physical-a -0.0007 0.002 0.11 0.743 0.993 0.999 0.995-1.003 
Body Pain 0.002 0.002 0.99 0.321 1.019 1.002 0.998-1.006 
Body Pain-a 0.003 0.002 1.55 0.213 1.030 1.003 0.998-1.008 
General Health -0.012 0.002 22.88 <.0001* 0.891 0.988 0.984-0.993 
General Health-a -0.007 0.003 5.89 0.015* 0.935 0.993 0.988-0.999 
Mental Health 0.002 0.002 0.64 0.423 1.019 1.002 0.997-1.006 
Mental Health-a -0.001 0.003 0.24 0.622 0.987 0.999 0.994-1.004 
Role Emotional -0.003 0.001 6.120 0.013* 0.973 0.997 .0995-0.999 
Role Emotional-a -0.0006 0.001 0.21 0.651 0.994 0.999 0.997-1.002 
Social Function 0.003 0.002 1.66 0.197 1.026 1.003 0.999-1.006 
Social Function-a 0.0003 0.002 0.02 0.898 1.003 1.000 0.996-1.005 
Vitality -0.015 0.002 39.10 <.0001* 0.863 0.985 0.981-0.990 
IV:SF-36V Scores 
Vitality-a -0.004 0.003 2.20 0.138 0.959 0.996 0.990-1.001 
0.650  
0.805-a 
0.014  
0.066-a 
 * significant at p=0.05 abd CI does not include 1        
 a = adjusted for diagnosis, number of comorbidities, priority group, service category, age, gender, rece/ethnicity, year   
 Adj OR = OR for every 10 point change in score   
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Table 33 Model III logistic regression results 
    DV: Adjustability of Manual Wheelchair     
    Criterion = Group 2 - unadjustable manual depot wheelchair     
    Coefficient Std Error Wald CI p value Adj OR OR 95% CI c R-sq 
PCS 0.011 0.004 6.12 0.013* 1.115 1.011 1.002-1.020 
PCS-a 0.009 0.005 2.61 0.106 1.090 1.009 0.998-1.019 
MCS -0.021 0.003 52.87 <.0001* 0.813 0.980 0.974-0.985 
IV:SF-36V 
Scores 
MCS-a -0.010 0.003 9.96 0.001* 0.902 0.990 0.983-0.996 
0.582   
0.798-
a 
0.004  
0.065-
a 
 * significant at p=0.05 abd CI does not include 1        
 
a = adjusted for diagnosis, number of comorbidities, priority group, service category, age, gender, rece/ethnicity, 
year   
 Adj OR = OR for every 10 point change in score   
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4.6  DISCUSSION  
In the U.S. general population, 40% of individuals who use wheelchairs report 
poor health and 96% report activity limitation [55]. The purpose of the study described 
herein was to establish a relationship between adjustability, thus customizability, of 
wheelchairs and HS or HRQoL.  
The first hypothesis investigated the effect of adjustable versus nonadjustable 
wheelchairs on social participation. Veterans who received adjustable manual and power 
wheelchairs were found to have less role limitation due to emotional problems. In 
addition, veterans who received adjustable power wheelchairs had better social 
functioning. Social participation was only measured at one point in time, which was a 
study limitation. Thus these veterans may have had less role limitation due to emotional 
problems and better social functioning prior to receiving their wheelchairs. In fact, they 
may have received the adjustable wheelchair because they were more emotionally and 
socially adept, and therefore better able to self-advocate. A future longitudinal study in 
which outcomes data are collected at more than one time point is needed to validate these 
findings. This longitudinal study would allow for a comparison of pre- and post- data or 
for the use of receipt of wheelchair scores as a control factor.  
The population of this study (veterans who received wheelchairs from the VHA), 
was a second limitation, as the population was comprised of a ten diagnostic groups plus 
an “other” diagnostic category. The effect a wheelchair may have on social participation 
may vary with diagnosis or circumstances under which the wheelchair was prescribed.  
For example, veterans may receive their wheelchairs after an acute event, such as a 
stroke. For these veterans, social participation scores may possibly reflect a decrease in 
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social participation due to the sudden, dehabilitating effects of a stroke and associated 
new wheelchair prescription for abrupt inability to ambulate. In contrast, for veterans 
with long term, progressive disabilities, receipt of a wheelchair may have a more positive 
effect on social participation. For these veterans, whose ambulation may have slowly 
deteriorated over the years, a device that enhanced their slowly declining mobility would 
have the effect of improving their social participation scores. To address this limitation, a 
subsequent analysis of hypothesis 1 was performed on a data set limited to veterans with 
MS, COPD/CHF, and arthritis. Limiting the dataset to progressive disorders, however, 
decreased the significance of the findings. Decreasing power by reducing the number of 
records included in the analysis could have been a factor for less significant findings. 
Limited information has been published using the SF-36 in populations who use 
wheelchairs. Trefler et. al [56] showed significant improvements in social functioning 
after wheelchair receipt, however, this work had limitations in the populations studied 
and the level of disability.  
A prospective study has been proposed to address the variance attributed to 
multiple diagnoses by focusing on one diagnosis – stroke. In addition, the prospective 
study design will allow administration of the SF-36V pre- and post- receipt of 
wheelchair. Outcomes data on participant “activity” based on the World Health 
Organization International Classification of Function [57] model will also be collected. 
A second study also proposed, will be a cross-sectional, retrospective designed study, that 
will link NPPD data with the Functional Status and Outcomes Database (FSOD) [58] 
based on the Functional Independence Measure™ (FIM ™) [59], Again participation will 
be limited to veterans with stroke. Linking the NPPD with the FSOD will provide 
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information on type of wheelchairs provided by functional level of participants. 
The results of the analyses of hypothesis 2 suggested HS significantly predicted 
whether an adjustable or nonadjustable manual wheelchair was prescribed, but HS was 
not a predictor of whether an adjustable or nonadjustable power wheelchair was 
prescribed. Veterans who received adjustable, ultralight manual wheelchairs had 
significantly lower physical function scores, as measured by the SF-36V, and 
significantly higher mental function, general health, and mental component summary 
scores than veterans who received nonadjustable, depot chairs, after adjusting for clinical 
and demographic factors.  
Interestingly, less variability was noted in the SF-36V scores of veterans receiving 
power wheelchairs than in the SF-36V scores of veterans receiving manual wheelchairs. 
For example, for manual chair recipients, the range of variability in mean SF-36V scores 
of those who received adjustable versus nonadjustable chairs was two to eight points, 
compared to a range of 0.1 to 1.8 points for power chair recipients (Table 3). In other 
words, more differences were found in HS of veterans who received adjustable manual 
wheelchairs versus nonadjustable manual wheelchairs. Conversely, little difference was 
determined in HS of veterans who received adjustable power wheelchairs versus 
nonadjustable power wheelchairs. The smaller variation among power users may have 
contributed to lack of significant findings. Less variation in characteristics of veterans 
who received power wheelchairs versus manual wheelchairs was found in another study 
by this investigative team [51]: stronger evidence was found for ethnic variation among 
veterans receiving manual wheelchairs from the VHA than veterans receiving power 
chairs from the VHA. 
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Further, the variability in mean HS scores of veterans receiving manual versus 
power chairs was not always in the same direction, suggesting manual chairs may have a 
different effect on HS than power chairs. For example, veterans who received ultralight 
manual chairs had lower mean PF and PCS scores than veterans who received depot 
manual chairs, indicating veterans receiving adjustable manual wheelchairs had lower 
physical function. In contrast, veterans receiving custom power wheelchairs had higher 
PF and PCS scores than veterans who received standard, nonadjustable power 
wheelchairs. A similar inverse trend was noted for GH, SF, VT, PCS, and MSC scores, 
however, the effect was reversed. Veterans receiving adjustable manual chairs had higher 
GH, SF, VT, PCS, and MSC scores. Veterans who received adjustable power chairs had 
lower GH, SF, VT, PCS, and MSC scores. Overall, veterans who received manual 
wheelchairs had higher HS than veterans who received power wheelchairs. More 
variability existed in HS among manual chair recipients than power chair recipients, but 
approximately ten times more manual chairs were provided by the VHA than power 
chairs, thus more opportunity for variability. The variability in HS between manual and 
power recipients was not merely a matter of degree. The HS profiles of veterans who 
received adjustable manual chairs differed from the profiles of veterans who received 
adjustable power chairs.  
Other limitations of this study include lack of established reliability and validity 
for using the SF-36 or SF-36V with a non-ambulatory population in addition to concerns 
about reliability and validity of the NPPD data itself [50-52, 60]. Although the SF-36 
norms are available for persons with chronic conditions that affect mobility yet remain 
ambulatory [6], and the SF-36 has been used extensively with individuals with SCI, MS, 
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ALS, PD, and stroke, who are frequently non-ambulatory [61-70], the SF-36 has not been 
standardized on individuals who use wheelchairs. Therefore, sensitivity of the SF-36V is 
to changes in HS of non-ambulatory veterans is unknown. Work towards standardization 
of the SF-36 for individuals with SCI, who are typically nonambulatory, has focused on 
the physical and mental component scores. In a study not yet published, Forchheimer (M. 
Forchheimer, written communication, February 17, 2003) found the factor structure of 
the SF-36 to be appropriate for use with SCI. In addition, the physical component score 
(PCS), but not the mental component score (MCS), of the SF-36 were associated with 
severity of neurological impairment. Several of the items on the physical functioning 
subscale (items 6, 7, 9-11) were found to be insensitive to the paralytic symptoms 
associated with SCI in a study by Tate et. al [6], who have made slight modifications to 
the wording of these items. For example, three items that dealt with walking were 
modified to use the verb “going”. Two items that dealt with stair climbing were changed 
to “going up several flights of stairs”. For persons with SCI, this wording allowed for the 
use of assistive devices without penalty. When using this modified version, the SF-36 
yielded a very strong relationship between the physical functioning subscale and the 
motor scale of the FIM, suggesting adequate construct validity [6].  
The study described herein and other NPPD studies [50-52, 60] have found 
inconsistencies in the coding of devices due to lack of standardization of data entry. For 
example, the code of the device may have designated a scooter, when in fact, after 
examining other fields such as vendor and cost, it became apparent that the veteran 
actually received a power wheelchair. In addition, inconsistencies in the coding of 
diagnoses were also found within the dataset. For example, within the NPCD, a veteran 
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may have been coded with ICD-9 code representing the diagnosis SCI-paraplegia, but 
also coded as having an injury at the cervical level. Therefore, considering SCI as one 
category, rather than interpreting data for veterans with tetraplegia separately from 
veterans with paraplegia, may be more reliable.  
Policy Implications: The mission of the VHA is to provide equitable, 
standardized, and quality care to veterans. A question that comes to mind is “Is the 
provision of wheelchairs equitable?” Or do VHA facilities with seating and mobility 
clinics provide a different quality wheelchair than facilities lacking this specialized 
expertise? In a study of 412 individuals with SCI who use wheelchairs full-time, who 
received their wheelchairs from SCI centers of excellence, Hunt et. al [71], 97% of 
manual wheelchair participants had ultralight wheelchairs. The remaining 3% used 
manual wheelchairs that were not ultralights. In contrast, 3% of the manual wheelchairs 
provided by the VHA are adjustable, ultralight wheelchairs [51]; 13% of veterans with 
SCIT, and 13% of veterans with SCIP received ultralight wheelchairs during the fiscal 
years 1999 to 2001. In addition, in the Hunt et. al study [71], no participants received a 
standard wheelchair. In contrast, the study described herein found the standard 
wheelchair to be the most frequently prescribed power wheelchair for individuals with 
tetraplegia and paraplegia due to SCI. Based on the relatively few ultralight wheelchairs 
provided by the VHA (3%), it is not surprising that a stronger relationship between 
physical health status and adjustability, therefore customizability of wheelchair was not 
found.  
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4.7  CONCLUSION 
Veterans who received adjustable, ultralight manual wheelchairs had significantly 
lower physical function scores, as measured by the SF-36V, and significantly higher 
mental function, general health, and mental component summary scores than veterans 
who received nonadjustable, depot chairs, when adjusting for clinical and demographic 
factors.  
The evidence for an association between adjustable wheelchairs and higher 
mental function was stronger than the evidence for an association between adjustable 
wheelchairs and lower physical function. The inability of the veteran functioning at a 
lower mental level to self-advocate, clinician bias, and safety considerations are factors 
possibly effecting the provision of adjustable wheelchairs to veterans with higher mental 
function. The weak association between the provision of adjustable wheelchairs and 
lower physical function may have been affected by the relatively few adjustable 
wheelchairs provided to veterans by the VHA. 
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5 CHAPTER FIVE 
5.1  CONCLUSIONS 
An underlying goal of this dissertation was to explore the as yet unexplored 
NPPD database, a small step towards realizing the long-range goal of documenting 
functional outcomes of various types of wheelchairs and scooters. Had King Philip of 
Spain had the selection of wheelchairs available to him in 1595 that are available now, 
certainly he would have wanted to know which wheelchair would best meet his needs. 
The king’s court would have wanted documentation of the benefits of the more expensive 
wheelchairs, before they could justify the cost. 
The first study probed the NPPD to determine how many wheelchairs and 
scooters were provided to veterans by the VHA during Federal fiscal years 1999, 2000, 
and 2001. Demographic (age, gender, race/ethnicity, service category, and priority group) 
and clinical information (diagnosis and number of comorbidities) of veterans who 
received wheelchairs and scooters were obtained by linking the NPPD with the NPCD.  
Wheelchairs were sorted according to eight types. There were four types of 
manual wheelchairs: the standard depot wheelchair, the lightweight rehabilitation 
wheelchair, the highly customizable ultralight wheelchair, and a miscellaneous category 
with a large percentage of bariatric wheelchairs. There were three types of power 
wheelchairs: the standard power wheelchair, a miscellaneous category with a large 
percentage of folding power wheelchairs, and the custom power wheelchair. The eighth 
category was scooters. When all wheelchairs were considered, the standard manual depot 
chair was the most frequently prescribed wheelchair for all diagnoses. Lightweight 
rehabilitation wheelchairs were the second most frequently prescribed wheelchairs for 
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veterans with MS, SCI, stroke, TBI, PD, and amputee; scooters were the second most 
frequently prescribed wheeled mobility device for veterans with ALS, COPF/CHF, and 
arthritis. When only manual wheelchairs were considered, the standard manual depot 
chair and lightweight rehabilitation wheelchairs were still the first and second most 
frequently prescribed wheelchairs for all diagnoses including SCI. When only power 
wheelchairs were considered, the standard power wheelchair was the most frequently 
prescribed for all diagnoses.  
The hypothesis postulated the type of wheelchair provided would differ 
significantly according to gender, race/ethnicity, and age. No significant differences were 
found for gender. Differences were more evident between Hispanics and Caucasians than 
between African Americans and Caucasians. When comparing manual wheelchairs, 
Hispanics (Odds Ratio=1.7), African Americans (Odds Ratio =1.1), and American 
Indians & Asians (Odds Ratio =1.6) were more likely than Caucasians to receive manual 
depot wheelchairs, and Hispanics were more likely than Caucasians to receive ultralight 
manual (Odds Ratio=1.8).  Hispanics (Odds Ratio =0.7) and African Americans (Odds 
Ratio =0.8) were less likely than Caucasians to receive lightweight rehabilitation 
wheelchairs. When comparing power wheelchairs Hispanics (Odds Ratio=1.6) were more 
likely than Caucasians to receive custom power chairs. When comparing all WMDs, 
older veterans were more likely to receive standard depot wheelchairs (p=<.0001) and 
younger veterans ultralight wheelchairs (p=<.0001). 
The second study investigated the variance in the cost of wheelchairs and scooters 
by VISN (hypothesis 1) and vendor (hypothesis 2). During FY00 and FY01, the VHA 
provided over 131,000 wheelchairs and scooters, at a cost of $109,010,198. Of this $109 
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million, $7,747,405 exceeded an established threshold, and was determined by this study 
to be potential excessive cost. At least part of this variation is attributed to lack of 
standardization of prosthetic purchase procedures and data entry within the VHA. 
Another consideration is the possibility of fraud and abuse, which merits further 
investigation, but was beyond the scope of this study. 
The third study linked NPPD data with SF-36V data, to document the relationship 
between adjustable versus nonadjustable wheelchairs and HRQoL. The first hypothesis 
postulated controlling for diagnosis, number of comorbidities, and demographic factors, 
veterans who are provided with more adjustable thus customizable manual and power 
wheelchairs will report more participation in society. The second hypothesis, based on 
the assumption that as the HRQoL of the wheelchair user declines, more demand is 
placed on the technology to maintain user function and participation [1], postulated 
veterans with poorer HS will be provided with more adjustable and customizable manual 
and power wheelchairs. 
The results indicated veterans who received adjustable, ultralight manual 
wheelchairs had significantly lower physical function scores, as measured by the SF-36V, 
and significantly higher mental function, general health, and mental component summary 
scores than veterans who received nonadjustable, depot chairs, when adjusting for 
clinical and demographic factors. Interestingly, according to the univariate analyses, 
veterans who received adjustable manual chairs reported significantly lower physical 
function, but significantly less role limitation due to physical problems.  
The evidence for an association between an adjustable wheelchair and higher 
mental function was stronger than the evidence for an association between an adjustable 
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wheelchair and lower physical function. Factors effecting provision of adjustable 
wheelchairs to patients with higher mental function include the inability of the lower 
functional patient to self-advocate, clinician bias, and safety considerations. The weak 
association between the provision of adjustable wheelchairs to patients with lower 
physical function may have been effected by the relatively few adjustable wheelchairs 
provided to veterans by the VHA. 
5.1.1   Policy Implications 
The mission of the VHA is to provide equitable, standardized, and quality care to 
veterans. This dissertation research has investigated the equity of WMD provision in 
three contexts: demographic factors, cost, and HS.  
There was more variation by ethnicity than by race, no significant variation by 
gender, and minimal variation by age. When all WMDs where analyzed, Caucasians were 
more likely to receive power devices including scooters, and minorities were more likely 
to receive manual wheelchairs. When manual and power devices were analyzed 
separately, Hispanics were more likely than Caucasians to receive adjustable thus 
customizable devices with little variation between African Americans and Caucasians. 
Further investigation is warranted before conclusions can be drawn. For example, the 
above analyses could be repeated at the VAMC facility level, including facilities with a 
high volume of adjustable manual and power chair prescriptions. 
Lack of standardization in the procedure by which prosthetic devices are entered 
into the NPPD was found in this and other studies [2, 3]. It is difficult to evaluate 
standardization of care when the data is inconsistent, i.e. “Is it the care that is 
inconsistent, the data, or both”? The VHA has a head start in monitoring of prescription 
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practices, in development of the NPPD, even if the system reliability and validity could 
be improved as recommended in this dissertation research, primarily in Chapter 3.  
 The NPPD has the capacity to monitor quality of care i.e. by linking the NPPD 
with VHA outcomes databases. This dissertation research linked the NPPD to the SF-
36V data of the VHS. Evidence can thus be generated in support of the use of AT to 
improve the quality of life of veterans. The findings of this research presented  
a stronger association between an adjustable wheelchair and higher mental function than 
an adjustable wheelchair and lower physical function. In addition, findings provided 
encouragement to continue to explore the relationship between AT and functional 
outcomes using a variety of outcomes measures. By linking the NPPD with other 
databases, quality of care can be monitored through the complete continuum of care: 
from onset in the acute records of the NPCD, through outpatient care, in the NPCD, 
associating outcomes with AT devices through the various changes in patient 
environment as the veteran progresses through the rehabilitation process.  
 In summary the NPPD, in spite of it’s shortcomings, provides researchers an 
excellent opportunity to study the effect of ATDs on rehabilitation outcomes, which in 
turn can support the mission of the VHA by facilitating standardized and equitable 
practice, while providing the best care possible to veterans. 
5.1.2   Limitations and Future Work 
 Three categories of limitations of this dissertation research were noted. The first 
was the more general limitation of using administrative databases in research. 
Administrative databases “are the by-product of running a healthcare system” [4] and do 
not provide information unique to each veteran. The implications of this limitation are 
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many. Evidence was provided for the type, number, cost, etc. of devices provided across 
VISNs, diagnoses, age, gender, race/ethnicities. However, we do not know how each 
veteran differed according to level of impairment and disability, functional levels, or 
mobility, activity, and participation needs. For example, we know how many veterans 
with a stroke were prescribed a wheelchair, what type, and the cost incurred. We do not 
know whether the veteran had a mild stroke and lived alone in his own home or had a 
massive brain stem stroke and lived in a VHA skilled nursing facility. Therefore the 
appropriateness of the wheelchair prescription cannot be determined.     
 Not only do medical administrative databases not provide information on patients, 
they do not provide information on the circumstances under which the devices were 
prescribed. The background and training of individuals prescribing the devices is an 
important factor. In a study of SCI Centers of Excellence, Hunt et. al [5] found 
substantially different wheelchair prescription practices than were found in this 
dissertation research. These limitations however, lay the foundation for future research. It 
is not enough to know one VISN provided wheelchairs at a lower cost than other VISNS. 
Future studies need to investigate which wheelchairs provide the best quality of life for 
which veterans, what is a reasonable cost for the most appropriate wheelchair, what 
clinician training is necessary before these decisions can be made, and how can the VHA 
disseminate this information to impact equality of care.   
 The second category of limitation included reliability and validity limitations of 
the NPPD data itself. Inconsistent coding of vendors and devices noted in this and other 
NPPD studies [2, 3] and discussed extensively in this dissertation effected the accuracy of 
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quantity and types of devices reported. Standardization of data entry is recommended to 
improve reliability and validity for future NPPD studies.  
The distribution of the cost data was not normal and extremely skewed which 
limited the statistical analyses that could be performed and the inferences that could be 
made.   At least part of this variation is attributed to lack of standardization of prosthetic 
purchase procedures and data entry within the VHA. Another consideration is the 
possibility of fraud and abuse, which merits further investigation, but was beyond the 
scope of this study.  
The third category of limitation was variance in the data resulting from 
differences in wheelchair provision practices across facilities. Standardization of data 
entry is not the same as standardization of prescription practices. Ideally, standardized 
data entry would provide options for differentiating the various wheelchair provision 
options and processes so they could be compared and contrasted. Unfortunately, lack of 
opportunities to code for these various options (an asset to the VHA system) further 
jeopardizes reliability and validity. If there was standardization in documenting how the 
device was provided, (i.e. from stock with adjustment from VHA technician versus 
supplied and adjusted by vendor) future studies could identify and rank the most effective 
VHA purchase options for WMDs.  
Variation in wheelchair prescription practices remains unknown as this data is not 
included in the NPPD, an administrative database, yet prescription practice is an 
important factor to consider before drawing conclusions from the results of this study. 
Potential excessive cost can be partially explained by a facility with a specialty clinic that 
provides wheelchairs to veterans with challenging seating and mobility needs (i.e. SCI, 
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tetraplegia, and MS) versus a VAMC that prescribes primarily scooters to veterans with 
deconditioning disorders. It is possible that VAMC facilities with wheelchair costs below 
the national median may not be adequately meeting the seating and mobility needs of 
veterans. Once clinical guidelines on manual and power wheelchair prescription within 
the VHA are finalized and distributed, future studies could incorporate guidelines as a 
factor along with wheelchair prescription and functional level.  
 Other ways future studies could build on this dissertation research include the 
following. The NPPD could be linked with other VHA databases, i.e. the Functional 
Status Outcome Database (FSOD) [6]. Prospective studies could be designed to use other 
measures functional outcomes. i.e. that follow the World Health Organization (WHO) 
[7], International Classification of Function (ICF) [8] model. Exploration of alternative 
outcomes measures could lead to expansion of existing VHA outcomes database(s). 
VACO has expressed interest in establishing outcomes for veterans with amputations. 
Outcomes databases exist for individuals with SCI. The VHA maintains an outcomes 
database for veterans with stroke. It is recommended that these databases be consolidated, 
or have the capacity to be integrated by the use of common fields. Otherwise orthopedic 
function will be contained in one database, neurological function in another, and 
cognitive function in yet another. This could be problematic for a veteran with SCI and a 
blast injury resulting in amputation. In addition, maintaining databases by body 
impairment goes against the prevailing rehabilitation model where individuals with 
disabilities are viewed in an activity and participation outcomes context rather than in an 
impairment context.  
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As a final recommendation for future work, more variance among manual 
wheelchair recipients was found in both the demographic (race/ethnic variance) and the 
HRQoL (HS) studies than for power wheelchair recipients. Future studies could further 
explore the implication of this finding, for example, do power wheelchairs require more 
clinical expertise in seating and mobility than standard manual wheelchairs?  Do power 
wheelchairs require more clinical expertise in seating and mobility than standard manual 
wheelchairs?  Thus, there is less variance in provision. Or is it because fewer power 
wheelchairs are provided? Or is there less variance in the characteristics of veterans who 
receive power chairs, i.e. is the spectrum narrower?  
 
In conclusion, the NPPD, developed to provide a better understanding of the 
relationship between quality, function, and cost [9], is a valuable and promising source of 
prosthetic data. This research provided three snapshots of the VHA WMD provision 
system: demographics, cost, and HRQoL of veterans who receive wheelchairs from the 
VHA. The next steps are (1) to improve the quality of the data by standardizing NPPD 
data entry, and (2) to design future studies to develop these uni-dimensional snapshots 
into multidimensional relationships that can provide evidence in support of the provision 
of AT to improve the quality of life for veterans, and contribute to the develop of practice 
guidelines for the prescription of AT devices. 
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APPENDIX A 
HCPCS Code and Corresponding Assigned Wheelchair Type 
 
HCPCS Codes with Corresponding NPPD Line and WC Type 
      HCPCS 
Code Description NPPD Line WC Type 
E1050 W/c reclining fxd arms 100 B M1 
E1060 W/c detachable arms 100 B M1 
E1070 W/c detachable foot r 100 B M1 
E1083 Hemi w/c fixed arms 100 B M1 
E1084 Hemi w/c detachable a 100 B M1 
E1085 Hemi w/c fixed arms 100 B M1 
E1086 Hemi w/c detachable a 100 B M1 
E1087 W/c lightwt fixed arm 100 B M2 
E1088 W/c lightweight det a 100 B M2 
E1089 W/c lightwt fixed arm 100 B M2 
E1090 W/c lightweight det a 100 B M2 
E1091 W/c youth 100 B M4 
E1092 W/c wide/w leg rests 100 B M4 
E1093 W/c wide/w foot rest 100 B M4 
E1100 W/c s-recl fxd arm leg res 100 B M1 
E1110 W/c semi-recl detach 100 B M1 
E1130 W/c stand det arm ft rest 100 C M1 
E1140 W/c standard detach a 100 C M1 
E1150 W/c standard w/ leg r 100 C M1 
E1160 W/c fixed arms 100 C M1 
E1170 W/c amp fxd arm leg rest 100 B M1 
E1171 W/c amputee w/o leg r 100 B M1 
E1172 W/c amputee /detach ar 100 B M1 
E1180 W/c amputee w/ foot r 100 B M1 
E1190 W/c amputee w/ leg re 100 B M1 
E1195 W/c amputee heavy dut 100 B M1 
E1200 W/c amputee fixed arm 100 B M1 
E1210 W/c motorfxd arm leg rest 100 A P1 
E1211 W/c motorized w/ det 100 A P1 
E1212 W/c motorized w full 100 A P1 
E1213 W/c motorized w/ det  100 A P1 
E1220 W/c special size/constrc 100 B P1 
E1221 W/c spec size w foot 100 B M4 
E1222 W/c spec size w/ leg 100 B M4 
E1223 W/c spec size w foot 100 B M4 
E1224 W/c spec size w/ leg 100 B M4 
E1225 W/c spec sz semi-recl 100 B M4 
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      HCPCS 
Code Description NPPD Line WC Type 
E1226 W/c spec sz full-recl 100 B M4 
E1227 W/c spec spec sz spec ht A 100 B M4 
E1228 W/c spec spec sz spec ht B 100 B M4 
E1230 Powered operated vehicle 100 A1 S1 
E1240 W/c litwt det arm leg rest 100 B M1 
E1250 W/c lightwt fixed arm 100 B M1 
E1260 W/c lightwt foot rest 100 B M1 
E1270 W/c lightweight leg r 100 B M1 
E1280 W/c h-duty det arm leg res 100 B M1 
E1285 W/c heavy duty fixed 100 B M1 
E1290 W/c hvy duty detach a 100 B M1 
E1295 W/c heavy duty fixed 100 B M1 
E1296 W/c special seat heig 100 B M1 
E1297 W/c special seat dept 100 B M1 
E1298 W/c spec seat depth/w 100 B M1 
K0001 Standard wheelchair 100 C M1 
K0002 Std hemi (low seat) w/c 100 B M1 
K0003 Lightweight wheelchair 100 B M2 
K0004 High strength ltwt whlchr 100 B M2 
K0005 Ultralightweight wheelchair 100 B M3 
K0006 Heavy duty wheelchair 100 B M4 
K0007 Extra heavy duty wheelchair 100 B M4 
K0008 Custom manual wheelchair/base 100 B M4 
K0009 Other manual wheelchair base 100 B M4 
K0010 Std wt frame power w/c 100 A P1 
K0011 Std wt pwr whlchr w control 100 A P2 
K0012 Ltwt portbl power whlchr 100 A P2 
K0013 Custom motorized/power wheelchair base 100 A P3 
K0014 Other power whlchr base 100 A P3 
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APPENDIX B 
SAS Code Chapter 2 Demographic Study Hypothesis Analyses 
 
Logistic Regression 
 
/*I need some data 
I made a copy of H1_boni_c and will edit it to get logistic regression 
data  
for dissertation revision - scooter and power Table 15 
Jene 26, 2004*/ 
/*two data sets  
 manual = 150553 obs 
else if power manual=0*/ 
proc logistic data=bonipow descending; 
 class rac(param=ref ref='6') dxp(param=ref ref='11') male(param=ref 
ref='0') ; 
 model  scoot = dxp numco age year male rac / stb; 
 units age=10/default=1; 
 contrast 'hisp vs. white' rac 1 0 0  /estimate=exp; 
 contrast 'amai vs. white' rac 0 1 0 /estimate=exp; 
 contrast 'black vs. white' rac 0 0 1 /estimate=exp; 
 /*selection=stepwise include=1*/;  
run;quit; 
proc logistic data=dog5 descending; 
 /*class male (param=ref ref='1') dxp (param=ref ref='11') rac 
(param=ref ref='6');*/ 
 model  power= als ms scit scip stroke pd ampu copd arthri  
 numco age year male hisp amai black otherrac  / stb 
 /*selection=stepwise include=1*/;  
run;quit; 
proc logistic data=dog5 descending; 
 /*class male (param=ref ref='1') dxp (param=ref ref='11') rac 
(param=ref ref='6');*/ 
 model  power= als ms scit scip stroke pd ampu copd arthri  
 numco age year male hisp amai black otherrac  / stb 
 /*selection=stepwise include=1*/;  
run;quit; 
/*take scooter out of power 
bonipow was = 40515 records*/ 
data bonipow2;  /*dropped to 16160 records, over 50% about right*/ 
set bonipow; 
if scoot = 1 then delete; 
run; 
proc logistic data=bonipow2 descending; 
 class rac(param=ref ref='6') dxp(param=ref ref='11') male(param=ref 
ref='0') ; 
 model  powcus = dxp numco age year male rac / stb; 
 units age=10/default=1; 
 contrast 'hisp vs. white' rac 1 0 0  /estimate=exp; 
 contrast 'amai vs. white' rac 0 1 0 /estimate=exp; 
 contrast 'black vs. white' rac 0 0 1 /estimate=exp; 
 /*selection=stepwise include=1*/;  
run;quit; 
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proc logistic data=bonipow2 descending; 
 /*class male (param=ref ref='1') dxp (param=ref ref='11') rac 
(param=ref ref='6');*/ 
 model  powcus= als ms scit scip stroke pd ampu copd arthri  
 numco age year male hisp amai black otherrac  / stb 
 /*selection=stepwise include=1*/;  
run;quit; 
/*run model collapsing power + scooter*/ 
data dog5; 
set dog4; 
if dxp=1 then als=1; else als=0; 
if dxp=2 then ms=1; else ms=0; 
if dxp=3 then scit=1; else scit=0; 
if dxp=4 then scip=1; else scip=0; 
if dxp=5 then stroke=1; else stroke=0; 
if dxp=7 then pd=1; else pd=0; 
if dxp=8 then ampu=1; else ampu=0; 
if dxp=9 then copd=1; else copd=0; 
if dxp=10 then arthri=1; else arthri=0; 
if dxp=11 then otherdx=0; /*reference*/ 
if rac=1 then hisp = 1; else hisp = 0; 
if rac=3 then amai = 1; else amai = 0; 
if rac=4 then black = 1; else black = 0; 
if rac=6 then white = 0; 
if rac=7 then otherrac = 1; else otherrac = 0; 
run; 
/*create variables for manual and power*/ 
data dog3; 
set dog2; 
if wctype=1 then manual=1; 
else if wctype=2 then manual=1; 
else if wctype=3 then manual=1; 
else if wctype=4 then manual=1;  
else manual =0; 
if wctype=5 then power=1; 
else if wctype=6 then power=1; 
else if wctype=7 then power=1; 
else power=0; 
if wctype=8 then scooter=1; 
else scooter=0; 
run; 
data dog4; 
set dog3; 
if scooter=1 then output dog4; 
else if power=1 then output dog4; 
run; 
data dog2; 
set dog; 
if dxp=1 then als=1; else als=0; 
if dxp=2 then ms=1; else ms=0; 
if dxp=3 then scit=1; else scit=0; 
if dxp=4 then scip=1; else scip=0; 
if dxp=5 then stroke=1; else stroke=0; 
if dxp=7 then pd=1; else pd=0; 
if dxp=8 then ampu=1; else ampu=0; 
if dxp=9 then copd=1; else copd=0; 
if dxp=10 then arthri=1; else arthri=0; 
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if dxp=11 then otherdx=0; /*reference*/ 
if rac=1 then hisp = 1; else hisp = 0; 
if rac=3 then amai = 1; else amai = 0; 
if rac=4 then black = 1; else black = 0; 
if rac=6 then white = 0; 
if rac=7 then otherrac = 1; else otherrac = 0; 
run; 
proc logistic data=powscoot3 descending; 
 /*class male (param=ref ref='1') dxp (param=ref ref='11') rac 
(param=ref ref='6');*/ 
 model  power= als ms scit scip stroke pd ampu copd arthri  
 numco age year male hisp amai black otherrac  / stb 
 /*selection=stepwise include=1*/;  
run;quit; 
data cat3; 
year=3; 
set disser.demo_type01adj_age2_dxp2  /*disser.demo_type00adj_age2_dxp2  
disser.demo_type01adj_age2_dxp2*/; 
run; 
data dog; 
set cat1 cat2 cat3; 
run; 
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APPENDIX C 
SAS Code Chapter 3 Selection and Validation of Cut-Off Points for Low Outliers 
    SAS proc freq results Cut-off calculations 
          logical %excluded   
hcpcs description freq % Cum freq Cum % 10% 50% cut-off cut-off 75% 100% 
E1050 reclining std/fxd arm 85 0.07 85 0.07 $59 $400 $100 11.76% $794 $4,778 
E1060 std/detach arm 985 0.81 1070 0.88 $118 $322 $100 7.61% $609 $8,716 
E1070 std/detach foot 1323 1.09 2393 1.97 $36 $159 $100 26.23% $249 $3,775 
E1083 hemi/fixed arm 21 0.02 2414 1.99 $32 $378 $100 19.05% $471 $668 
E1084 hemi/detach arm 54 0.04 2468 2.03 $158 $416 $100 1.85% $617 $1,623 
E1086 hemi/detach arm 45 0.04 2513 2.07 $232 $385 $100 2.22% $600 $3,015 
E1087 lt weight/fixed arm 143 0.12 2656 2.18 $144 $331 $200 3.50% $650 $2,573 
E1088 lt weight/detach arm 1148 0.94 3804 3.13 $240 $430 $200 6.97% $842 $10,565 
E1089 lt weight/fixed arm 73 0.06 3877 3.19 $113 $466 $200 20.55% $763 $4,778 
E1090 lt weight/detach arm 493 0.41 4370 3.59 $250 $538 $200 6.40% $966 $11,067 
E1092 wide/w leg rest 78 0.06 4448 3.66 $56 $399 $100 11.54% $452 $2,799 
E1093 wide/w foot rest 78 0.06 4526 3.72 $200 $363 $100 5.13% $506 $4,315 
E1100 semi rec/detach arm 80 0.07 4606 3.79 $106 $591 $100 8.75% $1,138 $11,686 
E1110 semi rec/fixed arm&leg 259 0.21 4865 4.00 $286 $693 $100 3.47% $1,377 $6,958 
E1130 std/detach arm&foot 607 0.50 5472 4.50 $107 $145 $100 7.25% $202 $1,705 
E1140 std/detach arm 2658 2.19 8130 6.69 $115 $167 $100 8.16% $192 $7,057 
E1150 std/w leg rest 1569 1.29 9699 7.98 $70 $201 $100 11.79% $256 $9,186 
E1160 std/fixd arms 151 0.12 9850 8.10 $112 $159 $100 8.61% $299 $5,544 
E1171 amp/wo leg rest 30 0.02 9880 8.12 $29 $280 $100 20.00% $660 $1,925 
E1172 amp/detach arm 127 0.10 10007 8.23 $115 $326 $100 6.30% $855 $2,942 
E1180 amp/w foot rest 86 0.07 10093 8.30 $203 $379 $100 4.65% $385 $1,400 
E1190 amp/w leg rest 165 0.14 10258 8.44 $160 $237 $100 0.61% $352 $3,000 
E1195 amp heavy duty 48 0.04 10306 8.48 $304 $615 $100 2.08% $1,406 $3,119 
E1200 amp/fixed arm 51 0.04 10357 8.52 $119 $139 $100 7.84% $295 $3,072 
E1210 power/arm leg rest 74 0.06 10431 8.58 $1,688 $3,594 $1,000 6.76% $5,527 $12,915 
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E1211 power/w detach 1357 1.12 11788 9.69 $1,672 $3,732 $1,000 6.56% $5,180 $19,412 
  SAS proc freq results Cut-off calculations 
       logical %excluded   
hcpcs description freq % Cum freq Cum % 10% 50% cut-off cut-off 75% 100% 
E1212 power/w full 1245 1.02 13033 10.72 $1,132 $4,000 $1,000 9.48% $4,963 $17,729 
E1213 power/w detach 382 0.31 13415 11.03 $1,693 $3,506 $1,000 4.97% $4,959 $20,040 
E1220 spec size/construction 249 0.20 13664 11.24 $25 $891 $100 16.47% $1,798 $12,315 
E1221 manual/spec size w foot 131 0.11 13795 11.34 $156 $639 $100 4.58% $1,077 $9,053 
E1222 manual/spec size w leg 42 0.03 13837 11.38 $219 $639 $100 4.76% $1,128 $1,901 
E1223 manual/spec size w foot 274 0.23 14111 11.60 $124 $177 $100 7.30% $240 $9,357 
E1224 manual/spec size w leg 20 0.02 14131 11.62 $142 $385 $100 0.00% $920 $2,200 
E1225 
manual/spec size semi 
recl 38 0.03 14169 11.65 $96 $1,070 $100 10.53% $1,470 $4,603 
E1226 
manual/spec size full 
recl 240 0.20 14409 11.85 $394 $497 $100 3.75% $690 $15,537 
E1227 manual/spec size 21 0.02 14430 11.87 $96 $945 $100 4.76% $1,113 $1,694 
E1228 manual/spec size 25 0.02 14455 11.89 $177 $349 $100 0.00% $511 $2,162 
E1230 scooter 15546 12.78 30001 24.67 $1,235 $1,910 $900 5.31% $2,240 $17,883 
E1240 lt weight/swing arm 416 0.34 30417 25.01 $44 $345 $200 24.04% $475 $4,313 
E1250 lt weight/swing foot 65 0.05 30482 25.07 $6 $445 $200 18.46% $600 $3,524 
E1260 lt weight/swing foot 1345 1.11 31827 26.17 $132 $237 $200 38.36% $338 $3,090 
E1270 lt weight/swing elev foot 318 0.26 32145 26.43 $49 $370 $200 14.78% $683 $3,391 
E1280 heavy duty/ elev leg 166 0.14 32311 26.57 $144 $524 $100 8.43% $1,623 $3,596 
E1285 
heavy duty/ swing 
detach foot 254 0.21 32565 26.78 $295 $612 $100 1.97% $1,116 $9,871 
E1290 
heavy duty/ swing 
detach foot 533 0.44 33098 27.22 $195 $541 $100 5.63% $1,100 $5,768 
E1295 heavy duty/ elev foot 68 0.06 33166 27.27 $96 $563 $100 10.29% $755 $5,905 
E1296 spec height 72 0.06 33238 27.33 $150 $400 $100 6.94% $621 $5,214 
E1297 spec depth 44 0.04 33282 27.37 $48 $315 $100 13.64% $599 $3,220 
E1298 spec depth width 166 0.14 33448 27.51 $172 $782 $100 3.01% $1,213 $4,757 
K0001 std wheelchair 45657 37.55 79105 65.05 $119 $162 $100 4.88% $198 $13,667 
K0002 std hemi 485 0.40 79590 65.45 $155 $353 $100 5.36% $467 $3,665 
K0003 lightweight 9075 7.46 88665 72.91 $184 $352 $100 3.33% $486 $9,045 
K0004 
high strength 
lightweight 16466 13.54 105131 86.46 $228 $350 $200 6.97% $493 $12,346 
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K0005 ultralight 3384 2.78 108515 89.24 $422 $1,030 $400 10.58% $1,305 $11,514 
  SAS proc freq results Cut-off calculations 
       logical %excluded   
hcpcs description freq % Cum freq Cum % 10% 50% cut-off cut-off 75% 100% 
K0006 heavy duty 2418 1.99 110933 91.23 $232 $441 $100 3.60% $630 $9,843 
K0007 extra heavy duty 1366 1.12 112299 92.35 $292 $488 $100 3.22% $785 $9,594 
K0008 custom manual base 1173 0.96 113472 93.32 $218 $801 $200 8.95% $1,289 $10,422 
K0009 other manual base 694 0.57 114166 93.89 $146 $600 $100 3.75% $1,368 $9,604 
K0010 std power 1021 0.84 115187 94.73 $726 $2,700 $1,000 10.97% $3,844 $18,189 
K0011 std power/prog control 2939 2.42 118126 97.14 $1,739 $3,750 $1,000 6.67% $4,868 $25,851 
K0012 lt weight folding power 854 0.70 118980 97.84 $349 $1,891 $1,000 13.35% $2,780 $15,389 
K0013 custom power base 726 0.60 119706 98.44 $1,862 $4,337 $1,000 7.02% $6,866 $22,864 
K0014 other power base 1895 1.56 121601 100.00 $1,750 $4,317 $1,000 7.18% $6,370 $24,459 
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APPENDIX D 
SAS Code Chapter 3 Cost Study Vendor Name Edit 
 
/*Clean up vendor names*/ 
data cutoff2; 
set disser.cutoff2; 
run; 
proc sort data=cutoff2; 
by vendor; 
run; 
proc sort data=cut28 out=cut30; 
by vendor; 
run; 
/*data vendor; 
set cutoff2; 
by vendor; 
if FIRST.VENDOR=1 THEN OUTPUT; 
run;*/ 
data vendora; 
set cut30; 
 vendor=COMPRESS(vendor,'**');/*delete leading '**' */ 
 put vendor; 
 run; 
data vendorb; 
set vendora; 
if substr(vendor,1,23) = "21st Century Scientific"          
   then vendor= "21ST CENTURY SCIENTIFIC"; 
   if substr(vendor,1,12) = "21ST CENTURY"          
   then vendor= "21ST CENTURY SCIENTIFIC"; 
   if substr(vendor,1,12) = "21st CENTURY"          
   then vendor= "21ST CENTURY SCIENTIFIC"; 
 put vendor; 
 run; 
data vendorc; 
set vendorb; 
if substr(vendor,1,16) = "ABBA WHEELCHAIRS"          
   then vendor= "ABBA WHEELCHAIRS"; 
 put vendor; 
 run; 
data vendord; 
set vendorc; 
if substr(vendor,1,8) = "ABLE MED"          
   then vendor= "ABLE MEDICAL AIDS"; 
 put vendor; 
 run; 
data vendore; 
set vendord; 
if substr(vendor,1,11) = "ACCELERATED"          
   then vendor= "ACCELERATED REHAB DESIGNS INC"; 
 put vendor; 
if substr(vendor,1,10) = "ACCESS & M"          
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   then vendor= "ACCESS AND MOBILITY PRODUCTS"; 
 put vendor; 
 run; 
data vendorf; 
set vendore; 
if substr(vendor,1,20) = "ACCESSIBLE VEHICLES"          
   then vendor= "ACCESSIBLE VEHICLES OF LEXINGTON";/*ALL visn 9*/ 
 put vendor; 
if substr(vendor,1,14) = "ACCESS AND MOB"          
   then vendor= "ACCESS AND MOBILITY PRODUCTS"; 
 put vendor; 
 run; 
data vendorg; 
set vendorf; 
if substr(vendor,1,20) = "ACCESS TO RECREATION"          
   then vendor= "ACCESS TO RECREATION"; 
 put vendor; 
if substr(vendor,1,7) = "ACS MOB"          
   then vendor= "ACS MOBILITY"; 
 put vendor; 
 run; 
data vendorh; 
set vendorg; 
if substr(vendor,1,17) = "ADAPTIVE MOBILITY"          
   then vendor= "ADAPTIVE MOBILITY"; 
 put vendor; 
if substr(vendor,1,15) = "ADAPTIVE SWITCH"          
   then vendor= "ADAPTIVE SWITCH LABS"; 
 put vendor; 
 run; 
data vendork; 
set vendorh; 
if substr(vendor,1,13) = "ADVANCED CARE"          
   then vendor= "ADVANCED CARE INC"; /*ALL VISN 3*/ 
 put vendor; 
if substr(vendor,1,21) = "ADVANCED MOBILITY INC"          
   then vendor= "ADVANCED MOBILITY"; 
 put vendor; 
 if substr(vendor,1,22) = "ADVANCED MOBILITY INC."          
   then vendor= "ADVANCED MOBILITY"; 
 put vendor; 
 run; 
data vendorL; 
set vendorK; 
 if substr(vendor,1,7) = "ALI MED"          
   then vendor= "ALIMED INC"; 
 put vendor; 
 if substr(vendor,1,6) = "ALIMED"          
   then vendor= "ALIMED INC"; 
 put vendor; 
run; 
data vendorm; 
set vendorl; 
 if substr(vendor,1,19) = "ALTERNATIVE MEDICAL"          
   then vendor= "ALTERNATICE MEDICAL INC"; 
 put vendor; 
 if substr(vendor,1,16) = "ALTIMATE MEDICAL"          
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   then vendor= "ALTIMATE MEDICAL INC"; 
 put vendor; 
run; 
data vendorN; 
set vendorM; 
if substr(vendor,1,18) = "AFTER MARKET GROUP"          
   then vendor= "AFTER MARKET GROUP"; 
  run; 
data vendoro; 
set vendorn; 
if substr(vendor,1,19) = "ALTERNATICE MEDICAL"          
   then vendor= "ALTERNATIVE MEDICAL INC"; 
 put vendor; 
run; 
data vendorP; 
set vendorO; 
if substr(vendor,1,19) = "ALTERNATICE MEDICAL"          
   then vendor= "ALTERNATIVE MEDICAL INC"; 
 put vendor; 
 if substr(vendor,1,22) = "AMERICAN MEDICAL DEPOT"          
   then vendor= "AMERICAN MEDICAL DEPOT"; 
 put vendor; 
if substr(vendor,1,23) = "AMERICAN MEDICAL RENTAL"          
   then vendor= "AMERICAN MEDICAL RENTAL & SUPPLY"; 
 put vendor; 
run; 
data vendorQ; 
set vendorp; 
if substr(vendor,1,17) = "AMERICAN SURGICAL"          
   then vendor= "AMERICAN SURGICAL CORP"; 
 put vendor; 
 if substr(vendor,1,5) = "AMIGO"          
   then vendor= "AMIGO MOBILITY"; 
 put vendor; 
 if substr(vendor,1,13) = "AMJ MEDICAL M"          
   then vendor= "AMJ MEDICAL MANAGEMENT LLC"; 
 put vendor; 
run; 
data vendorqq;  
set vendorq; 
if substr(vendor,1,11) = "AFTERMARKET"          
   then vendor= "AFTER MARKET GROUP"; 
   if substr(vendor,1,12) = "AFTER MARKET"          
   then vendor= "AFTER MARKET GROUP"; 
   if substr(vendor,1,4) = "ALCO"          
   then vendor= "ALCO SALES & SERVICE"; 
   if substr(vendor,1,22) = "AMERICAN MEDICAL DEPOT"          
   then vendor= "AMERICAN MEDICAL DEPOT"; 
   if substr(vendor,1,23) = "AMERICAN MEDICAL RENTAL"          
   then vendor= "AMERICAN MEDICAL RENTAL"; 
 put vendor; 
 run; 
data vendorR; 
set vendorQQ; 
if substr(vendor,1,16) = "BODYPOINT DESIGN"          
   then vendor= "BODYPOINT DESIGN INC"; 
 put vendor; 
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 if substr(vendor,1,5) = "BRIKE"          
   then vendor= "BRIKE INTERNATIONAL"; 
 put vendor; 
 if substr(vendor,1,5) = "BRODA"          
   then vendor= "BRODA"; 
 put vendor; 
 if substr(vendor,1,11) = "BRUNO INDEP"          
   then vendor= "BRUNO INDEPNDENT LIVING AIDS"; 
 put vendor; 
 if substr(vendor,1,5) = "C & W"          
   then vendor= "C W HEALTHCARE"; 
 put vendor; 
 if substr(vendor,1,15) = "C W HEALTH CARE"          
   then vendor= "C W HEALTHCARE"; 
 put vendor; 
run; 
data vendorS; 
set vendorR; 
if substr(vendor,1,11) = "CANYON PROD"          
   then vendor= "CANYON PRODUCTS"; 
 put vendor; 
 if substr(vendor,1,11) = "CARING RESP"          
   then vendor= "CARING RESPIRATORY"; 
 put vendor; 
 if substr(vendor,1,15) = "CENTRAL ALABAMA"          
   then vendor= "CENTRAL ALABAMA MOBILITY"; 
 put vendor; 
 if substr(vendor,1,23) = "CENTRAL OHIO WHEELCHAIR"          
   then vendor= "CENTRAL OHIO WHEELCHAIR"; 
 put vendor; 
 if substr(vendor,1,8) = "CHARLTON"          
   then vendor= "CHARLTON MOBILITY"; 
 put vendor; 
 if substr(vendor,1,16) = "CHESAPEAKE REHAB"          
   then vendor= "CHESAPEAKE REHAB EQUIP"; 
 put vendor; 
 if substr(vendor,1,7) = "COLOURS"          
   then vendor= "COLOURS"; 
 put vendor; 
run; 
data vendorT; 
set vendorS; 
if substr(vendor,1,17) = "COMMONWEALTH HOME"          
   then vendor= "COMMONWEALTH HOME HEALTH CARE"; 
 put vendor; 
 if substr(vendor,1,11) = "COUNTRY HEALTH"          
   then vendor= "COUNTRY HEALTH INC"; 
 put vendor; 
 if substr(vendor,1,4) = "COP2"          
   then vendor= "COP2 INC"; 
 put vendor; 
 if substr(vendor,1,5) = "CROWN"          
   then vendor= "CROWN THERAPEUTICS INC"; 
 put vendor; 
 if substr(vendor,1,15) = "CUSTOM MOBILITY"          
   then vendor= "CUSTOM MOBILITY INC"; 
 put vendor; 
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 if substr(vendor,1,16) = "Chesapeake Rehab"          
   then vendor= "CHESAPEAKE REHAB EQUIP"; 
 put vendor; 
 if substr(vendor,1,7) = "Colours"          
   then vendor= "COLOURS"; 
 put vendor; 
run; 
data vendortt; 
set vendort; 
if substr(vendor,1,12) = "CARE MEDICAL"          
   then vendor= "CARE MEDICAL"; 
if substr(vendor,1,5) = "C & C"          
   then vendor= "C&C DIVERSIFIED"; 
if substr(vendor,1,9) = "CONVAQUIP"          
   then vendor= "CONVAQUIP INDUSTRIES"; 
if substr(vendor,1,5) = "C & W"          
   then vendor= "C W HEALTHCARE"; 
if substr(vendor,1,3) = "C W"          
   then vendor= "C W HEALTHCARE"; 
 put vendor; 
 RUN; 
data vendoru; 
set vendortt; 
if substr(vendor,1,22) = "CRAIG CARTER GOLF CARS"          
   then vendor= "Craig Carter Golf Cars Inc"; 
 put vendor; 
 if substr(vendor,1,6) = "DALTON"          
   then vendor= "DALTON MEDICAL CORP"; 
 put vendor; 
 if substr(vendor,1,14) = "DIVERSIFIED OP"          
   then vendor= "DIVERSIFIED OPHTHALMICS INC"; 
 put vendor; 
 if substr(vendor,1,25) = "DURABLE MEDICAL EQUIPMENT"          
   then vendor= "DURABLE MEDICAL EQUIPMENT CO"; 
 put vendor; 
 if substr(vendor,1,12) = "DURO MED IND"          
   then vendor= "DURO MED INDUSTRIES"; 
 put vendor; 
 if substr(vendor,1,8) = "DURO-MED"          
   then vendor= "DURO MED INDUSTRIES"; 
 put vendor; 
 if substr(vendor,1,5) = "E & J"          
   then vendor= "EVERST & JENNINGS"; 
 put vendor; 
 if substr(vendor,1,5) = "EVERST AND JENNINGS"          
   then vendor= "EVERST & JENNINGS"; 
 put vendor; 
run; 
data vendorV; 
set vendorU; 
if substr(vendor,1,11) = "EAGLE SPORT"          
   then vendor= "EAGLE SPORTCHAIRS"; 
 put vendor; 
 if substr(vendor,1,10) = "ED MEDICAL"          
   then vendor= "ED MEDICAL INC"; 
 put vendor; 
 if substr(vendor,1,17) = "ELECTRIC MOBILITY"          
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   then vendor= "ELECTRIC MOBILITY CORP"; 
 put vendor; 
 if substr(vendor,1,17) = "ELEC MOBILITY CORP"          
   then vendor= "ELECTRIC MOBILITY CORP"; 
 put vendor; 
 if substr(vendor,1,11) = "EMPIRE HOME"          
   then vendor= "EMPIRE HOME MEDICAL INC"; 
 put vendor; 
 if substr(vendor,1,4) = "EPVA"          
   then vendor= "EPVA WHEELCHAIR REPAIR"; 
 put vendor; 
 if substr(vendor,1,3) = "E&J"          
   then vendor= "EVERST & JENNINGS"; 
 put vendor; 
 if substr(vendor,1,5) = "EVEREST AND JENNINGS"          
   then vendor= "EVEREST & JENNINGS"; 
 put vendor; 
run; 
data vendorW; 
set vendorV; 
  if substr(vendor,1,13) = "ELEC MOBILITY"          
   then vendor= "ELECTRIC MOBILITY CORP"; 
 put vendor; 
 if substr(vendor,1,13) = "Electric Mobility Corporation"          
   then vendor= "ELECTRIC MOBILITY CORP"; 
 put vendor; 
 if substr(vendor,1,12) = "EQUIPMENT CO"          
   then vendor= "EQUIPMENT COMPANY UMLIMITED"; 
 put vendor; 
 if substr(vendor,1,19) = "EVEREST AND JENNING"          
   then vendor= "EVEREST & JENNINGS"; 
 put vendor; 
 if substr(vendor,1,20) = "EVEREST AND JENNINGS"          
   then vendor= "EVEREST & JENNINGS"; 
 put vendor; 
 if substr(vendor,1,19) = "EVERST AND JENNING"          
   then vendor= "EVEREST & JENNINGS"; 
 put vendor; 
run; 
data vendorx; 
set vendorw; 
if substr(vendor,1,17) = "EVERST & JENNINGS"          
   then vendor= "EVEREST & JENNINGS"; 
   put vendor; 
if substr(vendor,1,17) = "EVEREST & JENNING"          
   then vendor= "EVEREST & JENNINGS"; 
   put vendor; 
 if substr(vendor,1,18) = "EVEREST & JENNINGS"          
   then vendor= "EVEREST & JENNINGS"; 
   put vendor; 
if substr(vendor,1,13) = "electric mobility corporation"          
   then vendor= "ELECTRIC MOBILITY CORP"; 
   put vendor; 
   if substr(vendor,1,16) = "chesapeake rehab"          
   then vendor= "CHESAPEAKE REHAB EQUIP"; 
 put vendor; 
 if substr(vendor,1,12) = "ELEC MOBILTY"          
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   then vendor= "ELECTRIC MOBILITY CORP"; 
 put vendor; 
 run; 
 data vendory; 
set vendorx; 
if substr(vendor,1,17) = "Electric Mobility"          
   then vendor= "ELECTRIC MOBILITY CORP"; 
   put vendor;if substr(vendor,1,16) = "electric mobility"          
   then vendor= "ELECTRIC MOBILITY CORP"; 
   put vendor; 
   if substr(vendor,1,16) = "ELECTRIC MOBILTY"          
   then vendor= "ELECTRIC MOBILITY CORP"; 
 put vendor; 
 if substr(vendor,1,11) = "Empire Home"          
   then vendor= "EMPIRE HOME MEDICAL INC"; 
 put vendor; 
 if substr(vendor,1,12) = "Equipment Co"          
   then vendor= "EQUIPMENT COMPANY UMLIMITED"; 
 put vendor; 
 run; 
 data vendoryy  ; 
 set vendory ; 
if substr(vendor,1,12) = "Craig Carter"          
   then vendor= "Craig Carter Golf Cars Inc"; 
    put vendor; 
 run; 
data vendorZ; 
set vendorYy; 
if substr(vendor,1,8) = "EVER-MED"          
   then vendor= "EVERMED"; 
 put vendor; 
 if substr(vendor,1,6) = "FALCON"          
   then vendor= "FALCON REHABILITATION PRODUCTS"; 
 put vendor; 
 if substr(vendor,1,9) = "FAST SERV"          
   then vendor= "FASTSERV MEDICAL"; 
 put vendor; 
 if substr(vendor,1,9) = "FASTSERVE"          
   then vendor= "FASTSERVE OF ANDERSON"; 
 put vendor; 
 RUN; 
data vendorAA; 
set vendorZ; 
if substr(vendor,1,7) = "GENDROM"          
   then vendor= "GENDROM INC"; 
   put vendor; 
if substr(vendor,1,16) = "FLORIDA HOMECARE"          
   then vendor= "FLORIDA HOMECARE MEDICAL INC"; 
   put vendor; 
if substr(vendor,1,22) = "electric mobility corp"          
   then vendor= "ELECTRIC MOBILITY CORP"; 
   put vendor; 
   if substr(vendor,1,16) = "FASTSERV MEDICAL"          
   then vendor= "FASTSERV MEDICAL"; 
 put vendor; 
 RUN; 
data vendorAB; 
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set vendorAA; 
if substr(vendor,1,11) = "GRAHAMFIELD"          
   then vendor= "GRAHAM FIELD"; 
   put vendor; 
if substr(vendor,1,12) = "GRAHAM-FIELD"          
   then vendor= "GRAHAM FIELD"; 
   put vendor; 
if substr(vendor,1,12) = "GRAHAM FIELD"          
   then vendor= "GRAHAM FIELD"; 
   put vendor; 
if substr(vendor,1,14) = "GOLDEN TECHNOL"          
   then vendor= "GOLDEN TECHNOLOGIES INC"; 
   put vendor; 
if substr(vendor,1,6) = "GERBER"          
   then vendor= "GERBER CHAIRMATES INC"; 
   put vendor; 
if substr(vendor,1,5) = "GENES"          
   then vendor= "GENE'S VAN CONVERSION/ INC"; 
   put vendor; 
if substr(vendor,1,7) = "GENDRON"          
   then vendor= "GENDRON INC"; 
   put vendor; 
RUN; 
data vendorAC; 
set vendorAB; 
if substr(vendor,1,8) = "HASTINGS"          
   then vendor= "HASTINGS HOME HEALTH CENTER"; 
   put vendor; 
if substr(vendor,1,10) = "GULF COAST"          
   then vendor= "GULF COAST REHAB EQUIPMENT"; 
   put vendor; 
if substr(vendor,1,10) = "GENE'S VAN"          
   then vendor= "GENE'S VAN CONVERSION/ INC"; 
   put vendor; 
   if substr(vendor,1,8) = "GUARDIAN"          
   then vendor= "GUARDIAN PRODUCTS"; 
   put vendor; 
   RUN; 
data vendorAD; 
set vendorAC; 
if substr(vendor,1,7) = "HERMELL"          
   then vendor= "HERMELL PRODUCTS INC"; 
   put vendor; 
if substr(vendor,1,4) = "HILL"          
   then vendor= "HILL ROM INC"; 
   put vendor; 
if substr(vendor,1,9) = "HOVEROUND"          
   then vendor= "HOVEROUND CORP"; 
   put vendor; 
   if substr(vendor,1,22) = "INDEPENDENCE PROVIDERS"          
   then vendor= "INDEPENDENCE PROVIDERS INC"; 
   put vendor; 
   if substr(vendor,1,17) = "INTERWEST MEDICAL"          
   then vendor= "INTERWEST MEDICAL"; 
   put vendor; 
   RUN; 
   data vendorAE; 
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set vendorAD; 
if substr(vendor,1,8) = "INVACARE"          
   then vendor= "INVACARE"; 
   put vendor; 
if substr(vendor,1,3) = "JAY"          
   then vendor= "JAY MEDICAL"; 
   put vendor; 
if substr(vendor,1,59) = "JOE'S"          
   then vendor= "JOE'S MOBILITY"; 
   put vendor; 
   if substr(vendor,1,13) = "JOHN DAVIS CO"          
   then vendor= "JOHN DAVIS CO"; 
   put vendor; 
   if substr(vendor,1,12) = "JORDAN RESES"          
   then vendor= "JORDDAN RESES HOME HEALTH CARE"; 
   put vendor; 
if substr(vendor,1,12) = "JORDAN-RESES"          
   then vendor= "JORDDAN RESES HOME HEALTH CARE"; 
   put vendor; 
   RUN; 
 data vendorAF; 
set vendorAE; 
if substr(vendor,1,20) = "LIGHTNING HANDCYCLES"          
   then vendor= "LIGHTNING HANDCYCLES"; 
   put vendor; 
if substr(vendor,1,15) = "LIGHTENING HAND"          
   then vendor= "LIGHTNING HANDCYCLES"; 
   put vendor; 
if substr(vendor,1,4) = "LEVO"          
   then vendor= "LEVO USA INC"; 
   put vendor; 
if substr(vendor,1,7) = "LEISURE"          
   then vendor= "LEISURE LIFT INC"; 
   put vendor; 
if substr(vendor,1,5) = "JOE'S"          
   then vendor= "JOE'S MOBILITY"; 
   put vendor; 
   if substr(vendor,1,5) = "LABAC"          
   then vendor= "LABAC SYSTEMS INC"; 
   put vendor; 
   if substr(vendor,1,6) = "LA BAC"          
   then vendor= "LABAC SYSTEMS INC"; 
   put vendor; 
   RUN; 
   data vendoraaf ; 
   set vendoraf; 
   if substr(vendor,1,13) = "FREEDOM RYDER"          
   then vendor= "FREEDOM RYDER HANDCYCLES"; 
   if substr(vendor,1,5) = "FUQUA"          
   then vendor= "FUQUA ENTERPRISES INC"; 
   if substr(vendor,1,12) = "GRAHAM FIELD"          
   then vendor= "EVEREST & JENNINGS"; 
   if substr(vendor,1,7) = "HALL'S"          
   then vendor= "HALLS WHEELS"; 
   if substr(vendor,1,19) = "HEALTHCARE EQUIPMENT"          
   then vendor= "HEALTHCARE EQUIPMENT & SUPPLIES"; 
   if substr(vendor,1,19) = "HOME MEDICAL"          
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   then vendor= "HOME MEDICAL SUPPLY"; 
   put vendor; 
   run; 
data vendorAG; 
set vendorAaF; 
if substr(vendor,1,7) = "LINCARE"          
   then vendor= "LINCARE INC"; 
   put vendor; 
if substr(vendor,1,5) = "LUMEX"          
   then vendor= "GRAHAM FIELD"; 
   put vendor; 
if substr(vendor,1,12) = "Leisure Lift"          
   then vendor= "LEISURE LIFT INC"; 
   put vendor; 
if substr(vendor,1,20) = "Lightning Handcycles"          
   then vendor= "LIGHTNING HANDCYCLES"; 
   put vendor; 
  if substr(vendor,1,20) = "Lightning Handcycles"          
   then vendor= "LIGHTNING HANDCYCLES"; 
   put vendor; 
   RUN; 
data vendorAh; 
set vendorAg; 
if substr(vendor,1,17) = "MEDICAL HOME CARE"          
   then vendor= "MEDICAL HOME CARE INC"; 
   put vendor; 
if substr(vendor,1,9) = "MED-EQUIP"          
   then vendor= "MED-EQUIP INC"; 
   put vendor; 
if substr(vendor,1,10) = "MAC'S LIFT"          
   then vendor= "MAC'S LIFT GATE INC"; 
   put vendor; 
   RUN; 
data vendorAhh; 
set vendorAh; 
if substr(vendor,1,7) = "MEDBLOC"          
   then vendor= "MEDBLOC INC"; 
   put vendor; 
if substr(vendor,1,22) = "MEDICAL EQUIPMENT SPEC"          
   then vendor= "MEDICAL EQUIPMENT SPECIALITY"; 
   put vendor; 
if substr(vendor,1,6) = "HANGER"          
   then vendor= "HANGER PROSTHETICS"; 
   put vendor; 
if substr(vendor,1,18) = "MEDICAL INDUSTRIES"          
   then vendor= "MEDICAL INDUSTRIES AMERICA INC"; 
   put vendor; 
if substr(vendor,1,16) = "MEDICAL MOBILITY (8789)"          
   then vendor= "MEDICAL MOBILITY"; 
   put vendor; 
 if substr(vendor,1,13) = "MEDICAL PLACE"          
   then vendor= "MEDICAL PLACE INC"; 
   put vendor; 
if substr(vendor,1,17) = "MEDICAL-EQUIPMENT"          
   then vendor= "MEDICAL-EQUIPMENT INC"; 
  if substr(vendor,1,9) = "MED-EQUIP"          
   then vendor= "MED-EQUIP INC"; 
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   put vendor; 
   RUN; 
   data vendorAi; 
set vendorAhh; 
if substr(vendor,1,11) = "MEDLINE IND"          
   then vendor= "MEDLINE INDUSTRIES INC"; 
   put vendor; 
if substr(vendor,1,23) = "MEDICAL MOBILITY (8789)"          
   then vendor= "MEDICAL MOBILITY"; 
   put vendor; 
if substr(vendor,1,9) = "MEDI-SERV"          
   then vendor= "MEDI SERVE HOMECARE"; 
   put vendor; 
if substr(vendor,1,17) = "MEDICAL HOME CARE"          
   then vendor= "MEDICAL HOME CARE INC"; 
   put vendor; 
if substr(vendor,1,9) = "MED-EQUIP"          
   then vendor= "MED-EQUIP INC"; 
   put vendor; 
if substr(vendor,1,10) = "MAC'S LIFT"          
   then vendor= "MAC'S LIFT GATE INC"; 
   put vendor; 
   RUN; 
data vendorBJ; 
set vendorAI; 
if substr(vendor,1,7) = "MEDTECH"          
   then vendor= "MEDTECH SERVICE"; 
   put vendor; 
if substr(vendor,1,10) = "MID-CITIES"          
   then vendor= "MID CITIES HOME MEDICAL/ INC."; 
   put vendor; 
if substr(vendor,1,13) = "MIKES MEDICAL"          
   then vendor= "MIKE'S MEDICAL"; 
   put vendor; 
if substr(vendor,1,18) = "MOBILITY EQUIPMENT"          
   then vendor= "MOBILITY EQUIPMENT INC"; 
   put vendor; 
if substr(vendor,1,13) = "MOBILITY PLUS"          
   then vendor= "MOBILITY PLUS INC"; 
   put vendor; 
if substr(vendor,1,17) = "MOBILITY PRODUCTS"          
   then vendor= "MOBILITY PRODUCTS CO"; 
   put vendor; 
   RUN; 
data vendorbK; 
set vendorbJ; 
if substr(vendor,1,7) = "MEDTECH"          
   then vendor= "MEDTECH SERVICE"; 
   put vendor; 
if substr(vendor,1,10) = "MID-CITIES"          
   then vendor= "MID CITIES HOME MEDICAL/ INC."; 
   put vendor; 
if substr(vendor,1,13) = "MIKES MEDICAL"          
   then vendor= "MIKE'S MEDICAL"; 
   put vendor; 
if substr(vendor,1,18) = "MOBILITY EQUIPMENT"          
   then vendor= "MOBILITY EQUIPMENT INC"; 
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   put vendor; 
if substr(vendor,1,13) = "MOBILITY PLUS"          
   then vendor= "MOBILITY PLUS INC"; 
   put vendor; 
if substr(vendor,1,22) = "MOBILITY SYSTEMS & SOL"          
   then vendor= "MOBILITY SYSTEMS AND SOLUTIONS/ INC"; 
   put vendor; 
   RUN; 
data vendorbL; 
set vendorbK; 
if substr(vendor,1,12) = "MORNING STAR"          
   then vendor= "MORNING STAR MOBILITY INC"; 
   put vendor; 
if substr(vendor,1,13) = "MOTION DESIGN"          
   then vendor= "MOTION DESIGNS/ INC"; 
   put vendor; 
if substr(vendor,1,9) = "MOVING ON"          
   then vendor= "MOVIN ON MOBILITY INC"; 
   put vendor; 
if substr(vendor,1,13) = "MOVING PEOPLE"          
   then vendor= "MOVING PEOPLE.NET"; 
   put vendor; 
if substr(vendor,1,8) = "MULLANEY"          
   then vendor= "MULLANEY'S ACTIVE MOBILITY"; 
   put vendor; 
if substr(vendor,1,16) = "Mobility Express"          
   then vendor= "MOBILITY EXPRESS"; 
   put vendor; 
   RUN; 
data vendorblL; 
set vendorbL; 
if substr(vendor,1,16) = "MEDICAL MOBILITY"          
   then vendor= "MEDICAL MOBILITY"; 
if substr(vendor,1,8) = "LAPLANTE"          
   then vendor= "LAPLANTE MEDICAL SUPPLY"; 
if substr(vendor,1,9) = "LaPLANTE"          
   then vendor= "LA PLANTE MEDICAL SUPPLY"; 
   put vendor; 
   if substr(vendor,1,16) = "NATIONAL SEATING"          
   then vendor= "NATIONAL SEATING & MOBILITY"; 
   put vendor; 
if substr(vendor,1,8) = "NEW HALL"          
   then vendor= "NEW HALL'S WHEELS"; 
   put vendor; 
if substr(vendor,1,5) = "NORCO"          
   then vendor= "NORCO INC"; 
   put vendor; 
if substr(vendor,1,19) = "NORTH COAST MEDICAL"          
   then vendor= "MORTH COAST MEDICAL INC"; 
   put vendor; 
if substr(vendor,1,7) = "OPTIWAY"          
   then vendor= "OPTIWAY TECHNOLOGY INC"; 
   put vendor; 
if substr(vendor,1,14) = "ORTHO-KINETICS"          
   then vendor= "ORTHO KINETICS INC"; 
   put vendor; 
if substr(vendor,1,14) = "ORTHO KINETICS"          
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   then vendor= "ORTHO KINETICS INC"; 
   put vendor; 
   RUN; 
data vendorcN; 
set vendorbll; 
if substr(vendor,1,8) = "PERMOBIL"          
   then vendor= "PERMOBIL INC"; 
   put vendor; 
if substr(vendor,1,7) = "COLOURS"          
   then vendor= "PERMOBIL INC"; 
   put vendor; 
if substr(vendor,1,12) = "PCP-CHAMPION"          
   then vendor= "PCP CHAMPION DIV"; 
   put vendor; 
if substr(vendor,1,12) = "PCP CHAMPION"          
   then vendor= "PCP CHAMPION DIV"; 
   put vendor; 
if substr(vendor,1,9) = "OTTO BOCK"          
   then vendor= "OTTO BOCK ORTHOPEDIC"; 
   put vendor; 
if substr(vendor,1,23) = "MORTH COAST MEDICAL INC"          
   then vendor= "NORTH COAST MEDICAL INC"; 
   put vendor; 
   if substr(vendor,1,22) = "PROGRESSIVE HEALTHCARE"          
   then vendor= "PROGRESSIVE HEALTHCARE SYSTEMS"; 
   put vendor; 
if substr(vendor,1,18) = "PROGRESSIVE HELATH"          
   then vendor= "PROGRESSIVE HEALTHCARE SYSTEMS"; 
   put vendor; 
if substr(vendor,1,5) = "PRIDE"          
   then vendor= "PRIDE HEALTH CARE INC"; 
   put vendor; 
  if substr(vendor,1,12) = "ORTHOTIC LAB"          
   then vendor= "PSAS"; 
   put vendor; 
   if substr(vendor,1,17) = "ORTHOTIC LAB/VAMC"          
   then vendor= "ORTHOTIC LAB VAMC"; 
   put vendor; 
if substr(vendor,1,14) = "PROGRESSIVE HE"          
   then vendor= "PROGRESSIVE HEALTHCARE"; 
   put vendor; 
if substr(vendor,1,6) = "PROS S"          
   then vendor= "PSAS"; 
   put vendor; 
if vendor= "PROSTHETIC ORTHOTIC SPECIALISTS" THEN DELETE; 
/*need to delete this so my other programs would work 
it would have been deleted in the next go-round anyway 
since it only has a occurance of 1 */ 
if vendor= "PROSTHETICS OF LOUISVILLE" THEN  
 vendor= "LOUISVILLE,PROSTHETICS OF"; 
if substr(vendor,1,4) = "PSAS"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,8) = "Permobil"          
   then vendor= "PERMOBIL INC"; 
   put vendor; 
if substr(vendor,1,7) = "QUICKIE"          
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   then vendor= "QUICKIE"; 
   put vendor; 
  if substr(vendor,1,10) = "RJM & ASSOC"          
   then vendor= "RJM & ASSOCIATES"; 
   put vendor; 
 run; 
data vendorcQ; 
set vendorcn; 
if substr(vendor,1,9) = "PENNYRILE"          
   then vendor= "PENNEYRILE HOME MEDICAL"; 
if substr(vendor,1,9) = "PIEDMONT"          
   then vendor= "PIEDMONT MEDICAL SUPPLY"; 
   put vendor; 
RUN; 
DATA vendorcR; 
set vendorcQ;   
 if substr(vendor,1,10) = "RJM & ASSO"          
   then vendor= "RJM & ASSOCIATES"; 
   put vendor; 
 if substr(vendor,1,8) = "RJM ASSO"          
   then vendor= "RJM & ASSOCIATES"; 
   if substr(vendor,1,6) = "ROTECH"          
   then vendor= "ROTECH MEDICAL CORPORATION"; 
   if substr(vendor,1,6) = "Rotech"          
   then vendor= "ROTECH MEDICAL CORPORATION"; 
  if substr(vendor,1,9) = "SAFE-LITE"          
   then vendor= "SAFE LITE OPTICAL CO INC"; 
  if substr(vendor,1,6) = "SAMMON"          
   then vendor= "SAMMONS PRESTON INC"; 
  if substr(vendor,1,6) = "SENIOR NOTES INC."          
   then vendor= "SENIOR NOTES INC"; 
   put vendor; 
 if substr(vendor,1,12) = "SMITH NEPHEW"          
   then vendor= "SMITH & NEPHEW"; 
   put vendor; 
if substr(vendor,1,14) = "SMITH & NEPHEW"          
   then vendor= "SMITH & NEPHEW"; 
   put vendor; 
if substr(vendor,1,17) = "SENIOR NOTES INC."          
   then vendor= "SENIOR NOTES INC"; 
   put vendor; 
if substr(vendor,1,9) = "SAFE LITE"          
   then vendor= "SAFELITE OPTICAL CO INC"; 
   put vendor; 
if substr(vendor,1,8) = "SIEBERT"          
   then vendor= "SIEBERT & ASSOCIATES INC"; 
   put vendor; 
  if substr(vendor,1,11) = "SOUTHERN IL"          
   then vendor= "SOUTHERN ILLINOIS SURGICAL"; 
   put vendor; 
if substr(vendor,1,3) = "SPD"          
   then vendor= "SPD"; 
   put vendor; 
if substr(vendor,1,9) = "STAND AID"          
   then vendor= "STAND AID"; 
   put vendor; 
if substr(vendor,1,9) = "STOCK"          
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   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,7) = "SUN MED"          
   then vendor= "SUN MEDICAL"; 
   put vendor; 
if substr(vendor,1,7) = "SUN MED"          
   then vendor= "SUN MEDICAL"; 
   put vendor; 
if substr(vendor,1,7) = "SUN-MED"          
   then vendor= "SUN MEDICAL"; 
   put vendor; 
if substr(vendor,1,6) = "SUNMED"          
   then vendor= "SUN MEDICAL"; 
   put vendor; 
   RUN; 
DATA vendorcS; 
set vendorcR; 
if substr(vendor,1,10) = "PROSTHETIC"          
   then vendor= "PSAS"; 
   put vendor; 
   if substr(vendor,1,5) = "STOCK"          
   then vendor= "PSAS"; 
   put vendor; 
   RUN; 
DATA vendorcT; 
set vendorcS; 
if substr(vendor,1,6) = "REDMAN"          
   then vendor= "REDMAN POWER CHAIR LLC"; 
   put vendor; 
   if substr(vendor,1,5) = "STOCK"          
   then vendor= "PSAS"; 
   put vendor; 
   RUN; 
DATA vendorcU; 
set vendorcT; 
if substr(vendor,1,6) = "Redman"          
   then vendor= "REDMAN POWER CHAIR LLC"; 
   put vendor; 
   if substr(vendor,1,4) = "ROHO"          
   then vendor= "ROHO"; 
   put vendor; 
   RUN; 
DATA vendorcV; 
set vendorcU; 
if substr(vendor,1,7) = "QUICKIE"          
   then vendor= "SUNRISE MEDICAL INC"; 
   put vendor; 
if substr(vendor,1,14) = "SUNRISEMEDICAL"          
   then vendor= "SUNRISE MEDICAL INC"; 
   put vendor; 
if substr(vendor,1,7) = "SUNRISE"          
   then vendor= "SUNRISE MEDICAL INC"; 
   put vendor; 
if substr(vendor,1,7) = "TITANIUM SPORTS"          
   then vendor= "TI SPORT"; 
   put vendor; 
if substr(vendor,1,7) = "TISport"          
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   then vendor= "TI SPORT"; 
   put vendor; 
if substr(vendor,1,7) = "TISPORT"          
   then vendor= "TI SPORT"; 
   put vendor; 
if substr(vendor,1,9) = "TI SPORTS"          
   then vendor= "TI SPORT"; 
   put vendor; 
if substr(vendor,1,9) = "THERADYNE"          
   then vendor= "THERADYNE"; 
   put vendor; 
if substr(vendor,1,8) = "THERAFIN"          
   then vendor= "THERAFIN CORP"; 
   put vendor; 
if substr(vendor,1,17) = "THE MEDICAL STORE"          
   then vendor= "THE MEDICAL STORE INC"; 
   put vendor; 
if substr(vendor,1,6) = "TEFTEC"          
   then vendor= "TEFTEC CORP"; 
   put vendor; 
if substr(vendor,1,11) = "SUN MEDICAL"          
   then vendor= "SUNRISE MEDICAL INC"; 
   put vendor; 
   RUN; 
DATA vendorcW; 
set vendorcV; 
if substr(vendor,1,22) = "ROCKY MOUNTAIN MEDICAL"          
   then vendor= "ROCKY MOUNTAIN MEDICAL"; 
   put vendor; 
   if substr(vendor,1,15) = "SARATOGA ACCESS"          
   then vendor= "SARATOGA ACCESS"; 
   put vendor; 
    if substr(vendor,1,13) = "SCOOTER DEPOT"          
   then vendor= "SCOOTER DEPOT"; 
   put vendor; 
    if substr(vendor,1,17) = "SCOOTERS AND MORE"          
   then vendor= "SCOOTERS AND MORE"; 
   put vendor; 
   If substr(vendor,1,17) = "SPORTAID"          
   then vendor= "SPORTAID"; 
   put vendor; 
   if substr(vendor,1,9) = "SNUG SEAT"          
   then vendor= "SNUG SEAT"; 
   put vendor; 
   if substr(vendor,1,9) = "STANDING CO"          
   then vendor= "STANDING COMPANY"; 
   put vendor; 
   If substr(vendor,1,8) = "SPORTAID"          
   then vendor= "SPORTAID"; 
   put vendor; 
if substr(vendor,1,3) = "V A"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,11) = "U S DEPT OF"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,11) = "U S DEPT OF"          
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   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,15) = "TITANIUM SPORTS"          
   then vendor= "TI SPORT"; 
   put vendor; 
if substr(vendor,1,7) = "TiSport"          
   then vendor= "TI SPORT"; 
   put vendor; 
if substr(vendor,1,7) = "TOP END"          
   then vendor= "TOP END INC"; 
   put vendor; 
if substr(vendor,1,18) = "UNITED MEDICAL/INC"          
   then vendor= "UNITED MEDICAL EQUIPMENT CO INC"; 
   put vendor; 
RUN; 
DATA vendorcx; 
set vendorcw; 
if substr(vendor,1,7) = "VA 1210"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA ADM"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA MED"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA Med"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA NAT"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,6) = "VA Nat"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA Nat"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA Nat"          
   then vendor= "PSAS"; 
   put vendor; 
   if substr(vendor,1,8) = "VA DEPOT"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,9) = "VA HEALTH"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA ORT"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA PRO"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,7) = "VA STOT"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,6) = "VA SUP"          
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   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA WAR"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA WES"          
   then vendor= "PSAS"; 
   put vendor; 
   if substr(vendor,1,5) = "VA-PR"          
   then vendor= "PSAS"; 
   put vendor; 
   if substr(vendor,1,6) = "VA/STO"          
   then vendor= "PSAS"; 
   put vendor; 
   if substr(vendor,1,7) = "VACIHCS"          
   then vendor= "PSAS"; 
   put vendor; 
  if substr(vendor,1,5) = "VA ST"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,5) = "VAMC"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,11) = "WESTERN MED"          
   then vendor= "WESTERN MEDICAL INC"; 
   put vendor; 
if substr(vendor,1,9) = "WAREHOUSE"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,8) = "WALGREEN"          
   then vendor= "WALGREENS"; 
   put vendor; 
if substr(vendor,1,7) = "VISN"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,7) = "VETERAN"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,4) = "VAMC"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,11) = "WHEEL-CARE"          
   then vendor= "WHEELCARE INC"; 
   put vendor; 
if substr(vendor,1,11) = "WHEELCARE"          
   then vendor= "WHEELCARE INC"; 
   put vendor; 
if substr(vendor,1,4) = "VISN"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,16) = "mobility systems"          
   then vendor= "MOBILITY SYSTEMS INC"; 
   put vendor; 
if substr(vendor,1,14) = "Wright Medical"          
   then vendor= "WRIGHT MEDICAL INC"; 
   put vendor; 
if substr(vendor,1,20) = "WHEELCHAIR INSTITUTE"          
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   then vendor= "WHEELCHAIR INSTITUTE OF KANSAS"; 
   put vendor; 
if substr(vendor,1,21) = "WHEELCHAIRS OF KANSAS"          
   then vendor= "WHEELCHAIR INSTITUTE OF KANSAS"; 
   put vendor; 
if substr(vendor,1,20) = "WHEELCHAIR OF KANSAS"          
   then vendor= "WHEELCHAIR INSTITUTE OF KANSAS"; 
   put vendor; 
if substr(vendor,1,28) = "WHEELCHAIR & SCOOTER EXPRESS"          
   then vendor= "WHEELCHAIR AND SCOOTER EXPRESS"; 
   put vendor; 
if substr(vendor,1,17) = "WHEELCHAIR CENTER"          
   then vendor= "WHEELCHAIR CENTER INC"; 
   put vendor; 
if substr(vendor,1,4) = "VISN"          
   then vendor= "PSAS"; 
   put vendor; 
   RUN; 
DATA vendorcY; 
set vendorcx; 
if substr(vendor,1,7) = "VA 1210"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA ADM"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA MED"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,10) = "VA MEDICAL"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA NAT"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,6) = "VA Nat"          
   then vendor= "PSAS"; 
   put vendor; 
  if substr(vendor,1,8) = "VA DEPOT"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,9) = "VA HEALTH"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA ORT"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,7) = "VA PROS"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,8) = "VA STOCK"          
   then vendor= "PSAS"; 
   put vendor; 
if substr(vendor,1,6) = "VA SUP"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,6) = "VA WAR"          
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   then vendor= "PSAS"; 
   put vendor; 
  if substr(vendor,1,5) = "VA-PR"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,4) = "VAMC"          
   then vendor= "PSAS"; 
   put vendor; 
   RUN; 
DATA vendorcZ; 
set vendorcY; 
if substr(vendor,1,8) = "VETERANS"          
   then vendor= "PSAS"; 
   put vendor; 
 if substr(vendor,1,8) = "VA/STOCK"          
   then vendor= "PSAS"; 
   put vendor; 
   if substr(vendor,1,9) = "WAREHOUSE"          
   then vendor= "PSAS"; 
   put vendor; 
   if substr(vendor,1,8) = "WALGREEN"          
   then vendor= "WALGREENS"; 
   put vendor; 
   if substr(vendor,1,15) = "WESTERN MEDICAL"          
   then vendor= "WESTERN MEDICAL INC"; 
   if substr(vendor,1,9) = "WHEELCARE"          
   then vendor= "WHEELCARE INC"; 
   put vendor; 
   if substr(vendor,1,22) = "WHEELCHAIR AND SCOOTER"          
   then vendor= "WHEELCHAIR & SCOOTER EXPRESS"; 
   put vendor; 
   if substr(vendor,1,17) = "WHEELCHAIR CENTER"          
   then vendor= "WHEELCHAIR CENTER INC"; 
   put vendor; 
if substr(vendor,1,21) = "WHEELCHAIRS OF KANSAS"          
   then vendor= "WHEELCHAIRS OF KANSAS"; 
   put vendor; 
if substr(vendor,1,20) = "WHEELCHAIR OF KANSAS"          
   then vendor= "WHEELCHAIRS OF KANSAS"; 
   put vendor; 
   if substr(vendor,1,20) = "WHEELCHAIR INSTITUTE"          
   then vendor= "WHEELCHAIR INSTITUTE OF KANSAS"; 
   put vendor; 
   if substr(vendor,1,14) = "Wright Medical"          
   then vendor= "WRIGHT MEDICAL INC"; 
   put vendor; 
   if substr(vendor,1,16) = "mobility systems"          
   then vendor= "MOBILITY SYSTEMS"; 
   put vendor; 
   RUN; 
DATA vendorcZZ; 
set vendorcz; 
if substr(vendor,1,11) = "STANDING CO"          
   then vendor= "STANDING COMPANY"; 
   put vendor; 
   RUN; 
   proc sort data=vendorczz; 
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   by vendor; 
   run; 
data KACHOO; /*1325 to 696 vendors*/ 
set VENDORcZZ; 
by vendor; 
if FIRST.VENDOR=1 THEN OUTPUT; 
run; 
data kazoo; /*1325 to 696 vendors*/ 
set cutoff2; 
by vendor; 
if FIRST.VENDOR=1 THEN OUTPUT; 
run; 
data disser.vendor_clean_reviz;/*unique clean vendors*/ 
set vendorczz; 
run; 
data vendorczz; 
set disser.vendor_clean_reviz; 
run; 
/*Now I have to delete vendors with less than 4 total sales*/ 
/*ods trace on/label listing; 
proc freq data=vendoredita; 
   tables vendor; 
run; 
ods trace off;*/ 
ods output onewayfreqs=freq;/*Jill's program*/ 
proc freq data=vendorczz; 
   tables vendor; /*all records with vendor names edited*/ 
run; 
data vendor_morethan5 (keep=vendor); 
   set freq; /*get rid of vendors with LE 4 sales*/ 
   if frequency LE 4 then delete; 
run; 
proc sort data=vendorczz; by vendor;run; 
proc sort data=vendor_morethan5 ; by vendor;run; 
data cut29; 
   merge vendorczz  vendor_morethan5  (in=five); 
   by vendor; 
   if five; 
run;   /*all records of vendors who have 5 or more sales*/ 
proc freq data=vendor5_or_more;  /*test to see if all <5 are gone*/ 
tables vendor; 
run;/*yup all gone - left 113336 obs <5 sales got rid of 766 records*/ 
data disser.vendor5_or_more_reviz; 
set vendor5_or_more; 
run; 
data kazoo; /*this is a check to see how many vendors in >5 group*/ 
set vendor5_or_more; 
by vendor; 
if FIRST.VENDOR=1 THEN OUTPUT; 
run;               /*only 243 vendors left*/ 
/*delete vendors whose total cost is less than $800*/ 
data vendor5; 
set disser.vendor5_or_more_reviz; 
run; 
/*firt I need to calculate a total cost*/ 
data vendor_totalcost; 
set vendor5; 
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by vendor; 
retain vendor cost freq; 
if first.vendor then do; 
vendorcost=0; 
end; 
vendorcost + cost; 
freq + 1; 
if last.vendor then output vendor_totalcost; 
run; /* good I have the total cost for each of the 243 vendors 
save as word file: "topvendors"*/ 
proc sort data=vendor_totalcost; 
by vendorcost; 
run; 
proc print data=vendor_totalcost width=minimum; 
var vendor vendorcost; 
run; 
data disser.vendor_totalcost; 
set vendor_totalcost; 
run; 
data vendor_100;  /*these are my top 100 vendors for the analysis*/ 
set vendor_totalcost; 
grabem=0; 
if vendorcost GT 55000 then grabem=1; 
if grabem=1 then output vendor_100; 
run; 
PROC sort DATA=H5dataset2 ; 
by vendorcost; 
RUN; 
data H5dataset2;  /*YESS!!! all records of top 100 vendors verified 
!!*/ 
merge vendor5 (in=five) vendor_100 (in=onehundred) ; 
by vendor; 
if onehundred; 
run; 
data disser.H5vendor; 
set H5dataset2; 
run; 
/*now need top 20 HCPCS in volume*/ 
proc sort data=H5dataset2; 
by HCPCSPSAS; 
run; 
proc freq data= H5dataset2; 
tables HCPCSPSAS; 
run;  /*this is all hcpcs  
I need to sort them to get top 20 
need a frequency variable*/ 
ods output onewayfreqs=hcpfreq; 
proc freq data=H5dataset2; 
tables HCPCSPSAS; 
run; 
proc sort data=hcpfreq; by frequency; run; 
/*Perfect ! got hcpcspsas sorted by frequency*/ 
proc print data=hcpfreq  width=minimum;  
var frequency HCPCSPSAS  ; 
run; 
data final3; 
set hcpfreq; /*here are my 20 most frequent HCPCSPSAS*/ 
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if frequency GT 700 then output final3; 
run;   
data disser.top20hcpcspsas; 
set final3; 
run; 
proc print data=final3; 
var hcpcspsas frequency percent; 
run; 
/*now merge these back into dataset of all records top 100 vendor*/ 
proc sort data=final3; by HCPCSPSAS;run; 
data H5data;  /*YESS!!! all records of top 100 vendors verified !!*/ 
merge H5dataset2 (in=ven) final3 (in=hcp) ; 
by hcpcspsas; 
if hcp; 
run; 
data disser.H5data; 
set H5data; 
run; 
 
/*delete vendors who have less than $800 in sales 
Did not need to do this 
got them all with LT 5 
data lessthan800;  weren't any-got them all with LT 5 records 
set vendor_totalcost; 
if vendorcost LT 800.00 then delete; 
run; */ 
 
 
/*difference between making adj and not 
USE SUM FUNCTION sas ii PAGE 3-9*/ 
data no (keep= vendor cost); 
set disser.chair_cost00; 
run; 
data nono; 
set no no1; 
run; 
data money;/*$109,010,198.00 total for 00+01*/ 
set nono; 
tcost+cost; 
run; 
data money2;/*$50,097,805.00 total for 00*/ 
set no; 
tcost+cost; 
run; 
data money3;/*$58,912,393.00 total for 01*/ 
set no1; 
tcost+cost; 
run; 
proc print data=money3; 
run; 
/*now repeat for un-adusted data*/ 
data go1 (keep= vendor cost); 
set disser.nppd01_chair_reviz; 
run; 
data gogo; 
set go go1; 
run; 
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data money4;/*$104,524,242.00 total for 00+01*/ 
set gogo; 
tcost+cost; 
run; 
data money5;/*$48,097,022.00 total for 00*/ 
set go; 
tcost+cost; 
run; 
data money6;/*$56,427,220.00 total for 01*/ 
set go1; 
tcost+cost; 
run; 
proc print data=money6; 
run; 
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APPENDIX  E 
SAS Code Chapter 3 Cost Study Hypothesis 1 Analyses 
 
-../*this is the program I wrote after my defense 
first need to clean data 
combine 00 and 01*/ 
data chair_cost003 (rename=(hcpcpsas=hcpcspsas)); 
set disser.chair_cost00; 
year=1; 
run;  /*63351 obs*/ 
data chair_cost01; /*67861 obs*/ 
set disser.chair_cost01; 
year=2; 
run; 
data chair_cost_both2; /*131212*/ 
set chair_cost003 chair_cost01; 
run; 
data chair_cost_both (keep=VISN hcpcspsas cost vendor); /*131212*/ 
set chair_cost_both2; 
run; 
/*now need to determine cut-off points*/ 
data disser.chair_cost_both; 
set chair_cost_both; 
run; 
data chair_cost_no_zero2;/*delete missing values*/ 
set chair_cost_both; 
/*if cost = '' then delete;*/ 
if cost = '.' then delete; 
run; 
data chair_cost_no_zero5;/*delete 0.00 values*/ 
set chair_cost_no_zero2; 
if cost = 0.00 then delete; 
run; 
/*how many hcpcs do I have?*/ 
proc freq data=chair_cost_no_zero5; 
 tables hcpcspsas; 
   run; 
/*delete hcpcs codes with less than 20 obs*/ 
data chair_cost_hcp4; 
set chair_cost_no_zero5; 
if hcpcspsas= 'E1085' then delete; 
if hcpcspsas= 'E1091' then delete; 
if hcpcspsas= 'E1170' then delete; 
if hcpcspsas= 'E1299' then delete; 
run; /*121762 obs remaining*/ 
data disser.chair_cost; 
set chair_cost_hcp4; 
run; 
data chair_cost_hcp; 
set chair_cost_hcp4; 
if hcpcspsas= 'E1065' then delete; 
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run; /*121601 obs remaining*/ 
ods output onewayfreqs=freq; 
proc freq data=chair_cost_hcp; 
tables hcpcspsas; 
run; 
/* run for all 64 HCPCS codes*/ 
proc freq data=chair_cost_hcp; 
tables cost; 
where hcpcspsas= "K0013"; 
run; 
data disser.chair_cost_hcp; 
set chair_cost_hcp; 
run; 
data chair_cost_hcp;/*121601*/ 
set disser.chair_cost_hcp; 
run; 
/*next I have to drop obs below cut-off point out of dataset*/ 
data cut1;/*121591 - 10 excluded*/ 
set chair_cost_hcp; 
if hcpcspsas="E1050" and cost LT 100 then delete; 
run; 
/*make sure this is correct*/ 
proc sort data=chair_cost_hcp; 
by hcpcspsas cost; 
run;/*program works correctly*/ 
data cut;/*113724*/ 
set disser.chair_cost_hcp; 
if hcpcspsas="E1050" and cost LT 100 then delete; 
if hcpcspsas="E1060" and cost LT 100 then delete; 
if hcpcspsas="E1070" and cost LT 100 then delete; 
if hcpcspsas="E1083" and cost LT 100 then delete; 
if hcpcspsas="E1084" and cost LT 100 then delete; 
if hcpcspsas="E1086" and cost LT 100 then delete; 
if hcpcspsas="E1092" and cost LT 100 then delete; 
if hcpcspsas="E1093" and cost LT 100 then delete; 
if hcpcspsas="E1100" and cost LT 100 then delete; 
if hcpcspsas="E1110" and cost LT 100 then delete; 
if hcpcspsas="E1130" and cost LT 100 then delete; 
if hcpcspsas="E1140" and cost LT 100 then delete; 
if hcpcspsas="E1150" and cost LT 100 then delete; 
if hcpcspsas="E1160" and cost LT 100 then delete; 
if hcpcspsas="E1171" and cost LT 100 then delete; 
if hcpcspsas="E1172" and cost LT 100 then delete; 
if hcpcspsas="E1180" and cost LT 100 then delete; 
if hcpcspsas="E1190" and cost LT 100 then delete; 
if hcpcspsas="E1195" and cost LT 100 then delete; 
if hcpcspsas="E1200" and cost LT 100 then delete; 
if hcpcspsas="E1220" and cost LT 100 then delete; 
if hcpcspsas="E1221" and cost LT 100 then delete; 
if hcpcspsas="E1222" and cost LT 100 then delete; 
if hcpcspsas="E1223" and cost LT 100 then delete; 
if hcpcspsas="E1224" and cost LT 100 then delete; 
if hcpcspsas="E1125" and cost LT 100 then delete; 
if hcpcspsas="E1126" and cost LT 100 then delete; 
if hcpcspsas="E1127" and cost LT 100 then delete; 
if hcpcspsas="E1128" and cost LT 100 then delete; 
if hcpcspsas="E1280" and cost LT 100 then delete; 
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if hcpcspsas="E1285" and cost LT 100 then delete; 
if hcpcspsas="E1290" and cost LT 100 then delete; 
if hcpcspsas="E1295" and cost LT 100 then delete; 
if hcpcspsas="E1296" and cost LT 100 then delete; 
if hcpcspsas="E1297" and cost LT 100 then delete; 
if hcpcspsas="E1298" and cost LT 100 then delete; 
if hcpcspsas="K0001" and cost LT 100 then delete; 
if hcpcspsas="K0002" and cost LT 100 then delete; 
if hcpcspsas="K0003" and cost LT 100 then delete; 
if hcpcspsas="K0006" and cost LT 100 then delete; 
if hcpcspsas="K0007" and cost LT 100 then delete; 
if hcpcspsas="K0009" and cost LT 100 then delete; 
if hcpcspsas="E1087" and cost LT 200 then delete; 
if hcpcspsas="E1088" and cost LT 200 then delete; 
if hcpcspsas="E1089" and cost LT 200 then delete; 
if hcpcspsas="E1090" and cost LT 200 then delete; 
if hcpcspsas="E1240" and cost LT 200 then delete; 
if hcpcspsas="E1250" and cost LT 200 then delete; 
if hcpcspsas="E1260" and cost LT 100 then delete; 
if hcpcspsas="E1270" and cost LT 200 then delete; 
if hcpcspsas="K0004" and cost LT 200 then delete; 
if hcpcspsas="K0008" and cost LT 200 then delete; 
if hcpcspsas="K0005" and cost LT 400 then delete; 
if hcpcspsas="E1230" and cost LT 900 then delete; 
if hcpcspsas="E1210" and cost LT 1000 then delete; 
if hcpcspsas="E1211" and cost LT 1000 then delete; 
if hcpcspsas="E1212" and cost LT 1000 then delete; 
if hcpcspsas="E1213" and cost LT 1000 then delete; 
if hcpcspsas="K0010" and cost LT 1000 then delete; 
if hcpcspsas="K0011" and cost LT 1000 then delete; 
if hcpcspsas="K0012" and cost LT 1000 then delete; 
if hcpcspsas="K0013" and cost LT 1000 then delete; 
if hcpcspsas="K0014" and cost LT 1000 then delete; 
run; 
data disser.cutoff2; 
set cut; 
run; 
data cutoff2; 
set disser.cutoff2; 
run; 
/*is this distribution normal? 
no data is very skewed even if analyzed by hcpcspsas 
use median*/ 
proc univariate data = cut2; 
where hcpcspsas="E1050"; 
var cost; 
histogram cost / normal; 
run; 
/*Kruskall Wallis test between VISN 
one for each hcscscode*/ 
proc npar1way wilcoxon  data=cut2; 
class VISN; 
by hcpcspsas; 
var cost; 
run; 
proc univariate data = cutoff; 
class hcpcspsas; 
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by VISN; 
var cost; 
/*histogram cost / normal;*/ 
run; 
proc sort data=cutoff2; 
by VISN; 
run; 
proc freq data=cutoff; 
tables hcpcspsas; 
by VISN; 
run; 
/*now I need the national median plus 10% and the national median plus 
25%*/ 
data med_nat; 
set disser.cutoff2; 
costplus10=cost*1.1;/*create new var*/ 
costplus25=cost*1.25; 
run; 
/*This gives me the medians of the cost of each wc 
I need medians*/ 
proc means data=med_nat n median nonobs maxdec=0; 
var cost; 
class HCPCSPSAS; 
output out=disser.med_national n(cost)=ncost  median(cost)=mediancost   
 median(costplus10)=cut10 median(costplus25)=cut25;/*excel file 
national.xls*/ 
run; 
data med_nat; 
set disser.med_nat; 
RUN; 
proc means data=med_nat n median nonobs maxdec=0; 
var cost; 
class HCPCSPSAS; 
where visn=22; 
output out=med_v_22 n(cost)=ncost  median(cost)=mediancost; 
run; 
/*7/27/2004 now need a total over amount per vins and per vendor  */ 
data disser.cutoff2 (drop = costplus10 costplus25);  
set disser.MED_NAT; 
run; 
data cut; 
set disser.cutoff2; 
run;  
data cut2; 
set cut; 
medcut=0; 
run; 
data cut26; 
set cut5; 
if HCPCSPSAS = "E1050" then medcut=783; 
if HCPCSPSAS = "E1060" then medcut=739; 
if HCPCSPSAS = "E1070" then medcut=356; 
if HCPCSPSAS = "E1083" then medcut=828; 
if HCPCSPSAS = "E1084" then medcut=872; 
if HCPCSPSAS = "E1086" then medcut=775; 
if HCPCSPSAS = "E1087" then medcut=888; 
if HCPCSPSAS = "E1088" then medcut=910; 
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if HCPCSPSAS = "E1089" then medcut=1175; 
if HCPCSPSAS = "E1090" then medcut=1139; 
if HCPCSPSAS = "E1092" then medcut=765; 
if HCPCSPSAS = "E1093" then medcut=752; 
if HCPCSPSAS = "E1100" then medcut=1281; 
if HCPCSPSAS = "E1110" then medcut=1419; 
if HCPCSPSAS = "E1130" then medcut=311; 
if HCPCSPSAS = "E1140" then medcut=340; 
if HCPCSPSAS = "E1150" then medcut=422; 
if HCPCSPSAS = "E1160" then medcut=332; 
if HCPCSPSAS = "E1171" then medcut=911; 
if HCPCSPSAS = "E1172" then medcut=703; 
if HCPCSPSAS = "E1180" then medcut=758; 
if HCPCSPSAS = "E1190" then medcut=475; 
if HCPCSPSAS = "E1195" then medcut=1253; 
if HCPCSPSAS = "E1200" then medcut=291; 
if HCPCSPSAS = "E1210" then medcut=7917; 
if HCPCSPSAS = "E1211" then medcut=7608; 
if HCPCSPSAS = "E1212" then medcut=8400; 
if HCPCSPSAS = "E1213" then medcut=7197; 
if HCPCSPSAS = "E1220" then medcut=2252; 
if HCPCSPSAS = "E1220" then medcut=2252; 
if HCPCSPSAS = "E1221" then medcut=1391; 
if HCPCSPSAS = "E1222" then medcut=1518; 
if HCPCSPSAS = "E1223" then medcut=363; 
if HCPCSPSAS = "E1224" then medcut=811; 
if HCPCSPSAS = "E1225" then medcut=2146; 
if HCPCSPSAS = "E1226" then medcut=994; 
if HCPCSPSAS = "E1227" then medcut=1890; 
if HCPCSPSAS = "E1228" then medcut=698; 
if HCPCSPSAS = "E1230" then medcut=3870; 
if HCPCSPSAS = "E1240" then medcut=823; 
if HCPCSPSAS = "E1250" then medcut=903; 
if HCPCSPSAS = "E1260" then medcut=488; 
if HCPCSPSAS = "E1270" then medcut=953; 
if HCPCSPSAS = "E1280" then medcut=1192; 
if HCPCSPSAS = "E1285" then medcut=1264; 
if HCPCSPSAS = "E1290" then medcut=1146; 
if HCPCSPSAS = "E1295" then medcut=1245; 
if HCPCSPSAS = "E1296" then medcut=842; 
if HCPCSPSAS = "E1297" then medcut=894; 
if HCPCSPSAS = "E1298" then medcut=1624; 
if HCPCSPSAS = "K0001" then medcut=327; 
if HCPCSPSAS = "K0002" then medcut=718; 
if HCPCSPSAS = "K0003" then medcut=713; 
if HCPCSPSAS = "K0004" then medcut=723; 
if HCPCSPSAS = "K0005" then medcut=2133; 
if HCPCSPSAS = "K0006" then medcut=900; 
if HCPCSPSAS = "K0007" then medcut=992; 
if HCPCSPSAS = "K0008" then medcut=1835; 
if HCPCSPSAS = "K0009" then medcut=1323; 
if HCPCSPSAS = "K0010" then medcut=5864; 
if HCPCSPSAS = "K0011" then medcut=7793; 
if HCPCSPSAS = "K0012" then medcut=3987; 
if HCPCSPSAS = "K0013" then medcut=9262; 
if HCPCSPSAS = "K0014" then medcut=9008; 
run; 
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data cut27; 
set cut26; 
dollarexceed=cost-medcut; 
run; 
data cut28; 
set cut27; 
if dollarexceed GT 0 then output; 
run; 
data disser.dollarexceed; 
set cut28; 
run; 
proc means data=cut28  sum n ; 
var dollarexceed;   
class visn; 
output OUT=dollarexceed_visn2  N=n sum=sumover; 
run; 
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APPENDIX  F 
SAS Code Chapter 3 Cost Study Hypothesis 2 Analyses 
 
/*post dissertation analysis for vendor 
use cleaned dataset from H4 - rid o, missing and low values 
then cleaned vendor names, 3 sales, and took too 100 vendors and top 20 
hecpcs codes 
then */ 
data cutoff2; 
set disser.cutoff2; 
/*if vendor="DENVER DISTRIBUTION CENTER" then output;*/ 
run; 
data H5data; 
set disser.h5data; 
run; 
/*need to find median values for each of the 100 vendors 
top 100 vendors are in H5vendor*/ 
data H5vendor;  /*110962 records*/ 
set disser.H5vendor; 
run;     
/*need a list of vendors for my excel spreadsheet*/ 
proc sort data=h5vendor; 
by vendor; 
run; 
data h5vendor_single; 
set h5vendor; 
if first.vendor then output h5vendor_single; 
by vendor; 
run;  /*export this to excel to get vendor names*/ 
/*get median for each of these vendors*/ 
data H5data;  
set disser.H5data;  
run; 
proc means data=H5data n median maxdec=0; 
var cost; 
class vendor; 
where HCPCSPSAS="K0012"; 
output out=vendor_median_k0012 n(cost)=ncost  median(cost)=mediancost; 
run; 
data hoveround; /*5 obs*/ 
set cutoff2; 
if vendor="HOVEROUND CORP" then output; 
run; 
/*now determine dollar amount over the cutoff by vendor 
7/28/2004 
Use dataset from h4 with same cutoffs 
disser.dollarexceed (cut28)*/ 
proc means data=cut29  sum n ; 
var dollarexceed;   
class vendor; 
output OUT=dollarexceed_vendor2  N=n sum=sumover; 
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run; 
proc means data=disser.chair_cost_both sum n ; /*total dollars spent*/ 
var cost;  
output OUT=cost  N=n sum=sumover; 
run; 
data disser.chair_cost_both; 
set disser.chair_cost00 disser.chair_cost01; 
run; 
proc means data=cut29  sum n ; 
var dollarexceed;   
class vendor; 
by hcpcspsas; 
output OUT=wally  N=n sum=sumover; 
run; 
PROC FREQ DATA=CUT29; 
tables hcpcspsas; 
where vendor ="INVACARE"; 
run; 
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APPENDIX G 
SAS Code Chapter 4 HRQoL Study Hypothesis 1 Analyses 
/*SF-36V analysis, Hypothesis 1*/ 
/*need SF numco 
rebuild dataset-*/ 
data nppdsf; 
set disser.nppd_sf_all; 
run; 
data pecos;  
set nppdsf;   /*delete scooters*/ 
if wctype = 8 then delete; 
else if wctype = 0 then delete; 
run; 
data pecos2;  
set pecos; 
if creatdate GT deldate then delete; 
run; 
data pecos3;  
set pecos2; 
if type = "INITIAL ISSUE" then output; 
run; 
data pecos4;  
set pecos3; 
numco_sf=sum(of anemia--stroke);      
run; 
data pecos5 (drop = austin_ssn anemia      cancer     oa        
cataract        hepatis       copd 
         chf         dm         divertis  eprostat        gallblad      
gout 
         hattack     hip        hbp       angina          bowelds       
irrheart 
         lbp         otherart   ulcer     pvd             rheumato      
seizures 
         skcancer    tia        thyroid   uti             prostats      
stroke); 
set pecos4; 
run; 
data pecos6;  
set pecos5; 
if DATES - 90 lT deldate then delete; 
/*have wc for 90 days then take SF36*/ 
run; 
data pecos7; 
set pecos6; 
group=0; 
run; 
data pecos8; 
set pecos7; 
if wctype=3 then group=1;/*THIS IS GROUP 1MA-ultralight*/ 
else if wctype=1 then group=2;/*THIS IS GROUP 1MN-depot*/ 
else if wctype=7 then group=3;/*THIS IS GROUP 2PA-cuspow*/ 
else if wctype=5 then group=4;/*THIS IS GROUP 2PN-stdpow*/ 
else group=0; 
 206
run; 
data disser.h7; 
set pecos8; 
run; 
data pecos8 ; 
set disser.h7 ; 
run; 
/*start analyses 
look at correlation of DV*/ 
proc corr data=pecos8; 
var rp re sf; 
run; 
/* Is sample distribution normal*/ 
proc univariate data=pecos8; 
var sf; 
run; 
/*Univariate Analyses*/ 
data manual; 
set pecos8; 
if group=1 then output; 
else if group=2 then output; 
run; 
data power; 
set pecos8; 
if group=3 then output; 
else if group=4 then output; 
run; 
proc freq data=power ; 
tables group*dxp/chisq ; 
run;   /*not enough res0urces to run an exact test*/ 
proc ttest data=power; 
class group;  
var rp re sf numco_sf dxp ; 
run; 
/*now tests*/ 
proc glm data=power; 
class group; 
model re sf = group ; 
run; 
/*let's run the difference between manual and power for RE and SF*/ 
data pecos9; 
set pecos8; 
if wctype=3 then manu=1; 
if wctype=1 then manu=1; 
if wctype=7 then manu=0; 
if wctype=5 then manu=0; 
run; 
proc ttest data=pecos9; 
class manu;  
var re sf; 
run; 
proc npar1way data=power wilcoxon median; 
class group; 
var rp re; 
run; 
/*now run for progressive only*/ 
data progressivepow; 
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set power; 
if dxp=2 then output; 
else if dxp=9 then output; 
else if dxp=10 then output; 
run; 
proc freq data=progressiveman ; 
tables group*dxp; 
run;  
proc glm data=progressiveman; 
class group; 
model rp re sf = group dxp numco; 
title"manual"; 
run;quit; 
proc npar1way data=progressivepow wilcoxon median; 
class group; 
var rp re; 
run; 
proc freq data=progressiveman ; 
tables group*dxp; 
run;   /*not enough res0urces to run an exact test*/ 
proc ttest data=progressiveman; 
class group;  
var rp re sf numco numco_sf; 
title ""; 
run; 
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APPENDIX H 
 
SAS Code Chapter 4 HRQoL Study Hypothesis 2 Analyses 
/*analysis for Hypothesis 2 or 8 in proposal*/ 
data irina;  
set disser.nppd_sf_all; 
run; 
data irina1;    
set irina; 
if wctype = 1 then output; 
else if wctype=3 then output; 
else if wctype = 5 then output;  
else if wctype= 7 then output; 
run; 
data irina2; 
set irina1; 
if deldate EQ DATES then delete; 
run; 
data disser.SF_WC  disser.WC_SF  QUE; 
set irina2; 
if deldate GT DATES then output disser.sf_wc; 
if DATES GT deldate then output disser.wc_sf; 
else output que; 
run; 
data wally; 
set disser.SF_WC; 
if creatdate GT deldate then delete; 
run; 
data wally1; 
set wally; 
numco_sf=sum(of anemia--stroke);      
run; 
data wally2 (drop = austin_ssn anemia      cancer     oa        
cataract        hepatis       copd 
         chf         dm         divertis  eprostat        gallblad      
gout 
         hattack     hip        hbp       angina          bowelds       
irrheart 
         lbp         otherart   ulcer     pvd             rheumato      
seizures 
         skcancer    tia        thyroid   uti             prostats      
stroke); 
set wally1; 
run; 
data wally3; 
set wally2; 
if wctype=3 then group=1;/*THIS IS GROUP 1-ultralight*/ 
else if wctype=1 then group=2;/*THIS IS GROUP 2-depot*/ 
else if wctype=7 then group=3;/*THIS IS GROUP 3-cuspow*/ 
else if wctype=5 then group=4;/*THIS IS GROUP 4-stdpow*/ 
else group=0; 
run; 
proc freq data=wally3; 
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tables group; 
run; 
data disser.h8; 
set wally3;  /*use this data set to add age in*/ 
run; 
data wally3; 
set disser.h8;  
run; 
data manual; 
set irina5; 
if group=1 then output; 
else if group=2 then output; 
run; 
data power; 
set irina5; 
if group=3 then output; 
else if group=4 then output; 
run; 
/*univariate analyses*/ 
proc ttest data=power; 
class group;  
var pf rp bp gh mh re sf vt pcs mcs numco_sf  ; 
run; 
proc freq data=power ; 
tables group*dxp/chisq ; 
run; 
proc corr data=manual; 
var pf rp bp gh mh re sf vt pcs mcs; 
run; 
proc corr data=power; 
var pf rp bp gh mh re sf vt pcs mcs; 
run; 
/*missing age  in this dataset*/ 
data age  (keep= patientid bd); 
set disser.demodoggie; 
run; 
proc sort data=age; 
by patientid; 
run; 
proc sort data=wally3; 
by patientid; 
run; 
data wally4; 
merge age (in=candles)  wally3 (in=chairs); 
by patientid; 
if chairs; 
run; 
data wally5; 
set wally4; 
age2=deldate-bd; 
run; 
data manual; 
set wally6; 
if group=1 then output; 
else if group=2 then output; 
run; 
data power; 
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set wally6; 
if group=3 then output; 
else if group=4 then output; 
run;  
/*age2 and dummy for service category is in is in now*/ 
data disser.manual; 
set manual; 
run; 
data disser.power; 
set power; 
run; 
proc ttest data=power; 
class group;  
var age2  ; 
run; 
proc freq data=manual; 
tables group*category/chisq expected cellchi2; 
/*exact pchi ;*/ 
run;   /*not enough res0urces to run an exact test*/ 
proc freq data=power; 
tables group*dxp/chisq expected cellchi2; 
/*exact pchi ;*/ 
run; 
/*now run test for H2-Logistic 
control for year*/ 
data wally6; 
set wally5; 
if category="NSC/IP" then cat=1;  
else if category="NSC/OP" then cat=2; 
else if category="SC/IP" then cat=3; 
else if category="SC/OP" then cat=4; 
run;/*see Kazis_revize.sas for dummy coding*/ 
data manual2;/*dummy code*/ 
set manual; 
if dxp=1 then als=1; else als=0; 
if dxp=2 then ms=1; else ms=0; 
if dxp=3 then scit=1; else scit=0; 
if dxp=4 then scip=1; else scip=0; 
if dxp=5 then stroke=1; else stroke=0; 
if dxp=7 then pd=1; else pd=0; 
if dxp=8 then ampu=1; else ampu=0; 
if dxp=9 then copd=1; else copd=0; 
if dxp=10 then arthri=1; else arthri=0; 
if dxp=6 then otherdx=0; /*add TBI to other*/ 
if dxp=11 then otherdx=0; /*reference*/ 
if prioadj1=1 then pg1=1; else pg1=0; 
if prioadj1=2 then pg2=1; else pg2=0; 
if prioadj1=3 then pg3=1; else pg3=0; 
if prioadj1=4 then pg4=1; else pg4=0; 
if prioadj1=5 then pg5=1; else pg5=0; 
if prioadj1=6 then pg6=1; else pg6=0; 
if prioadj1=7 then pg7=1; else pg7=0; 
if cat=1 then cat1=1; else cat1=0; 
if cat=2 then cat2=1; else cat2=0; 
if cat=3 then cat3=1; else cat3=0; 
if cat=4 then cat4=1; else cat4=0; 
run; 
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data manual3; 
set manual2; 
if race=1 then white=1; else white=0; 
if race=2 then black=1; else black=0; 
if race=3 then hisp=1; else hisp=0; 
if race=4 then indian=1; else indian=0; 
if race=6 then haw=1; else haw=0; 
if race=6 then as=1; else as=0; 
run; 
/*Model 3 adj*/proc logistic data=manual3 descending; 
 model  group = als ms scit scip stroke pd ampu copd arthri pg1 pg2 
pg3 pg4 pg5 pg6  
 cat1 cat2 cat3 numco_sf age2 male black hisp indian haw as year pcs 
mcs/RL lackfit RSQ ; 
 units age2=10 pcs=10 mcs=10/default=1; 
 run;quit; 
/*proc logistic data=manual3 descending; 
 class  prioadj1(param=ref ref='7') cat(param=ref ref='4') 
 dxp(param=ref ref='11') race(param=ref ref='1') ; 
 model group = dxp prioadj1 cat numco_sf age2 male year pcs mcs; 
 units age2=10 pcs=10/default=1; 
 run;quit;*/ 
/*Model 3 unadj*/proc logistic data=manual3 descending; 
 model  group = year pcs mcs /RL lackfit RSQ ; 
 units pcs=10 mcs=10/default=1; 
 run;quit; 
/*Model 2 adj*/proc logistic data=manual3 descending; 
 model  group = als ms scit scip stroke pd ampu copd arthri pg1 pg2 
pg3 pg4 pg5 pg6  
 cat1 cat2 cat3 numco_sf age2 male black hisp indian haw as year pf 
rp bp gh mh re sf vt/RL lackfit RSQ  ; 
 units age2=10 pf=10 rp=10 bp=10 gh=10 mh=10 re=10 sf=10 vt=10 
/default=1; 
 run;quit; 
/*proc logistic data=manual3 descending; 
 class  prioadj1(param=ref ref='7') cat(param=ref ref='4') 
 dxp(param=ref ref='11') race(param=ref ref='1') ; 
 model group = dxp prioadj1 cat numco_sf age2 male year pf rp bp gh 
mh re sf vt; 
 units age2=10 pf=10 rp=10 bp=10 gh=10 mh=10 re=10 sf=10 
vt=10/default=1; 
 run;quit;*/ 
/*Model 2 unadj*/ 
 proc logistic data=manual3 descending; 
 model  group = year pf rp bp gh mh re sf vt /RL lackfit RSQ ; 
 units pf=10 rp=10 bp=10 gh=10 mh=10 re=10 sf=10 vt=10 /default=1; 
 run;quit; 
 /*Model 1*/proc logistic data=manual3 descending; 
 model  group = als ms scit scip stroke pd ampu copd arthri  
  numco_sf year pf mh /RL lackfit RSQ; 
 units pf=10  mh=10 /default=1; 
 run;quit; 
/*proc logistic data=manual3 descending; 
 class dxp(param=ref ref='11'); 
 model group = dxp numco_sf  year pf mh ; 
 units pf=10  mh=10/default=1; 
 run;quit;*/ 
Filename: Hubbard_dissertation11_16_2004 
Directory: C:\Documents and Settings\spaethd\Desktop 
Template: C:\Documents and Settings\spaethd\Application 
Data\Microsoft\Templates\Normal.dot 
Title: ETD Template 
Subject:  
Author: hubbards 
Keywords:  
Comments:  
Creation Date: 11/16/2004 7:33:00 AM 
Change Number: 3 
Last Saved On: 11/16/2004 11:17:00 AM 
Last Saved By: DM Spaeth 
Total Editing Time: 5 Minutes 
Last Printed On: 11/16/2004 11:20:00 AM 
As of Last Complete Printing 
 Number of Pages: 220 
 Number of Words: 85,126 (approx.) 
 Number of Characters: 485,224 (approx.) 
 
